var title_f11_25_11664="Stocking donner PI";
var content_f11_25_11664=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PI%2F80635&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PI%2F80635&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Using a stocking donner to put on compression stockings",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 345px; height: 498px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f11_25_11664=[""].join("\n");
var outline_f11_25_11664=null;
var title_f11_25_11665="Bunny line botulinum toxin injection sites";
var content_f11_25_11665=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F67933&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F67933&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 522px\">",
"   <div class=\"ttl\">",
"    Example of botulinum toxin injection sites for \"bunny lines\"",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 502px; height: 326px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f11_25_11665=[""].join("\n");
var outline_f11_25_11665=null;
var title_f11_25_11666="Patient information: Painful periods (The Basics)";
var content_f11_25_11666=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div>",
"   &nbsp;",
"  </div>",
"  <div id=\"basicsTopicMinWidth\">",
"   <div id=\"basicsTopicRight\">",
"    <div id=\"placeholder\">",
"     <div id=\"basics-graphics\">",
"      <span class=\"basics-box-top\">",
"      </span>",
"      <h4>",
"       <img src=\"file://www.uptodate.com/images/basics-graphics-title.png\"/>",
"       <span class=\"openRelatedGraphics\" id=\"PI/15423\" rel=\"graphic_box\">",
"        <a href=\"#\" title=\"View All Related Graphics\">",
"         View All",
"        </a>",
"       </span>",
"      </h4>",
"      <ul>",
"       <li>",
"        <a class=\"graphic graphic_figure\" href=\"UTD.htm?14/52/15171\">",
"         Female reproductive anatomy",
"        </a>",
"       </li>",
"      </ul>",
"      <a href=\"#\" id=\"basics-seeall\">",
"       See All Graphics",
"      </a>",
"     </div>",
"     <script type=\"text/javascript\">",
"      if ($(\"#basics-graphics li\").length &lt;= 4) {",
"				$(\"#basics-seeall\").remove();",
"			} else {",
"				$(\"#basics-graphics li:gt(3)\").addClass(\"hidden\");",
"				$(\"#basics-seeall\").click(function(){",
"					$(\"#basics-graphics li.hidden\").removeClass(\"hidden\");",
"					$(this).remove();",
"					return false;",
"				});",
"			}",
"     </script>",
"     <div class=\"ieSpacer\">",
"     </div>",
"     <div id=\"basics-more\">",
"      <h4>",
"       <img src=\"file://www.uptodate.com/images/basics-more-title.png\"/>",
"      </h4>",
"      <dl>",
"       <dt class=\"basics\">",
"        The Basics",
"       </dt>",
"       <dd>",
"        <a href=\"UTD.htm?41/23/42353\">",
"         Patient information: Chronic pelvic pain in women (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?5/8/5251\">",
"         Patient information: Endometriosis (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?20/52/21314\">",
"         Patient information: Uterine fibroids (The Basics)",
"        </a>",
"       </dd>",
"       <dt class=\"beyondthebasics\">",
"        Beyond the Basics",
"       </dt>",
"       <dd>",
"        <a href=\"UTD.htm?31/55/32627\">",
"         Patient information: Chronic pelvic pain in women (Beyond the Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?25/63/26611\">",
"         Patient information: Endometriosis (Beyond the Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?20/20/20804\">",
"         Patient information: Uterine fibroids (Beyond the Basics)",
"        </a>",
"       </dd>",
"      </dl>",
"      <div id=\"tooltipper\">",
"      </div>",
"     </div>",
"    </div>",
"   </div>",
"   <div id=\"basicsTopicLeft\">",
"    <div id=\"topicTitle\">",
"     Patient information: Painful periods (The Basics)",
"    </div>",
"    <span class=\"view\">",
"     View in",
"     <a class=\"lang\" href=\"./es-419/painful-periods-the-basics?source=topic_page\">",
"      Spanish",
"     </a>",
"    </span>",
"    <a class=\"contributor contributor_credentials\" href=\"./authors-and-editors/patient-information\">",
"     Written by the doctors and editors at UpToDate",
"    </a>",
"    <div id=\"topicText\">",
"     <p class=\"headingAnchor\" id=\"H213736697\">",
"      <span class=\"h1\">",
"       Why are my periods so painful?",
"      </span>",
"      &nbsp;&mdash;&nbsp;During your period, your body makes chemicals called &ldquo;prostaglandins.&rdquo; These chemicals cause the uterus to contract or tighten. It&rsquo;s the same kind of contraction that happens during labor and childbirth. Contractions during a period are normal. But, they can be painful. The medical name for painful periods is &ldquo;dysmenorrhea.&rdquo;",
"     </p>",
"     <p>",
"      Some medical conditions can make the pain during your period worse. The most common one is called &ldquo;endometriosis.&rdquo; In this condition, tissues that should grow only in the uterus grow outside the uterus.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H213736704\">",
"      <span class=\"h1\">",
"       What do painful periods feel like?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Women with painful periods have cramping in the lower belly. The cramps may be mild or bad. You might also have pain in your back or thighs. Pain often starts with your period or right before your period.",
"     </p>",
"     <p>",
"      Some women also have:",
"     </p>",
"     <p>",
"      <ul class=\"bulletCompact-block\">",
"       <li>",
"        Nausea",
"       </li>",
"       <li>",
"        Diarrhea",
"       </li>",
"       <li>",
"        Extreme tiredness",
"       </li>",
"       <li>",
"        Headache",
"       </li>",
"       <li>",
"        Bloating (a feeling of fullness in the belly)",
"       </li>",
"      </ul>",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H213736711\">",
"      <span class=\"h1\">",
"       Is there anything I can do on my own to feel better?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Yes. You can:",
"     </p>",
"     <p>",
"      <ul class=\"bulletCompact-block\">",
"       <li>",
"        Take pain medicines such as",
"        <a class=\"drug drug_patient\" href=\"UTD.htm?14/17/14614?source=see_link\">",
"         ibuprofen",
"        </a>",
"        (sold as Motrin&reg; or Advil&reg;) and",
"        <a class=\"drug drug_patient\" href=\"UTD.htm?43/35/44597?source=see_link\">",
"         naproxen",
"        </a>",
"        (sold as Aleve&reg;). Start taking them as soon as symptoms of your period begin. Keep taking them for 2 or 3 days.",
"       </li>",
"       <li>",
"        Put a heating pad or hot water bottle on your lower belly",
"       </li>",
"       <li>",
"        Exercise on a regular basis",
"       </li>",
"      </ul>",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H213736718\">",
"      <span class=\"h1\">",
"       Should I see a doctor or nurse?",
"      </span>",
"      &nbsp;&mdash;&nbsp;See your doctor or nurse if:",
"     </p>",
"     <p>",
"      <ul class=\"bulletCompact-block\">",
"       <li>",
"        The pain is getting worse",
"       </li>",
"       <li>",
"        Pain medicine isn&rsquo;t helping",
"       </li>",
"       <li>",
"        You also have pain well before or well after your period",
"       </li>",
"      </ul>",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H213736725\">",
"      <span class=\"h1\">",
"       Are there tests I should have?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Your doctor or nurse will decide which tests you should have based on your age, other symptoms, and individual situation.",
"     </p>",
"     <p>",
"      Most women need only a physical exam. &nbsp;In the exam, your doctor will check the size and shape of your vagina, cervix, uterus, and ovaries (",
"      <a class=\"graphic graphic_figure graphicRef80271 \" href=\"UTD.htm?14/52/15171\">",
"       figure 1",
"      </a>",
"      ). If the exam isn&rsquo;t normal or pain medicine doesn&rsquo;t help, your doctor might do other tests. These include:",
"     </p>",
"     <p>",
"      <ul class=\"bullet-block\">",
"       <li>",
"        Pelvic ultrasound &ndash; This test uses sound waves to make a picture of your uterus, ovaries, and vagina to see if they look normal.",
"       </li>",
"       <li>",
"        Tests for infections that you catch during sex",
"       </li>",
"       <li>",
"        Laparoscopy &ndash; This is a type of surgery. The doctor will put you to sleep and make a small cut just below your belly button. Then, he or she will use a thin tool with a camera on it to see inside your belly.",
"       </li>",
"      </ul>",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H213736732\">",
"      <span class=\"h1\">",
"       How are painful periods treated?",
"      </span>",
"      &nbsp;&mdash;&nbsp;That depends on what is causing your painful periods. The most common treatments are:",
"     </p>",
"     <p>",
"      <ul class=\"bulletCompact-block\">",
"       <li>",
"        Pain medicines",
"       </li>",
"       <li>",
"        Birth control pills or other types of birth control that involve hormones",
"       </li>",
"      </ul>",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H213736739\">",
"      <span class=\"h1\">",
"       More on this topic",
"      </span>",
"     </p>",
"     <p>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?5/8/5251?source=see_link\">",
"       Patient information: Endometriosis (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?20/52/21314?source=see_link\">",
"       Patient information: Uterine fibroids (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?41/23/42353?source=see_link\">",
"       Patient information: Chronic pelvic pain in women (The Basics)",
"      </a>",
"     </p>",
"     <p>",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?25/63/26611?source=see_link\">",
"       Patient information: Endometriosis (Beyond the Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?20/20/20804?source=see_link\">",
"       Patient information: Uterine fibroids (Beyond the Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?31/55/32627?source=see_link\">",
"       Patient information: Chronic pelvic pain in women (Beyond the Basics)",
"      </a>",
"     </p>",
"    </div>",
"    <div id=\"reviewProcess\">",
"     <span>",
"      All topics are updated as new evidence becomes available and our",
"      <a class=\"policy policy_editorialpolicy\" href=\"/home/editorial-policy\">",
"       peer review process",
"      </a>",
"      is complete.",
"     </span>",
"    </div>",
"    <div id=\"topicRetrievedDate\">",
"     <span class=\"emphasis\">",
"      This topic retrieved from UpToDate on:",
"     </span>",
"     Apr 20, 2013.",
"    </div>",
"    <div class=\"patTopicTool\" id=\"patTopicToolBottom\">",
"     <a class=\"toolbutton findicon findInPageLink\" href=\"#\" title=\"Find in Topic\">",
"      Find",
"     </a>",
"     <a class=\"toolbutton printicon\" href=\"UTD.htm?11/25/11666?view=print\" title=\"Print This Topic\">",
"      Print",
"     </a>",
"     <a class=\"toolbutton emailicon etacLink\" href=\"#\" title=\"Email This Topic\">",
"      Email",
"     </a>",
"    </div>",
"    <div id=\"disclaimer\">",
"     The content on the UpToDate website is not intended nor recommended as a substitute for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or other qualified health care professional regarding any medical questions or conditions.",
"The use of UpToDate content is governed by the",
"     <a class=\"legal legal_termsofuse\" href=\"/home/terms-use\" target=\"_blank\">",
"      UpToDate Terms of Use",
"     </a>",
"     . &copy;2013 UpToDate, Inc. All rights reserved.",
"    </div>",
"    <div id=\"topicVersionRevision\">",
"     Topic 15423 Version 1.0",
"    </div>",
"   </div>",
"   <!--  basicsTopicLeft -->",
"  </div>",
"  <!-- basicsTopicMinWidth -->",
" </div>",
" <!-- topicContent -->",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0603-218.28.111.102-5CC63B1F68-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f11_25_11666=[""].join("\n");
var outline_f11_25_11666=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H213736697\">",
"      Why are my periods so painful?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H213736704\">",
"      What do painful periods feel like?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H213736711\">",
"      Is there anything I can do on my own to feel better?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H213736718\">",
"      Should I see a doctor or nurse?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H213736725\">",
"      Are there tests I should have?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H213736732\">",
"      How are painful periods treated?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H213736739\">",
"      More on this topic",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"PI/15423\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li>",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?14/52/15171\">",
"      Female reproductive anatomy",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?31/55/32627?source=related_link\">",
"      Patient information: Chronic pelvic pain in women (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?41/23/42353?source=related_link\">",
"      Patient information: Chronic pelvic pain in women (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?25/63/26611?source=related_link\">",
"      Patient information: Endometriosis (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?5/8/5251?source=related_link\">",
"      Patient information: Endometriosis (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?20/20/20804?source=related_link\">",
"      Patient information: Uterine fibroids (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?20/52/21314?source=related_link\">",
"      Patient information: Uterine fibroids (The Basics)",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f11_25_11667="Scalp folliculitis";
var content_f11_25_11667=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F62916&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F62916&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Scalp folliculitis",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 389px; height: 260px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Pustules are evident on the scalp.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Beth G Goldstein, MD, and Adam O Goldstein, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f11_25_11667=[""].join("\n");
var outline_f11_25_11667=null;
var title_f11_25_11668="Pulmonary manifestations of ascariasis";
var content_f11_25_11668=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Pulmonary manifestations of ascariasis",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?11/25/11668/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?11/25/11668/contributors\">",
"     Peter F Weller, MD, FACP",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?11/25/11668/contributors\">",
"     Karin Leder, MBBS, FRACP, PhD, MPH, DTMH",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?11/25/11668/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?11/25/11668/contributors\">",
"     Peter F Weller, MD, FACP",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?11/25/11668/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?11/25/11668/contributors\">",
"     Elinor L Baron, MD, DTMH",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?11/25/11668/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Sep 28, 2011.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Ascaris lumbricoides is an intestinal nematode (roundworm); it is one of the most common helminthic human infections worldwide [",
"    <a class=\"abstract\" href=\"UTD.htm?11/25/11668/abstract/1\">",
"     1",
"    </a>",
"    ]. Issues related to pulmonary infection are reviewed here. The epidemiology, clinical manifestations, and diagnosis of ascariasis are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?16/8/16520?source=see_link\">",
"     \"Ascariasis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17357396\">",
"    <span class=\"h1\">",
"     LIFE CYCLE",
"    </span>",
"    &nbsp;&mdash;&nbsp;The life cycle of ascariasis is summarized separately (",
"    <a class=\"graphic graphic_figure graphicRef79015 \" href=\"UTD.htm?14/45/15064\">",
"     figure 1",
"    </a>",
"    ). In general, within four days following oral ingestion of eggs, they hatch in the small intestine and release larvae which migrate hematogenously to the lungs. Within the alveoli of the lungs, the larvae mature over a period of approximately 10 days, then ascend the bronchial tree and are swallowed.",
"   </p>",
"   <p>",
"    Respiratory manifestations occur primarily in the first stage of infection; they rarely complicate the intestinal phase.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     CLINICAL MANIFESTATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The syndrome of eosinophilic pneumonitis among patients originally described by Loeffler was attributed to Ascaris infection retrospectively; ascariasis remains the most common cause of Loeffler's syndrome worldwide [",
"    <a class=\"abstract\" href=\"UTD.htm?11/25/11668/abstract/2,3\">",
"     2,3",
"    </a>",
"    ]. Transient respiratory symptoms can occur during migration of Ascaris larvae through the lungs; this occurs one to two weeks following ingestion of eggs. The severity of symptoms correlates to some degree with larval burden, although pulmonary symptoms are less common in regions with continuous transmission of A. lumbricoides [",
"    <a class=\"abstract\" href=\"UTD.htm?11/25/11668/abstract/4-8\">",
"     4-8",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Symptoms include dry cough and burning substernal discomfort. Some patients experience dyspnea and blood-tinged sputum. Urticaria occurs in about 15 percent of cases [",
"    <a class=\"abstract\" href=\"UTD.htm?11/25/11668/abstract/9\">",
"     9",
"    </a>",
"    ]. Fever occurs in many patients though rarely exceeds 38.3&ordm;C (101&ordm;F). Over half of patients have crackles and wheezing, in the absence of consolidation. Hepatomegaly may develop. Lymphadenopathy is generally not observed. Symptoms generally subside within 5 to 10 days. Ascaris pneumonia is self-limited and only very rarely fatal.",
"   </p>",
"   <p>",
"    Among children living in a high endemic area of South Africa, Ascaris infection has been associated with a slightly higher total IgE serum level, a decreased likelihood of a positive response to a panel of allergy skin tests, and an increased likelihood of exercise-induced bronchoconstriction [",
"    <a class=\"abstract\" href=\"UTD.htm?11/25/11668/abstract/10\">",
"     10",
"    </a>",
"    ]. It is possible that the exercise-induced bronchoconstriction in these children reflects non-atopic airway inflammation associated with the migration of Ascaris larvae through the lungs, rather than the atopic inflammation usually associated with asthma. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?1/30/1513?source=see_link\">",
"     \"Exercise-induced bronchoconstriction\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Chest x-ray",
"    </span>",
"    &nbsp;&mdash;&nbsp;Chest radiography may demonstrate round or oval infiltrates ranging in size from several millimeters to several centimeters in both lung fields. These lesions are more likely to be present when blood eosinophilia exceeds 10 percent. The infiltrates are migratory and may become confluent in perihilar areas; they usually clear completely after several weeks [",
"    <a class=\"abstract\" href=\"UTD.htm?11/25/11668/abstract/6,7,11\">",
"     6,7,11",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Laboratory tests",
"    </span>",
"    &nbsp;&mdash;&nbsp;Eosinophilia is the most common laboratory finding. It may be absent in the early symptomatic period, but increases in magnitude after several days of symptoms and resolves over many weeks [",
"    <a class=\"abstract\" href=\"UTD.htm?11/25/11668/abstract/7\">",
"     7",
"    </a>",
"    ]. Serum IgE levels and antibody titers to Ascaris are elevated [",
"    <a class=\"abstract\" href=\"UTD.htm?11/25/11668/abstract/6\">",
"     6",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Sputum analysis may demonstrate eosinophils and Charcot-Leyden crystals, which are composed of an eosinophil-derived enzyme, lysophospholipase (",
"    <a class=\"graphic graphic_picture graphicRef71997 \" href=\"UTD.htm?9/22/9583\">",
"     picture 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?11/25/11668/abstract/12\">",
"     12",
"    </a>",
"    ]. These crystals are also observed in other eosinophilic parasitic lung infections.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17357500\">",
"    <span class=\"h1\">",
"     PATHOPHYSIOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Ascaris pneumonia is generally a benign condition, and pathologic studies of human infections are limited [",
"    <a class=\"abstract\" href=\"UTD.htm?11/25/11668/abstract/13,14\">",
"     13,14",
"    </a>",
"    ]. Some studies have documented focal areas of fibrinous and eosinophilic exudative bronchopneumonia [",
"    <a class=\"abstract\" href=\"UTD.htm?11/25/11668/abstract/8,13,14\">",
"     8,13,14",
"    </a>",
"    ]. The eosinophilic cellular infiltrate probably accounts for the reduction in vital capacity that may be observed; this is generally self-limited [",
"    <a class=\"abstract\" href=\"UTD.htm?11/25/11668/abstract/8\">",
"     8",
"    </a>",
"    ]. Other patients experience primarily obstructive alterations in pulmonary function [",
"    <a class=\"abstract\" href=\"UTD.htm?11/25/11668/abstract/6\">",
"     6",
"    </a>",
"    ]. This finding is consistent with the experimental induction of asthmatiform airway hyperreactivity by infection of animals with Ascaris [",
"    <a class=\"abstract\" href=\"UTD.htm?11/25/11668/abstract/15\">",
"     15",
"    </a>",
"    ] or airway challenge of sensitized animals with Ascaris antigen [",
"    <a class=\"abstract\" href=\"UTD.htm?11/25/11668/abstract/16\">",
"     16",
"    </a>",
"    ]. Very rarely, adult worms can cause bronchopneumonia due to vomiting and aspiration or migration up the esophagus into the trachea [",
"    <a class=\"abstract\" href=\"UTD.htm?11/25/11668/abstract/17\">",
"     17",
"    </a>",
"    ]",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h1\">",
"     DIAGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Definitive diagnosis of ascariasis at the time of pulmonary symptoms requires detection of Ascaris larvae in respiratory secretions or gastric aspirates [",
"    <a class=\"abstract\" href=\"UTD.htm?11/25/11668/abstract/8,17\">",
"     8,17",
"    </a>",
"    ]. Eggs are not detectable in stool until at least 40 days following pulmonary symptoms; this is the time required for maturation of the intrapulmonary larvae (",
"    <a class=\"graphic graphic_picture graphicRef76433 \" href=\"UTD.htm?38/30/39392\">",
"     picture 2",
"    </a>",
"    ). Therefore, negative stool examinations at the time of pneumonitis do not exclude Ascaris as an etiology for pneumonia. Similarly, positive stool examinations for Ascaris eggs at the time of pneumonitis do not establish the etiology, since these eggs reflect infection acquired 2 to 12 months earlier. On the other hand, negative stool examinations at the time of pneumonitis followed by positive stool examinations two to three months later would support a diagnosis of ascariasis as the etiologic agent of the pneumonitis.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h1\">",
"     TREATMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;Specific therapy for Ascaris pneumonia usually is not necessary. Symptomatic alleviation of wheeze and cough can be managed with inhaled bronchodilators. In the setting of severe pneumonia, systemic corticosteroids may be administered; this also results in reduction of eosinophilia [",
"    <a class=\"abstract\" href=\"UTD.htm?11/25/11668/abstract/8\">",
"     8",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    After the worms have developed to maturity in the small intestine, anthelminthic therapy for intestinal ascariasis should be administered [",
"    <a class=\"abstract\" href=\"UTD.htm?11/25/11668/abstract/18\">",
"     18",
"    </a>",
"    ]. In general anthelminthic therapy should not be administered at the time of pulmonary symptoms because inflammation associated with dying organisms may cause more harm than migration.",
"   </p>",
"   <p>",
"    The approach to anthelminthic therapy is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?16/8/16520?source=see_link&amp;anchor=H15#H15\">",
"     \"Ascariasis\", section on 'Treatment'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3293595\">",
"    <span class=\"h1\">",
"     SUMMARY",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Ascaris lumbricoides is an intestinal nematode (roundworm); it is estimated that more than one billion people are infected with A. lumbricoides worldwide. The prevalence of infection is highest in tropical countries where warm, wet climates favor year-round transmission of infection. The prevalence is high in areas where suboptimal sanitation practices lead to increased contamination of soil and water. (See",
"      <a class=\"local\" href=\"#H1\">",
"       'Introduction'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Within four days following oral ingestion of eggs (via contaminated food or water), the eggs hatch in the small intestine and release larvae which migrate hematogenously to the lungs (",
"      <a class=\"graphic graphic_figure graphicRef79015 \" href=\"UTD.htm?14/45/15064\">",
"       figure 1",
"      </a>",
"      ). Within the alveoli of the lungs, the larvae mature over a period of approximately 10 days, then ascend the bronchial tree and are swallowed. (See",
"      <a class=\"local\" href=\"#H17357396\">",
"       'Life cycle'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Transient respiratory symptoms can occur during migration of Ascaris larvae through the lungs, approximately one to two weeks following ingestion of eggs. This eosinophilic pneumonitis is known as Loeffler&rsquo;s syndrome. Symptoms include dry cough and burning, substernal discomfort. Some patients experience dyspnea and blood-tinged sputum. Fever occurs in many patients. Over half of patients have crackles and wheezing, in the absence of focal consolidation. Urticaria occurs during the first 5 days of the illness in a small number of cases. Symptoms generally subside within 5 to 10 days. (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Clinical manifestations'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Chest radiography may demonstrate round or oval infiltrates ranging in size from several millimeters to several centimeters in both lung fields. The infiltrates are migratory and may become confluent in perihilar areas; they usually clear completely after several weeks. Eosinophilia may be absent in the early symptomatic period, but can increase in magnitude after several days of symptoms, and resolves over many weeks. Sputum analysis may demonstrate eosinophils and Charcot-Leyden crystals (",
"      <a class=\"graphic graphic_picture graphicRef71997 \" href=\"UTD.htm?9/22/9583\">",
"       picture 1",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Clinical manifestations'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Definitive diagnosis of ascariasis at the time of pulmonary symptoms requires detection of Ascaris larvae in respiratory secretions or gastric aspirates. Eggs are not detectable in stool until at least 40 days following pulmonary symptoms; this is the time required for maturation of the intrapulmonary larvae. Therefore, negative stool examinations at the time of pneumonitis do not exclude Ascaris as an etiology for pneumonia. (See",
"      <a class=\"local\" href=\"#H7\">",
"       'Diagnosis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Specific therapy for Ascaris pneumonia usually is not necessary. Symptomatic alleviation of wheeze and cough can be managed with inhaled bronchodilators. In the setting of severe pneumonia, systemic corticosteroids may be administered; this also results in reduction of eosinophilia. After the worms have developed to maturity in the small intestine, anthelminthic therapy for intestinal ascariasis should be administered. In general, anthelminthic therapy should not be administered at the time of pulmonary symptoms because inflammation associated with dying organisms may cause more harm than migration. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?16/8/16520?source=see_link&amp;anchor=H15#H15\">",
"       \"Ascariasis\", section on 'Treatment'",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/25/11668/abstract/1\">",
"      Khuroo MS. Ascariasis. Gastroenterol Clin North Am 1996; 25:553.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/25/11668/abstract/2\">",
"      LOFFLER W. Transient lung infiltrations with blood eosinophilia. Int Arch Allergy Appl Immunol 1956; 8:54.",
"     </a>",
"    </li>",
"    <li>",
"     Udwadia FE. Leoffler's syndrome. In: Progress in Respiration Research: Pulmonary Eosinophilia, John Wiley &amp; Sons, New York 1975. p.19.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/25/11668/abstract/4\">",
"      Koino, S. Experimental infections on human body with ascarides. Jpn Med World 1922; 2:317.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/25/11668/abstract/5\">",
"      TAKATA I. Experimental infection of man with Ascaris of man and the pig. Kitasato Arch Exp Med 1951; 23:151.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/25/11668/abstract/6\">",
"      Phills JA, Harrold AJ, Whiteman GV, Perelmutter L. Pulmonary infiltrates, asthma and eosinophilia due to Ascaris suum infestation in man. N Engl J Med 1972; 286:965.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/25/11668/abstract/7\">",
"      Gelpi AP, Mustafa A. Seasonal pneumonitis with eosinophilia. A study of larval ascariasis in Saudi Arabs. Am J Trop Med Hyg 1967; 16:646.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/25/11668/abstract/8\">",
"      Gelpi AP, Mustafa A. Ascaris pneumonia. Am J Med 1968; 44:377.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/25/11668/abstract/9\">",
"      Barrett-Connor E. Human intestinal nematodiasis in the United States. Calif Med 1972; 117:8.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/25/11668/abstract/10\">",
"      Calvert J, Burney P. Ascaris, atopy, and exercise-induced bronchoconstriction in rural and urban South African children. J Allergy Clin Immunol 2010; 125:100.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/25/11668/abstract/11\">",
"      Bean, WJ. Recognition of ascariasis by routine chest or abdomen roentgenograms. Am J Roentgenol Rad Ther Nucl Med 1965; 94:379.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/25/11668/abstract/12\">",
"      Weller PF, Bach DS, Austen KF. Biochemical characterization of human eosinophil Charcot-Leyden crystal protein (lysophospholipase). J Biol Chem 1984; 259:15100.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/25/11668/abstract/13\">",
"      Piggott J, Hansbarger EA Jr, Neafie RC. Human ascariasis. Am J Clin Pathol 1970; 53:223.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/25/11668/abstract/14\">",
"      BEAVER PC, DANARAJ TJ. Pulmonary ascariasis resembling eosinophilic lung; autopsy report with description of larvae in the bronchioles. Am J Trop Med Hyg 1958; 7:100.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/25/11668/abstract/15\">",
"      Booth BH, Patterson R, Talbot CH. Immediate-type hypersensitivity in dogs: cutaneous, anaphylactic, and respiratory responses to ascaris. J Lab Clin Med 1970; 76:181.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/25/11668/abstract/16\">",
"      Gundel RH, Gerritsen ME, Gleich GJ, Wegner CD. Repeated antigen inhalation results in a prolonged airway eosinophilia and airway hyperresponsiveness in primates. J Appl Physiol 1990; 68:779.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/25/11668/abstract/17\">",
"      PROFFITT RD, WALTON BC. Ascaris pneumonia in a two-year-old girl. Diagnosis by gastric aspirate. N Engl J Med 1962; 266:931.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/25/11668/abstract/18\">",
"      Warren KS, Mahmoud AA. Algorithms in the diagnosis and management of exotic diseases. xxii. ascariasis and toxocariasis. J Infect Dis 1977; 135:868.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 5713 Version 4.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0605-200.61.31.66-5C29EC338D-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f11_25_11668=[""].join("\n");
var outline_f11_25_11668=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H3293595\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H17357396\">",
"      LIFE CYCLE",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      CLINICAL MANIFESTATIONS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Chest x-ray",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Laboratory tests",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H17357500\">",
"      PATHOPHYSIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      TREATMENT",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3293595\">",
"      SUMMARY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"ID/5713\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ID/5713|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?14/45/15064\" title=\"figure 1\">",
"      Ascaris lumbricoides life cycle",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ID/5713|PIC\">",
"      <a href=\"#\" title=\"PICTURES\">",
"       PICTURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?9/22/9583\" title=\"picture 1\">",
"      Charcot Leyden crystals",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?38/30/39392\" title=\"picture 2\">",
"      Ascaris ovum in stool",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?16/8/16520?source=related_link\">",
"      Ascariasis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?1/30/1513?source=related_link\">",
"      Exercise-induced bronchoconstriction",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f11_25_11669="Herpes zoster vesicles";
var content_f11_25_11669=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ID%2F58282&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ID%2F58282&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Herpes zoster",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 324px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Grouped vesicles and underlying erythema are present in a dermatomal distribution.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: www.visualdx.com. Copyright Logical Images, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f11_25_11669=[""].join("\n");
var outline_f11_25_11669=null;
var title_f11_25_11670="Evaluation of the HIV-infected patient with anorectal symptoms";
var content_f11_25_11670=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Evaluation of the HIV-infected patient with anorectal symptoms",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?11/25/11670/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?11/25/11670/contributors\">",
"     C Mel Wilcox, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?11/25/11670/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?11/25/11670/contributors\">",
"     John G Bartlett, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?11/25/11670/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?11/25/11670/contributors\">",
"     Anna R Thorner, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?11/25/11670/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Sep 21, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Anorectal symptoms in the HIV-infected patient may reflect significant pathology and accurate diagnosis is essential to direct patient management.",
"   </p>",
"   <p>",
"    The general approach to the evaluation and management of the HIV-infected patient with anorectal symptoms will be discussed here. The treatment of the various disease entities is discussed elsewhere (see appropriate topic reviews).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     ETIOLOGY OF ANORECTAL SYMPTOMS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Anorectal disorders are associated with significant morbidity and have been commonly described among HIV-infected patients, particularly men who have sex with men (MSM) [",
"    <a class=\"abstract\" href=\"UTD.htm?11/25/11670/abstract/1-5\">",
"     1-5",
"    </a>",
"    ]. Common findings in this population include perirectal abscesses, anal fistulae, nonspecific ulcerations, infectious proctitis, anal warts, anal intraepithelial neoplasia, and anal cancer [",
"    <a class=\"abstract\" href=\"UTD.htm?11/25/11670/abstract/6-9\">",
"     6-9",
"    </a>",
"    ]. Less common noninfectious etiologies include ulcerative colitis or Crohn's disease.",
"   </p>",
"   <p>",
"    Anorectal carcinomas are more common in MSM than in the general population, and the risk increases dramatically among those who are HIV-infected. In a population-based survey that examined cancer rates among AIDS patients from 1980 to 2006, the incidence of AIDS-related cancers (eg, Kaposi&rsquo;s sarcoma) declined sharply while the incidence of some non-AIDS defining cancer, such as anal cancer, increased [",
"    <a class=\"abstract\" href=\"UTD.htm?11/25/11670/abstract/10\">",
"     10",
"    </a>",
"    ]. Furthermore, among persons with anal cancer, those with concomitant HIV infection were significantly younger at the time of diagnosis than those without HIV infection [",
"    <a class=\"abstract\" href=\"UTD.htm?11/25/11670/abstract/11\">",
"     11",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Risk factors for abnormal anal cytology in a study of 621 HIV-infected men and women included multiple human papillomavirus (HPV) types, immunosuppression (CD4 cell count &lt;50",
"    <span class=\"nowrap\">",
"     cells/mm",
"     <sup>",
"      3",
"     </sup>",
"     )",
"    </span>",
"    and history of anal intercourse [",
"    <a class=\"abstract\" href=\"UTD.htm?11/25/11670/abstract/12\">",
"     12",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?29/31/30202?source=see_link\">",
"     \"HIV infection and malignancy: Management considerations\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Given the prevalence of anorectal neoplasia [",
"    <a class=\"abstract\" href=\"UTD.htm?11/25/11670/abstract/13\">",
"     13",
"    </a>",
"    ], there has been adaptation of the cervical Pap smear for early detection of anal neoplasia. Although abnormal anal cytology is highly predictive of anal dysplasia [",
"    <a class=\"abstract\" href=\"UTD.htm?11/25/11670/abstract/14\">",
"     14",
"    </a>",
"    ], there are no outcome studies documenting a reduction in mortality, and the cost effectiveness of such a strategy has not been well documented. This topic is discussed elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?1/33/1562?source=see_link\">",
"     \"Anal intraepithelial neoplasia: Diagnosis, screening, prevention, and treatment\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    <a class=\"drug drug_general\" href=\"UTD.htm?42/35/43574?source=see_link\">",
"     Human papillomavirus vaccine",
"    </a>",
"    is effective in preventing cervical cancer in women and anal intraepithelial neoplasia in men. Preliminary data demonstrate that HPV vaccine is highly immunogenic in HIV-infected men, with seroconversion rates ranging from 95 to 100 percent among the four HPV types the vaccine protects against (HPV-6, 11, 16, and 18) [",
"    <a class=\"abstract\" href=\"UTD.htm?11/25/11670/abstract/15\">",
"     15",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?19/17/19738?source=see_link&amp;anchor=H5968486#H5968486\">",
"     \"Recommendations for the use of human papillomavirus vaccines\", section on 'Immunosuppressed or immunocompromised hosts'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     PATHOGENS TO CONSIDER",
"    </span>",
"    &nbsp;&mdash;&nbsp;Men who have sex with men (MSM) have increased rates of HIV and sexually transmitted infections (STIs) compared with demographically matched controls [",
"    <a class=\"abstract\" href=\"UTD.htm?11/25/11670/abstract/16\">",
"     16",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Sexually transmitted infections among HIV-infected MSM include gonorrhea, chlamydia, herpes simplex virus (HSV), and syphilis. In a prospective observational study of 557 HIV-infected men and women living in four United States cities, 13 percent had a prevalent STI and 7 percent acquired another STI within the next six months of follow-up [",
"    <a class=\"abstract\" href=\"UTD.htm?11/25/11670/abstract/17\">",
"     17",
"    </a>",
"    ]. Among HIV-infected MSM, the most frequent infection was rectal gonorrhea. This trend is concerning in light of the increasing rates of highly drug-resistant gonococcal infections [",
"    <a class=\"abstract\" href=\"UTD.htm?11/25/11670/abstract/18\">",
"     18",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?19/3/19514?source=see_link\">",
"     \"Treatment of uncomplicated gonococcal infections\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Symptomatic proctitis is more common among patients with gonococcal infection compared with those with Chlamydia trachomatis [",
"    <a class=\"abstract\" href=\"UTD.htm?11/25/11670/abstract/19\">",
"     19",
"    </a>",
"    ]. In contrast, lymphogranuloma venereum (LGV), which is caused by C. trachomatis serovars L1, L2, and L3, can cause more extensive infection. LGV is endemic in Africa, the Indian subcontinent, Southeast Asia, and parts of central and South America, although outbreaks of LGV proctitis have been reported in the Netherlands and the United States [",
"    <a class=\"abstract\" href=\"UTD.htm?11/25/11670/abstract/20\">",
"     20",
"    </a>",
"    ]. Patients with LGV may be misdiagnosed as having inflammatory bowel disease. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?20/36/21063?source=see_link\">",
"     \"Lymphogranuloma venereum\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?18/18/18728?source=see_link\">",
"     \"Genital Chlamydia trachomatis infections in men\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?9/10/9386?source=see_link\">",
"     \"Epidemiology, clinical manifestations, and diagnosis of genital herpes simplex virus infection\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?25/35/26166?source=see_link\">",
"     \"Diagnosis of gonococcal infections\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Proctitis may be caused by bacterial pathogens (eg, Neisseria gonorrhea, Chlamydia trachomatis, Shigella, Escherichia coli, and Clostridium difficile); protozoal causes (eg, Entamoeba histolytica); and viral pathogens (eg, herpes simplex virus and cytomegalovirus) [",
"    <a class=\"abstract\" href=\"UTD.htm?11/25/11670/abstract/1\">",
"     1",
"    </a>",
"    ]. It is important to distinguish infectious causes from inflammatory bowel disease [",
"    <a class=\"abstract\" href=\"UTD.htm?11/25/11670/abstract/1\">",
"     1",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?23/44/24265?source=see_link\">",
"     \"Differential diagnosis of microbial foodborne disease\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?21/62/22504?source=see_link\">",
"     \"AIDS-related cytomegalovirus gastrointestinal disease\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?28/39/29305?source=see_link\">",
"     \"Clostridium difficile in adults: Clinical manifestations and diagnosis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?32/56/33671?source=see_link\">",
"     \"Intestinal Entamoeba histolytica amebiasis\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Concomitant HIV and syphilis infections are prevalent among MSM, injection drug users (IDU), and individuals engaging in sex in exchange for drugs or money. One long-term study conducted among US military personnel found that 5.8 percent of 4239 patients with newly diagnosed HIV infection also had serologic evidence of syphilis infection [",
"    <a class=\"abstract\" href=\"UTD.htm?11/25/11670/abstract/21\">",
"     21",
"    </a>",
"    ]. A superficial chancre of primary syphilis or a mucous patch of secondary syphilis (eg, condyloma lata) may be seen perirectally, but are usually painless unless superinfected. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?3/49/3865?source=see_link\">",
"     \"Epidemiology, clinical presentation, and diagnosis of syphilis in the HIV-infected patient\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Finally, several outbreaks of hepatitis C have been reported among HIV-infected MSM worldwide; the most important risk factor for acquisition is a history of rectal trauma [",
"    <a class=\"abstract\" href=\"UTD.htm?11/25/11670/abstract/22-24\">",
"     22-24",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?0/30/490?source=see_link\">",
"     \"Screening for sexually transmitted infections\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Routine screening for STIs is recommended for all HIV-infected patients, including asymptomatic patients. However, one study of STI screening procedures in eight large HIV clinics found that screening rates are low, particularly at rectal and pharyngeal sites [",
"    <a class=\"abstract\" href=\"UTD.htm?11/25/11670/abstract/25\">",
"     25",
"    </a>",
"    ]. The approach to STI screening is discussed elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?0/30/490?source=see_link\">",
"     \"Screening for sexually transmitted infections\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h1\">",
"     HISTORY AND PHYSICAL EXAMINATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Generally speaking, infectious proctitis, fistulae, ulcerations, and perirectal abscesses are usually associated with pain on defecation. Patients with infectious proctitis may also complain of anal itching, rectal discharge, rectal bleeding, and rectal fullness [",
"    <a class=\"abstract\" href=\"UTD.htm?11/25/11670/abstract/1,26\">",
"     1,26",
"    </a>",
"    ]. The following are diagnostic clues to particular pathogens or concerns regarding malignancy:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Painful purulent discharge and absence of systemic symptoms would suggest the possibility of gonorrhoeae, herpes simplex, or Chlamydia trachomatis.",
"     </li>",
"     <li>",
"      Herpes simplex infection involving the distal rectum can present with tenesmus, occasional bleeding, and, less commonly, with associated bladder or bowel dysfunction, such as the inability to urinate.",
"     </li>",
"     <li>",
"      Rectal bleeding is the most common initial symptom of anal cancer, occurring in about 45 percent of patients. Anorectal pain or the sensation of a rectal mass is present in 30 percent, while 20 percent have no tumor-related symptoms [",
"      <a class=\"abstract\" href=\"UTD.htm?11/25/11670/abstract/27-29\">",
"       27-29",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The physical examination should include careful inspection of the skin and mucous membranes as well as palpation of the lymph nodes, which may be enlarged with herpes simplex virus and syphilis infections. Visual inspection of the anus for fissures, condylomata, perianal warts, and masses should precede digital examination:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The presence of severe pain on rectal examination strongly suggests ulcerative disease, hemorrhoids, or a neoplasm. Palpation of the anal canal may reveal masses or fissures not otherwise evident.",
"     </li>",
"     <li>",
"      Although lymphogranuloma venereum (LGV) genital disease usually presents with lymphadenopathy, LGV may lead to proctitis without any associated lymph node enlargement [",
"      <a class=\"abstract\" href=\"UTD.htm?11/25/11670/abstract/30\">",
"       30",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Weight loss, fever, fatigue, tenesmus and night sweats all raise the possibility of a neoplasm or an opportunistic infection in a patient with anorectal symptoms.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Anal pruritis has been described in association with the use of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?20/6/20585?source=see_link\">",
"     telaprevir",
"    </a>",
"    , a hepatitis C virus protease inhibitor. The pathogenesis of this drug-induced anal pruritis is poorly understood, but resolves with discontinuation of telaprevir. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?23/47/24314?source=see_link&amp;anchor=H148836537#H148836537\">",
"     \"Treatment regimens for chronic hepatitis C virus genotype 1\", section on 'Telaprevir'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?17/38/18026?source=see_link\">",
"     \"Treatment of hepatitis C virus infection in the HIV-infected patient\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    HIV-infected women with suspected or documented anal pathology should also have a gynecologic examination, including screening for cervical cancer. More detailed information on the history and examination of patients with these suspected etiologies is discussed elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?18/18/18728?source=see_link\">",
"     \"Genital Chlamydia trachomatis infections in men\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?9/10/9386?source=see_link\">",
"     \"Epidemiology, clinical manifestations, and diagnosis of genital herpes simplex virus infection\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?20/36/21063?source=see_link\">",
"     \"Lymphogranuloma venereum\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?25/35/26166?source=see_link\">",
"     \"Diagnosis of gonococcal infections\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h1\">",
"     DIAGNOSTIC STUDIES",
"    </span>",
"    &nbsp;&mdash;&nbsp;All patients with anorectal symptoms should have anoscopy or sigmoidoscopy with mucosal biopsy.",
"    <span class=\"nowrap\">",
"     Sedation/analgesia",
"    </span>",
"    may be required if pain is severe.",
"   </p>",
"   <p>",
"    Patients with tenesmus, rectal discharge, or anorectal pain with or without a history of receptive anal intercourse should undergo anoscopy for evaluation of anorectal pus for polymorphonuclear cells, gram stain for gonococci, culture for herpes simplex virus, and polymerase chain reaction (PCR) testing for C. trachomatis. A serologic screening test for syphilis (eg, Rapid Plasma Reagin; RPR) should also be sent to assess the possibility of syphilis. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?38/44/39624?source=see_link&amp;anchor=H3#H3\">",
"     \"Diagnostic testing for syphilis\", section on 'Diagnostic testing methods'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Those who are found to have a mass on rectal examination may have anal cancer. Clinical staging for anal canal cancers consists of biopsy of the primary tumor, computed tomography (CT) imaging of the chest, CT or magnetic resonance imaging (MRI) imaging of the abdomen and pelvis, and a positron emission tomography (PET) scan. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?37/54/38762?source=see_link\">",
"     \"Clinical features, staging, and treatment of anal cancer\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Anorectal disorders are associated with significant morbidity and have been commonly described among HIV-infected patients, particularly men who have sex with men (MSM). (See",
"      <a class=\"local\" href=\"#H1\">",
"       'Introduction'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Common findings in this population include perirectal abscesses, anal fistulae, nonspecific ulcerations, infectious proctitis, anal warts, anal intraepithelial neoplasia, and anal cancer. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Etiology of anorectal symptoms'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The differential diagnosis of infectious proctitis in MSM includes Neisseria gonorrhoeae, herpes simplex virus, Chlamydia trachomatis, and Treponema pallidum infections. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Etiology of anorectal symptoms'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      A thorough history should examine whether the patient has tenesmus, anal pruritis, purulent or bloody discharge, or presence of systemic symptoms. (See",
"      <a class=\"local\" href=\"#H4\">",
"       'History and physical examination'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      On physical examination signs of lymphadenitis, anal fissures, condylomata, and masses should be sought. (See",
"      <a class=\"local\" href=\"#H4\">",
"       'History and physical examination'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      All HIV-infected patients with anorectal symptoms should have anoscopy or sigmoidoscopy with mucosal biopsy. (See",
"      <a class=\"local\" href=\"#H5\">",
"       'Diagnostic studies'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/25/11670/abstract/1\">",
"      Hoentjen F, Rubin DT. Infectious proctitis: when to suspect it is not inflammatory bowel disease. Dig Dis Sci 2012; 57:269.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/25/11670/abstract/2\">",
"      Singhrao T, Higham E, French P. Lymphogranuloma venereum presenting as perianal ulceration: an emerging clinical presentation? Sex Transm Infect 2011; 87:123.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/25/11670/abstract/3\">",
"      Salit IE, Lytwyn A, Raboud J, et al. The role of cytology (Pap tests) and human papillomavirus testing in anal cancer screening. AIDS 2010; 24:1307.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/25/11670/abstract/4\">",
"      Hamadani A, Haigh PI, Liu IL, Abbas MA. Who is at risk for developing chronic anal fistula or recurrent anal sepsis after initial perianal abscess? Dis Colon Rectum 2009; 52:217.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/25/11670/abstract/5\">",
"      Barrett WL, Callahan TD, Orkin BA. Perianal manifestations of human immunodeficiency virus infection: experience with 260 patients. Dis Colon Rectum 1998; 41:606.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/25/11670/abstract/6\">",
"      Brewer DD, Golden MR, Handsfield HH. Unsafe sexual behavior and correlates of risk in a probability sample of men who have sex with men in the era of highly active antiretroviral therapy. Sex Transm Dis 2006; 33:250.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/25/11670/abstract/7\">",
"      Fox PA. Human papillomavirus and anal intraepithelial neoplasia. Curr Opin Infect Dis 2006; 19:62.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/25/11670/abstract/8\">",
"      Lee PK, Wilkins KB. Condyloma and other infections including human immunodeficiency virus. Surg Clin North Am 2010; 90:99.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/25/11670/abstract/9\">",
"      Machalek DA, Poynten M, Jin F, et al. Anal human papillomavirus infection and associated neoplastic lesions in men who have sex with men: a systematic review and meta-analysis. Lancet Oncol 2012; 13:487.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/25/11670/abstract/10\">",
"      Simard EP, Pfeiffer RM, Engels EA. Cumulative incidence of cancer among individuals with acquired immunodeficiency syndrome in the United States. Cancer 2011; 117:1089.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/25/11670/abstract/11\">",
"      Shiels MS, Pfeiffer RM, Engels EA. Age at cancer diagnosis among persons with AIDS in the United States. Ann Intern Med 2010; 153:452.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/25/11670/abstract/12\">",
"      Conley L, Bush T, Darragh TM, et al. Factors associated with prevalent abnormal anal cytology in a large cohort of HIV-infected adults in the United States. J Infect Dis 2010; 202:1567.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/25/11670/abstract/13\">",
"      Nahas CS, Lin O, Weiser MR, et al. Prevalence of perianal intraepithelial neoplasia in HIV-infected patients referred for high-resolution anoscopy. Dis Colon Rectum 2006; 49:1581.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/25/11670/abstract/14\">",
"      Cranston RD, Hart SD, Gornbein JA, et al. The prevalence, and predictive value, of abnormal anal cytology to diagnose anal dysplasia in a population of HIV-positive men who have sex with men. Int J STD AIDS 2007; 18:77.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/25/11670/abstract/15\">",
"      Wilkin T, Lee JY, Lensing SY, et al. Safety and immunogenicity of the quadrivalent human papillomavirus vaccine in HIV-1-infected men. J Infect Dis 2010; 202:1246.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/25/11670/abstract/16\">",
"      Mayer KH. Sexually transmitted diseases in men who have sex with men. Clin Infect Dis 2011; 53 Suppl 3:S79.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/25/11670/abstract/17\">",
"      Mayer KH, Bush T, Henry K, et al. Ongoing sexually transmitted disease acquisition and risk-taking behavior among US HIV-infected patients in primary care: implications for prevention interventions. Sex Transm Dis 2012; 39:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/25/11670/abstract/18\">",
"      Bolan GA, Sparling PF, Wasserheit JN. The emerging threat of untreatable gonococcal infection. N Engl J Med 2012; 366:485.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/25/11670/abstract/19\">",
"      McMillan A, Young H. Clinical correlates of rectal gonococcal and chlamydial infections. Int J STD AIDS 2006; 17:387.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/25/11670/abstract/20\">",
"      Nieuwenhuis RF, Ossewaarde JM, G&ouml;tz HM, et al. Resurgence of lymphogranuloma venereum in Western Europe: an outbreak of Chlamydia trachomatis serovar l2 proctitis in The Netherlands among men who have sex with men. Clin Infect Dis 2004; 39:996.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/25/11670/abstract/21\">",
"      Ganesan A, Fieberg A, Agan BK, et al. Results of a 25-year longitudinal analysis of the serologic incidence of syphilis in a cohort of HIV-infected patients with unrestricted access to care. Sex Transm Dis 2012; 39:440.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/25/11670/abstract/22\">",
"      Boesecke C, Rockstroh JK. Acute hepatitis C in patients with HIV. Semin Liver Dis 2012; 32:130.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/25/11670/abstract/23\">",
"      European AIDS Treatment Network (NEAT) Acute Hepatitis C Infection Consensus Panel. Acute hepatitis C in HIV-infected individuals: recommendations from the European AIDS Treatment Network (NEAT) consensus conference. AIDS 2011; 25:399.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/25/11670/abstract/24\">",
"      Vogel M, Page E, Boesecke C, et al. Liver fibrosis progression after acute hepatitis C virus infection in HIV-positive individuals. Clin Infect Dis 2012; 54:556.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/25/11670/abstract/25\">",
"      Hoover KW, Butler M, Workowski K, et al. STD screening of HIV-infected MSM in HIV clinics. Sex Transm Dis 2010; 37:771.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/25/11670/abstract/26\">",
"      Klein EJ, Fisher LS, Chow AW, Guze LB. Anorectal gonococcal infection. Ann Intern Med 1977; 86:340.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/25/11670/abstract/27\">",
"      Singh R, Nime F, Mittelman A. Malignant epithelial tumors of the anal canal. Cancer 1981; 48:411.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/25/11670/abstract/28\">",
"      Schneider TC, Schulte WJ. Management of carcinoma of anal canal. Surgery 1981; 90:729.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/25/11670/abstract/29\">",
"      Schraut WH, Wang CH, Dawson PJ, Block GE. Depth of invasion, location, and size of cancer of the anus dictate operative treatment. Cancer 1983; 51:1291.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/25/11670/abstract/30\">",
"      White JA. Manifestations and management of lymphogranuloma venereum. Curr Opin Infect Dis 2009; 22:57.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 3730 Version 5.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0504-122.72.76.133-EBA391572F-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f11_25_11670=[""].join("\n");
var outline_f11_25_11670=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H6\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      ETIOLOGY OF ANORECTAL SYMPTOMS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      PATHOGENS TO CONSIDER",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      HISTORY AND PHYSICAL EXAMINATION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      DIAGNOSTIC STUDIES",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?21/62/22504?source=related_link\">",
"      AIDS-related cytomegalovirus gastrointestinal disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?1/33/1562?source=related_link\">",
"      Anal intraepithelial neoplasia: Diagnosis, screening, prevention, and treatment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?37/54/38762?source=related_link\">",
"      Clinical features, staging, and treatment of anal cancer",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?28/39/29305?source=related_link\">",
"      Clostridium difficile in adults: Clinical manifestations and diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?25/35/26166?source=related_link\">",
"      Diagnosis of gonococcal infections",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?38/44/39624?source=related_link\">",
"      Diagnostic testing for syphilis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?23/44/24265?source=related_link\">",
"      Differential diagnosis of microbial foodborne disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?9/10/9386?source=related_link\">",
"      Epidemiology, clinical manifestations, and diagnosis of genital herpes simplex virus infection",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?3/49/3865?source=related_link\">",
"      Epidemiology, clinical presentation, and diagnosis of syphilis in the HIV-infected patient",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?18/18/18728?source=related_link\">",
"      Genital Chlamydia trachomatis infections in men",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?29/31/30202?source=related_link\">",
"      HIV infection and malignancy: Management considerations",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?32/56/33671?source=related_link\">",
"      Intestinal Entamoeba histolytica amebiasis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?20/36/21063?source=related_link\">",
"      Lymphogranuloma venereum",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?19/17/19738?source=related_link\">",
"      Recommendations for the use of human papillomavirus vaccines",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?0/30/490?source=related_link\">",
"      Screening for sexually transmitted infections",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?17/38/18026?source=related_link\">",
"      Treatment of hepatitis C virus infection in the HIV-infected patient",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?19/3/19514?source=related_link\">",
"      Treatment of uncomplicated gonococcal infections",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?23/47/24314?source=related_link\">",
"      Treatment regimens for chronic hepatitis C virus genotype 1",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f11_25_11671="Candida osteoarticular infections";
var content_f11_25_11671=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"   </img>",
"  </div>",
"  <div id=\"printHeaderText\">",
"   Official reprint from  UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"   <a href=\"file://www.uptodate.com\">",
"    www.uptodate.com",
"   </a>",
"   <br>",
"    &copy;2013 UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"   </br>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Candida osteoarticular infections",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?11/25/11671/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?11/25/11671/contributors\">",
"     Carol A Kauffman, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?11/25/11671/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?11/25/11671/contributors\">",
"     Kieren A Marr, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?11/25/11671/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?11/25/11671/contributors\">",
"     Anna R Thorner, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?11/25/11671/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Jan 13, 2013.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Invasive Candida infections tend to occur in selected patients, including those who are immunocompromised (eg, neutropenia, glucocorticoid therapy), have indwelling central venous catheters, have received broad-spectrum antibiotics, or are injection drug users [",
"    <a class=\"abstract\" href=\"UTD.htm?11/25/11671/abstract/1,2\">",
"     1,2",
"    </a>",
"    ]. Candida albicans is the most common pathogen, but other species, such as C. glabrata, C. parapsilosis, and C. tropicalis, can be involved [",
"    <a class=\"abstract\" href=\"UTD.htm?11/25/11671/abstract/2-8\">",
"     2-8",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Clinical issues related to Candida osteomyelitis and arthritis will be reviewed here. An overview of Candida infections is presented separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?41/5/42071?source=see_link\">",
"     \"Overview of Candida infections\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     MECHANISMS AND SITES OF INFECTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Candida osteoarticular infections are most often due to hematogenous seeding of the joint or bone in patients who have been candidemic [",
"    <a class=\"abstract\" href=\"UTD.htm?11/25/11671/abstract/1,2,8-11\">",
"     1,2,8-11",
"    </a>",
"    ]. The areas most often seeded during an episode of candidemia in adults are intervertebral discs and knee joints [",
"    <a class=\"abstract\" href=\"UTD.htm?11/25/11671/abstract/2,10,11\">",
"     2,10,11",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Exogenous inoculation also can lead to infection in the following settings:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      After trauma or at the time of intraarticular injection (most often the knee) or prosthesis implantation [",
"      <a class=\"abstract\" href=\"UTD.htm?11/25/11671/abstract/9,12,13\">",
"       9,12,13",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?10/25/10646?source=see_link\">",
"       \"Treatment and prevention of osteomyelitis following trauma\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      After surgical procedures, such as median sternotomy for heart surgery [",
"      <a class=\"abstract\" href=\"UTD.htm?11/25/11671/abstract/14\">",
"       14",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?17/40/18055?source=see_link&amp;anchor=H8#H8\">",
"       \"Candida infections of the abdomen and thorax\", section on 'Mediastinitis'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      In injection drug users, especially those who use brown heroin [",
"      <a class=\"abstract\" href=\"UTD.htm?11/25/11671/abstract/15\">",
"       15",
"      </a>",
"      ]. These patients may develop a unique syndrome consisting of septic arthritis (usually costochondral or sternoclavicular), endophthalmitis, and folliculitis involving the face, scalp, and chest.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Among patients with osteomyelitis, the site of involvement varies with age. The vertebrae are most commonly involved in adults [",
"    <a class=\"abstract\" href=\"UTD.htm?11/25/11671/abstract/2,8,11,16\">",
"     2,8,11,16",
"    </a>",
"    ], whereas the long bones of the extremities are more likely to be involved in children [",
"    <a class=\"abstract\" href=\"UTD.htm?11/25/11671/abstract/8,17\">",
"     8,17",
"    </a>",
"    ]. Of 207 cases of Candida osteomyelitis in adults and children, the most common sites of infection were the vertebra (in 51 percent), the femur (in 14 percent), the ribs (in 13 percent), and the sternum (in 11 percent) [",
"    <a class=\"abstract\" href=\"UTD.htm?11/25/11671/abstract/8\">",
"     8",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Among patients with septic arthritis, most infections have been described in native joints, but prosthetic joints can also be involved [",
"    <a class=\"abstract\" href=\"UTD.htm?11/25/11671/abstract/12,18\">",
"     12,18",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     CLINICAL MANIFESTATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Osteoarticular infections often become symptomatic weeks or months after an episode of candidemia or a surgical procedure, and the manifestations are generally more subtle than bacterial infections at the same sites. Both of these factors contribute to long delays in diagnosis, especially in patients with vertebral osteomyelitis [",
"    <a class=\"abstract\" href=\"UTD.htm?11/25/11671/abstract/1,2,8-11\">",
"     1,2,8-11",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The most common symptom of Candida osteomyelitis is local pain [",
"    <a class=\"abstract\" href=\"UTD.htm?11/25/11671/abstract/2,8,10\">",
"     2,8,10",
"    </a>",
"    ], and some patients also have tenderness, erythema, and edema [",
"    <a class=\"abstract\" href=\"UTD.htm?11/25/11671/abstract/8\">",
"     8",
"    </a>",
"    ]. Fever is present in less than one-third of patients [",
"    <a class=\"abstract\" href=\"UTD.htm?11/25/11671/abstract/2,8\">",
"     2,8",
"    </a>",
"    ]. Limitation of function and movement occurs in nearly one-third of patients [",
"    <a class=\"abstract\" href=\"UTD.htm?11/25/11671/abstract/8\">",
"     8",
"    </a>",
"    ]. Sinus tracts and purulent drainage occur in 32 percent of patients with nonvertebral osteomyelitis, but in only one percent of patients with vertebral osteomyelitis.",
"   </p>",
"   <p>",
"    In a literature review of 59 patients with Candida vertebral osteomyelitis, most patients (83 percent) had back pain for more than one month, and 29 percent had back pain for more than three months [",
"    <a class=\"abstract\" href=\"UTD.htm?11/25/11671/abstract/2\">",
"     2",
"    </a>",
"    ]. The primary site of involvement was the lower thoracic or lumbar spine in almost all patients. Approximately 20 percent had neurologic deficits.",
"   </p>",
"   <p>",
"    Similar findings were noted in another review of 65 patients with Candida vertebral osteomyelitis [",
"    <a class=\"abstract\" href=\"UTD.htm?11/25/11671/abstract/11\">",
"     11",
"    </a>",
"    ]. Among the 40 patients with documented candidemia before the onset of osteomyelitis, the delay between the detection of candidemia and the onset of symptoms was 2 to 12 months in 70 percent and more than one year in 10 percent.",
"   </p>",
"   <p>",
"    When a joint is infected, the major symptoms are pain and decreased range of motion. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?10/50/11049?source=see_link&amp;anchor=H9#H9\">",
"     \"Septic arthritis in adults\", section on 'Clinical manifestations'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?41/43/42680?source=see_link&amp;anchor=H21069313#H21069313\">",
"     \"Clinical manifestations and diagnosis of prosthetic joint infections\", section on 'Clinical manifestations'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h1\">",
"     DIAGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;A high index of suspicion is required to establish the diagnosis of Candida osteoarticular infections because the clinical, laboratory, and radiologic findings are not specific [",
"    <a class=\"abstract\" href=\"UTD.htm?11/25/11671/abstract/2,11\">",
"     2,11",
"    </a>",
"    ]. Two clinical clues are a history of or current or recent detection of candidemia and the presence of risk factors for Candida infection [",
"    <a class=\"abstract\" href=\"UTD.htm?11/25/11671/abstract/2,8,11\">",
"     2,8,11",
"    </a>",
"    ]. Among 207 patients with Candida osteomyelitis, 57 (28 percent) had preceding candidemia, and 31 (15 percent) had candidemia at the time of diagnosis with Candida osteomyelitis [",
"    <a class=\"abstract\" href=\"UTD.htm?11/25/11671/abstract/8\">",
"     8",
"    </a>",
"    ]. In a review of 65 patients with vertebral osteomyelitis, all but three had at least one risk factor, and the median number of risk factors was three in patients with candidemia [",
"    <a class=\"abstract\" href=\"UTD.htm?11/25/11671/abstract/11\">",
"     11",
"    </a>",
"    ]. The most frequent risk factors were the use of broad-spectrum antibiotics and central venous catheters.",
"   </p>",
"   <p>",
"    Additional clinical features suggestive of fungal arthritis include the insidious onset of monoarthritis, immunocompromise, failure to identify a causative pathogen on synovial fluid cultures, and failure to respond to courses of antibiotic therapy [",
"    <a class=\"abstract\" href=\"UTD.htm?11/25/11671/abstract/9\">",
"     9",
"    </a>",
"    ]. The erythrocyte sedimentation rate and C-reactive protein are usually elevated, whereas the white blood cell count is often normal or only mildly elevated [",
"    <a class=\"abstract\" href=\"UTD.htm?11/25/11671/abstract/8\">",
"     8",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Among imaging studies in patients with osteomyelitis, plain radiography can show erosive and destructive changes, but these changes may not be visible upon presentation. Magnetic resonance imaging (MRI) is the imaging modality of choice, as it is in bacterial osteomyelitis. In a study of 207 patients with Candida osteomyelitis, MRI findings included decreased signal intensity on T1-weighted images, increased signal intensity on contrast-enhanced T1-weighted images, and increased signal intensity on T2-weighted images [",
"    <a class=\"abstract\" href=\"UTD.htm?11/25/11671/abstract/8\">",
"     8",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?22/28/22985?source=see_link\">",
"     \"Vertebral osteomyelitis and discitis\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The diagnosis is established by culture of the infected site. Candida arthritis is more easily confirmed than osteomyelitis because synovial fluid can be readily obtained for culture. Even a single colony of Candida on culture of joint fluid or bone biopsy or aspirate should be viewed as pathogenic, and the patient should be treated with antifungal agents as described below.",
"   </p>",
"   <p>",
"    Culture of Candida species from a chronic draining wound, as often occurs with Candida sternal osteomyelitis, is frequently disregarded as skin flora. However, repeated isolation of Candida and no other pathogen makes it likely that Candida is the causative agent [",
"    <a class=\"abstract\" href=\"UTD.htm?11/25/11671/abstract/14\">",
"     14",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h1\">",
"     TREATMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;Candida septic arthritis in a native joint is easier to treat than osteomyelitis because adequate antifungal drug levels are more easily achieved in synovial fluid than in bone [",
"    <a class=\"abstract\" href=\"UTD.htm?11/25/11671/abstract/1,12,17,19,20\">",
"     1,12,17,19,20",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Fungal prosthetic joint infections are difficult to cure with medical therapy alone. Most such patients require prosthesis removal followed by an extended course of antifungal therapy to resolve their infections. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?6/19/6457?source=see_link\">",
"     \"Treatment of prosthetic joint infections\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Osteomyelitis is difficult to treat because the diagnosis is often delayed for weeks to months [",
"    <a class=\"abstract\" href=\"UTD.htm?11/25/11671/abstract/2,11\">",
"     2,11",
"    </a>",
"    ]; the infected bone is often poorly perfused, which limits both the host inflammatory response and the delivery of antifungal drugs; and there may be foreign material present, as occurs with median sternotomy. Few data are available on the penetration of antifungal agents into bone [",
"    <a class=\"abstract\" href=\"UTD.htm?11/25/11671/abstract/21\">",
"     21",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Septic arthritis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Adequate drainage is essential for the treatment of all cases of Candida septic arthritis [",
"    <a class=\"abstract\" href=\"UTD.htm?11/25/11671/abstract/22\">",
"     22",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Antifungal treatment recommendations for septic arthritis caused by",
"    <a class=\"drug drug_general\" href=\"UTD.htm?16/12/16586?source=see_link\">",
"     fluconazole",
"    </a>",
"    -susceptible Candida species such as C. albicans include oral fluconazole (400 mg [6",
"    <span class=\"nowrap\">",
"     mg/kg])",
"    </span>",
"    daily for at least 6 weeks or a lipid formulation of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?42/53/43863?source=see_link\">",
"     amphotericin B",
"    </a>",
"    (3 to 5",
"    <span class=\"nowrap\">",
"     mg/kg",
"    </span>",
"    IV daily) for at least 2 weeks, followed by oral fluconazole (400 mg [6",
"    <span class=\"nowrap\">",
"     mg/kg])",
"    </span>",
"    daily for a total of at least 6 weeks (",
"    <a class=\"graphic graphic_table graphicRef87679 \" href=\"UTD.htm?38/40/39563\">",
"     table 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?11/25/11671/abstract/22\">",
"     22",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Alternatively, an echinocandin or",
"    <a class=\"drug drug_general\" href=\"UTD.htm?42/53/43863?source=see_link\">",
"     amphotericin B",
"    </a>",
"    deoxycholate (0.5 to 1 mg IV daily) can be given for at least 2 weeks followed by oral",
"    <a class=\"drug drug_general\" href=\"UTD.htm?16/12/16586?source=see_link\">",
"     fluconazole",
"    </a>",
"    (400 mg [6",
"    <span class=\"nowrap\">",
"     mg/kg])",
"    </span>",
"    for at least 6 weeks.",
"   </p>",
"   <p>",
"    The recommended doses of the echinocandins are:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      <a class=\"drug drug_general\" href=\"UTD.htm?10/15/10486?source=see_link\">",
"       Caspofungin",
"      </a>",
"      &mdash; 70 mg loading dose, then 50 mg IV daily",
"     </li>",
"     <li>",
"      <a class=\"drug drug_general\" href=\"UTD.htm?19/51/20276?source=see_link\">",
"       Anidulafungin",
"      </a>",
"      &mdash; 200 mg loading dose, then 100 mg IV daily",
"     </li>",
"     <li>",
"      <a class=\"drug drug_general\" href=\"UTD.htm?43/31/44532?source=see_link\">",
"       Micafungin",
"      </a>",
"      &mdash; 100 mg IV daily",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Many Candida species are susceptible to the echinocandins, with the exception of C. parapsilosis. Systemic antifungal regimens for non-albicans Candida infections are discussed below. (See",
"    <a class=\"local\" href=\"#H10\">",
"     'Candida glabrata'",
"    </a>",
"    below and",
"    <a class=\"local\" href=\"#H11\">",
"     'Other Candida species'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    Instillation of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?42/53/43863?source=see_link\">",
"     amphotericin B",
"    </a>",
"    into the joint space has been described, but is",
"    <strong>",
"     not",
"    </strong>",
"    recommended because drug levels are adequate with systemic therapy and irritation of synovial tissues is common with intraarticular therapy.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h3\">",
"     Prosthetic joint infection",
"    </span>",
"    &nbsp;&mdash;&nbsp;In addition to antifungal drugs, the cure of prosthetic joint infections almost always requires removal of all prosthetic material. A two-stage procedure in which the infected prosthesis is removed, therapy is given, and a new prosthesis is implanted later is the preferred approach for prosthetic joint infections [",
"    <a class=\"abstract\" href=\"UTD.htm?11/25/11671/abstract/18\">",
"     18",
"    </a>",
"    ]. Although cures have been described with debridement without removal of the prosthesis [",
"    <a class=\"abstract\" href=\"UTD.htm?11/25/11671/abstract/12,13,23\">",
"     12,13,23",
"    </a>",
"    ], this approach is not recommended for most patients with fungal infections. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?6/19/6457?source=see_link\">",
"     \"Treatment of prosthetic joint infections\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Osteomyelitis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Treatment recommendations for osteomyelitis caused by",
"    <a class=\"drug drug_general\" href=\"UTD.htm?16/12/16586?source=see_link\">",
"     fluconazole",
"    </a>",
"    -susceptible Candida species such as C. albicans include oral fluconazole (400 mg [6",
"    <span class=\"nowrap\">",
"     mg/kg])",
"    </span>",
"    daily for 6 to 12 months or a lipid formulation of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?42/53/43863?source=see_link\">",
"     amphotericin B",
"    </a>",
"    (3 to 5",
"    <span class=\"nowrap\">",
"     mg/kg",
"    </span>",
"    IV daily) for at least 2 weeks followed by oral fluconazole (400 mg [6",
"    <span class=\"nowrap\">",
"     mg/kg])",
"    </span>",
"    for a total of 6 to 12 months (",
"    <a class=\"graphic graphic_table graphicRef87679 \" href=\"UTD.htm?38/40/39563\">",
"     table 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?11/25/11671/abstract/22\">",
"     22",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Alternatively, an echinocandin or",
"    <a class=\"drug drug_general\" href=\"UTD.htm?42/53/43863?source=see_link\">",
"     amphotericin B",
"    </a>",
"    deoxycholate (0.5 to 1 mg IV daily) can be given for at least 2 weeks followed by oral",
"    <a class=\"drug drug_general\" href=\"UTD.htm?16/12/16586?source=see_link\">",
"     fluconazole",
"    </a>",
"    (400 mg [6",
"    <span class=\"nowrap\">",
"     mg/kg])",
"    </span>",
"    for 6 to 12 months.",
"   </p>",
"   <p>",
"    The recommended doses of the echinocandins are:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      <a class=\"drug drug_general\" href=\"UTD.htm?10/15/10486?source=see_link\">",
"       Caspofungin",
"      </a>",
"      &mdash; 70 mg loading dose, then 50 mg IV daily",
"     </li>",
"     <li>",
"      <a class=\"drug drug_general\" href=\"UTD.htm?19/51/20276?source=see_link\">",
"       Anidulafungin",
"      </a>",
"      &mdash; 200 mg loading dose, then 100 mg IV daily",
"     </li>",
"     <li>",
"      <a class=\"drug drug_general\" href=\"UTD.htm?43/31/44532?source=see_link\">",
"       Micafungin",
"      </a>",
"      &mdash; 100 mg IV daily",
"      <br/>",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Many Candida species are susceptible to the echinocandins, with the exception of C. parapsilosis. Antifungal regimens for non-albicans Candida infections are discussed below. (See",
"    <a class=\"local\" href=\"#H10\">",
"     'Candida glabrata'",
"    </a>",
"    below and",
"    <a class=\"local\" href=\"#H11\">",
"     'Other Candida species'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    Surgical debridement plays an important role in the treatment of Candida osteomyelitis involving non-vertebral sites, but the role of surgical debridement for vertebral osteomyelitis is less clear. Some authors strongly recommend that debridement be performed [",
"    <a class=\"abstract\" href=\"UTD.htm?11/25/11671/abstract/11\">",
"     11",
"    </a>",
"    ], although most note efficacy with antifungal therapy alone [",
"    <a class=\"abstract\" href=\"UTD.htm?11/25/11671/abstract/2,10,24,25\">",
"     2,10,24,25",
"    </a>",
"    ]. Surgery is clearly indicated if there is an associated epidural abscess or instability of the spine. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?22/28/22985?source=see_link\">",
"     \"Vertebral osteomyelitis and discitis\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    In a review of 207 cases of Candida osteomyelitis that were reported between 1970 and 2011, 44 percent were treated with antifungal therapy alone, 5 percent with surgery alone, and 48 percent with antifungal therapy in combination with surgery [",
"    <a class=\"abstract\" href=\"UTD.htm?11/25/11671/abstract/8\">",
"     8",
"    </a>",
"    ]. Among the 92 patients treated with antifungal agents alone, 97 percent had a favorable response, but 16 (17 percent) relapsed. Among the 100 patients who had both antifungal treatment and surgery, 90 percent responded, but the relapse rate was 43 percent. Without detailed information about the type of antifungal drug used and the duration of treatment, it is difficult to know why the relapse rates were so high, especially for the group who received combined medical and surgical therapy. The authors suggested that many patients relapsed because the duration of therapy was too short.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H520647194\">",
"    <span class=\"h1\">",
"     ANTIFUNGAL THERAPY BASED ON SPECIES",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H520647031\">",
"    <span class=\"h2\">",
"     Candida albicans",
"    </span>",
"    &nbsp;&mdash;&nbsp;The majority of C. albicans isolates are susceptible to",
"    <a class=\"drug drug_general\" href=\"UTD.htm?16/12/16586?source=see_link\">",
"     fluconazole",
"    </a>",
"    , the echinocandins (",
"    <a class=\"drug drug_general\" href=\"UTD.htm?10/15/10486?source=see_link\">",
"     caspofungin",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?19/51/20276?source=see_link\">",
"     anidulafungin",
"    </a>",
"    , and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?43/31/44532?source=see_link\">",
"     micafungin",
"    </a>",
"    ), and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?42/53/43863?source=see_link\">",
"     amphotericin B",
"    </a>",
"    . Specific treatment recommendations are presented above. (See",
"    <a class=\"local\" href=\"#H4\">",
"     'Diagnosis'",
"    </a>",
"    above.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Candida glabrata",
"    </span>",
"    &nbsp;&mdash;&nbsp;The choice of therapy with C. glabrata osteoarticular infections is more limited than with C. albicans [",
"    <a class=\"abstract\" href=\"UTD.htm?11/25/11671/abstract/2-5\">",
"     2-5",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The greatest experience in treating C. glabrata osteoarticular infections is with",
"      <a class=\"drug drug_general\" href=\"UTD.htm?42/53/43863?source=see_link\">",
"       amphotericin B",
"      </a>",
"      &nbsp;[",
"      <a class=\"abstract\" href=\"UTD.htm?11/25/11671/abstract/2-5\">",
"       2-5",
"      </a>",
"      ], but most clinicians currently use this agent only for initial therapy for a few weeks and then switch to an azole, such as",
"      <a class=\"drug drug_general\" href=\"UTD.htm?16/38/17002?source=see_link\">",
"       voriconazole",
"      </a>",
"      , for long-term therapy.",
"     </li>",
"     <li>",
"      Because many isolates of C. glabrata are either totally or relatively resistant to",
"      <a class=\"drug drug_general\" href=\"UTD.htm?16/12/16586?source=see_link\">",
"       fluconazole",
"      </a>",
"      , this agent should",
"      <strong>",
"       not",
"      </strong>",
"      be used for the treatment of C. glabrata osteoarticular infections.",
"     </li>",
"     <li>",
"      Echinocandins are an alternative initial treatment for osteoarticular infections due to C. glabrata, followed by step-down therapy with oral",
"      <a class=\"drug drug_general\" href=\"UTD.htm?16/38/17002?source=see_link\">",
"       voriconazole",
"      </a>",
"      [",
"      <a class=\"abstract\" href=\"UTD.htm?11/25/11671/abstract/26-28\">",
"       26-28",
"      </a>",
"      ]. It is essential to obtain susceptibilities before using voriconazole because of the common occurrence of cross-resistance with",
"      <a class=\"drug drug_general\" href=\"UTD.htm?16/12/16586?source=see_link\">",
"       fluconazole",
"      </a>",
"      . (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?29/13/29914?source=see_link&amp;anchor=H9#H9\">",
"       \"Treatment of candidemia and invasive candidiasis in adults\", section on 'C. glabrata'",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?29/13/29914?source=see_link&amp;anchor=H8#H8\">",
"       \"Treatment of candidemia and invasive candidiasis in adults\", section on 'C. krusei'",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Other Candida species",
"    </span>",
"    &nbsp;&mdash;&nbsp;C. krusei are resistant to",
"    <a class=\"drug drug_general\" href=\"UTD.htm?16/12/16586?source=see_link\">",
"     fluconazole",
"    </a>",
"    but are almost uniformly susceptible to",
"    <a class=\"drug drug_general\" href=\"UTD.htm?16/38/17002?source=see_link\">",
"     voriconazole",
"    </a>",
"    and echinocandins. However, only a small number of case reports are available showing benefit from either voriconazole alone [",
"    <a class=\"abstract\" href=\"UTD.htm?11/25/11671/abstract/29\">",
"     29",
"    </a>",
"    ] or",
"    <a class=\"drug drug_general\" href=\"UTD.htm?10/15/10486?source=see_link\">",
"     caspofungin",
"    </a>",
"    with voriconazole [",
"    <a class=\"abstract\" href=\"UTD.htm?11/25/11671/abstract/28\">",
"     28",
"    </a>",
"    ] in treating osteoarticular infection due to C. krusei. For most patients, lipid formulation",
"    <a class=\"drug drug_general\" href=\"UTD.htm?42/53/43863?source=see_link\">",
"     amphotericin B",
"    </a>",
"    should be the agent of first choice, followed by step-down therapy to voriconazole after improvement is noted. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?29/13/29914?source=see_link&amp;anchor=H9#H9\">",
"     \"Treatment of candidemia and invasive candidiasis in adults\", section on 'C. glabrata'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?29/13/29914?source=see_link&amp;anchor=H8#H8\">",
"     \"Treatment of candidemia and invasive candidiasis in adults\", section on 'C. krusei'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    C. parapsilosis is less susceptible to echinocandins than are other Candida species. Thus, echinocandins should",
"    <strong>",
"     not",
"    </strong>",
"    be used to treat osteoarticular infections due to C. parapsilosis. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?29/13/29914?source=see_link&amp;anchor=H10#H10\">",
"     \"Treatment of candidemia and invasive candidiasis in adults\", section on 'C. parapsilosis'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    For other Candida species, antifungal susceptibility tests should be performed to help guide appropriate therapy.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3559292\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Invasive Candida infections tend to occur in selected patients, including those who are immunocompromised (eg, neutropenia, glucocorticoid therapy), have indwelling central venous catheters, have received broad-spectrum antibiotics, or are injection drug users. Candida albicans is the most common pathogen, but other species, such as C. glabrata, C. parapsilosis, and C. tropicalis, can be involved. (See",
"      <a class=\"local\" href=\"#H1\">",
"       'Introduction'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Candida osteoarticular infections are most often due to hematogenous seeding of the joint or bone in patients who have been candidemic. The areas most often seeded during an episode of candidemia in adults are intervertebral discs and knee joints. Exogenous inoculation also can lead to infections after trauma, surgical procedures, or intra-articular injections. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Mechanisms and sites of infection'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Osteoarticular infections often become symptomatic months after an episode of candidemia or a surgical procedure, and the manifestations are generally more subtle than bacterial infections at the same sites. Both of these factors contribute to long delays in diagnosis, especially in patients with vertebral osteomyelitis. The most common symptom of Candida osteomyelitis is local pain. When a joint is infected, the major symptoms are pain and decreased range of motion. (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Clinical manifestations'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      A high index of suspicion is required to establish the diagnosis of Candida osteoarticular infections because the clinical, laboratory, and radiologic findings are not specific. The diagnosis is established by culture of the infected site. Even a single colony of Candida on culture of joint fluid or bone biopsy or aspirate should be viewed as pathogenic, and the patient should be treated with antifungal agents. (See",
"      <a class=\"local\" href=\"#H4\">",
"       'Diagnosis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Adequate drainage is essential for the treatment of all cases of Candida septic arthritis. (See",
"      <a class=\"local\" href=\"#H6\">",
"       'Septic arthritis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Antifungal treatment recommendations for septic arthritis include oral",
"      <a class=\"drug drug_general\" href=\"UTD.htm?16/12/16586?source=see_link\">",
"       fluconazole",
"      </a>",
"      (400 mg [6",
"      <span class=\"nowrap\">",
"       mg/kg])",
"      </span>",
"      daily for at least 6 weeks or a lipid formulation of",
"      <a class=\"drug drug_general\" href=\"UTD.htm?42/53/43863?source=see_link\">",
"       amphotericin B",
"      </a>",
"      (3 to 5",
"      <span class=\"nowrap\">",
"       mg/kg",
"      </span>",
"      IV daily) for at least 2 weeks, followed by oral fluconazole (400 mg [6",
"      <span class=\"nowrap\">",
"       mg/kg])",
"      </span>",
"      daily for a total of at least 6 weeks (",
"      <a class=\"graphic graphic_table graphicRef87679 \" href=\"UTD.htm?38/40/39563\">",
"       table 1",
"      </a>",
"      ). Alternatively, an echinocandin or amphotericin B deoxycholate (0.5 to 1 mg IV daily) can be given for at least 2 weeks followed by oral fluconazole (400 mg [6",
"      <span class=\"nowrap\">",
"       mg/kg])",
"      </span>",
"      for at least 6 weeks. (See",
"      <a class=\"local\" href=\"#H6\">",
"       'Septic arthritis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      In addition to antifungal drugs, the cure of prosthetic joint infections almost always requires removal of all prosthetic material. (See",
"      <a class=\"local\" href=\"#H7\">",
"       'Prosthetic joint infection'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Treatment recommendations for osteomyelitis include oral",
"      <a class=\"drug drug_general\" href=\"UTD.htm?16/12/16586?source=see_link\">",
"       fluconazole",
"      </a>",
"      (400 mg [6",
"      <span class=\"nowrap\">",
"       mg/kg])",
"      </span>",
"      daily for 6 to 12 months or a lipid formulation of",
"      <a class=\"drug drug_general\" href=\"UTD.htm?42/53/43863?source=see_link\">",
"       amphotericin B",
"      </a>",
"      (3 to 5",
"      <span class=\"nowrap\">",
"       mg/kg",
"      </span>",
"      IV daily) for at least 2 weeks followed by oral fluconazole (400 mg [6",
"      <span class=\"nowrap\">",
"       mg/kg])",
"      </span>",
"      for a total of 6 to 12 months (",
"      <a class=\"graphic graphic_table graphicRef87679 \" href=\"UTD.htm?38/40/39563\">",
"       table 1",
"      </a>",
"      ). Alternatively, an echinocandin or amphotericin B deoxycholate (0.5 to 1 mg IV daily) can be given for at least 2 weeks followed by oral fluconazole (400 mg [6",
"      <span class=\"nowrap\">",
"       mg/kg])",
"      </span>",
"      for 6 to 12 months. (See",
"      <a class=\"local\" href=\"#H8\">",
"       'Osteomyelitis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Surgical debridement plays an important role in the treatment of Candida osteomyelitis involving non-vertebral sites, but the role of surgical debridement for vertebral osteomyelitis is less clear. Some authors strongly recommend that debridement be performed, although most note efficacy with antifungal therapy alone. Surgery is clearly indicated if there is an associated epidural abscess or instability of the spine. (See",
"      <a class=\"local\" href=\"#H8\">",
"       'Osteomyelitis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Antifungal regimens for non-albicans Candida infections are discussed above. (See",
"      <a class=\"local\" href=\"#H10\">",
"       'Candida glabrata'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H11\">",
"       'Other Candida species'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/25/11671/abstract/1\">",
"      Johnson MD, Perfect JR. Fungal Infections of the Bones and Joints. Curr Infect Dis Rep 2001; 3:450.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/25/11671/abstract/2\">",
"      Miller DJ, Mejicano GC. Vertebral osteomyelitis due to Candida species: case report and literature review. Clin Infect Dis 2001; 33:523.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/25/11671/abstract/3\">",
"      Ramamohan N, Zeineh N, Grigoris P, Butcher I. Candida glabrata infection after total hip arthroplasty. J Infect 2001; 42:74.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/25/11671/abstract/4\">",
"      Zmierczak H, Goemaere S, Mielants H, et al. Candida glabrata arthritis: case report and review of the literature of Candida arthritis. Clin Rheumatol 1999; 18:406.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/25/11671/abstract/5\">",
"      Gunthard HF, Meltzer H, Karpinski NC, Ziegler EJ. Spinal osteomyelitis caused by Candida glabrata: case report and review. Infect Dis Clin Pract 1998; 7:12.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/25/11671/abstract/6\">",
"      Ferra C, Doebbeling BN, Hollis RJ, et al. Candida tropicalis vertebral osteomyelitis: a late sequela of fungemia. Clin Infect Dis 1994; 19:697.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/25/11671/abstract/7\">",
"      Weers-Pothoff G, Havermans JF, Kamphuis J, et al. Candida tropicalis arthritis in a patient with acute myeloid leukemia successfully treated with fluconazole: case report and review of the literature. Infection 1997; 25:109.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/25/11671/abstract/8\">",
"      Gamaletsou MN, Kontoyiannis DP, Sipsas NV, et al. Candida osteomyelitis: analysis of 207 pediatric and adult cases (1970-2011). Clin Infect Dis 2012; 55:1338.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/25/11671/abstract/9\">",
"      Cu&eacute;llar ML, Silveira LH, Espinoza LR. Fungal arthritis. Ann Rheum Dis 1992; 51:690.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/25/11671/abstract/10\">",
"      Gathe JC Jr, Harris RL, Garland B, et al. Candida osteomyelitis. Report of five cases and review of the literature. Am J Med 1987; 82:927.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/25/11671/abstract/11\">",
"      Hendrickx L, Van Wijngaerden E, Samson I, Peetermans WE. Candidal vertebral osteomyelitis: report of 6 patients, and a review. Clin Infect Dis 2001; 32:527.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/25/11671/abstract/12\">",
"      Tunkel AR, Thomas CY, Wispelwey B. Candida prosthetic arthritis: report of a case treated with fluconazole and review of the literature. Am J Med 1993; 94:100.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/25/11671/abstract/13\">",
"      Brooks DH, Pupparo F. Successful salvage of a primary total knee arthroplasty infected with Candida parapsilosis. J Arthroplasty 1998; 13:707.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/25/11671/abstract/14\">",
"      Malani PN, McNeil SA, Bradley SF, Kauffman CA. Candida albicans sternal wound infections: a chronic and recurrent complication of median sternotomy. Clin Infect Dis 2002; 35:1316.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/25/11671/abstract/15\">",
"      Bisbe J, Miro JM, Latorre X, et al. Disseminated candidiasis in addicts who use brown heroin: report of 83 cases and review. Clin Infect Dis 1992; 15:910.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/25/11671/abstract/16\">",
"      Garbino J, Schnyder I, Lew D, et al. An unusual cause of vertebral osteomyelitis: Candida species. Scand J Infect Dis 2003; 35:288.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/25/11671/abstract/17\">",
"      Evdoridou J, Roilides E, Bibashi E, Kremenopoulos G. Multifocal osteoarthritis due to Candida albicans in a neonate: serum level monitoring of liposomal amphotericin B and literature review. Infection 1997; 25:112.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/25/11671/abstract/18\">",
"      Phelan DM, Osmon DR, Keating MR, Hanssen AD. Delayed reimplantation arthroplasty for candidal prosthetic joint infection: a report of 4 cases and review of the literature. Clin Infect Dis 2002; 34:930.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/25/11671/abstract/19\">",
"      O'Meeghan T, Varcoe R, Thomas M, Ellis-Pegler R. Fluconazole concentration in joint fluid during successful treatment of Candida albicans septic arthritis. J Antimicrob Chemother 1990; 26:601.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/25/11671/abstract/20\">",
"      P&eacute;rez-G&oacute;mez A, Prieto A, Torresano M, et al. Role of the new azoles in the treatment of fungal osteoarticular infections. Semin Arthritis Rheum 1998; 27:226.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/25/11671/abstract/21\">",
"      Fischman AJ, Alpert NM, Livni E, et al. Pharmacokinetics of 18F-labeled fluconazole in healthy human subjects by positron emission tomography. Antimicrob Agents Chemother 1993; 37:1270.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/25/11671/abstract/22\">",
"      Pappas PG, Kauffman CA, Andes D, et al. Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America. Clin Infect Dis 2009; 48:503.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/25/11671/abstract/23\">",
"      Merrer J, Dupont B, Nieszkowska A, et al. Candida albicans prosthetic arthritis treated with fluconazole alone. J Infect 2001; 42:208.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/25/11671/abstract/24\">",
"      R&ouml;ssel P, Sch&oslash;nheyder HC, Nielsen H. Fluconazole therapy in Candida albicans spondylodiscitis. Scand J Infect Dis 1998; 30:527.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/25/11671/abstract/25\">",
"      Hennequin C, Bour&eacute;e P, Hiesse C, et al. Spondylodiskitis due to Candida albicans: report of two patients who were successfully treated with fluconazole and review of the literature. Clin Infect Dis 1996; 23:176.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/25/11671/abstract/26\">",
"      Legout L, Assal M, Rohner P, et al. Successful treatment of Candida parapsilosis (fluconazole-resistant) osteomyelitis with caspofungin in a HIV patient. Scand J Infect Dis 2006; 38:728.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/25/11671/abstract/27\">",
"      Yang SC, Shao PL, Hsueh PR, et al. Successful treatment of Candida tropicalis arthritis, osteomyelitis and costochondritis with caspofungin and fluconazole in a recipient of bone marrow transplantation. Acta Paediatr 2006; 95:629.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/25/11671/abstract/28\">",
"      Pem&aacute;n J, Jarque I, Bosch M, et al. Spondylodiscitis caused by Candida krusei: case report and susceptibility patterns. J Clin Microbiol 2006; 44:1912.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/25/11671/abstract/29\">",
"      Sili U, Yilmaz M, Ferhanoglu B, Mert A. Candida krusei arthritis in a patient with hematologic malignancy: successful treatment with voriconazole. Clin Infect Dis 2007; 45:897.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 2466 Version 9.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.3 - C21.34",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Morehouse School of Medicine",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0605-79.122.249.114-59E8FFCE15-S473950.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f11_25_11671=[""].join("\n");
var outline_f11_25_11671=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H3559292\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      MECHANISMS AND SITES OF INFECTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      CLINICAL MANIFESTATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      TREATMENT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Septic arthritis",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      - Prosthetic joint infection",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Osteomyelitis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H520647194\">",
"      ANTIFUNGAL THERAPY BASED ON SPECIES",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H520647031\">",
"      Candida albicans",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Candida glabrata",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Other Candida species",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3559292\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"ID/2466\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ID/2466|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?38/40/39563\" title=\"table 1\">",
"      Treatment of Candida osteoarticular infections",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?17/40/18055?source=related_link\">",
"      Candida infections of the abdomen and thorax",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?41/43/42680?source=related_link\">",
"      Clinical manifestations and diagnosis of prosthetic joint infections",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?41/5/42071?source=related_link\">",
"      Overview of Candida infections",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?10/50/11049?source=related_link\">",
"      Septic arthritis in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?10/25/10646?source=related_link\">",
"      Treatment and prevention of osteomyelitis following trauma",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?29/13/29914?source=related_link\">",
"      Treatment of candidemia and invasive candidiasis in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?6/19/6457?source=related_link\">",
"      Treatment of prosthetic joint infections",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?22/28/22985?source=related_link\">",
"      Vertebral osteomyelitis and discitis",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f11_25_11672="Administration and complications of red cell transfusion in infants and children";
var content_f11_25_11672=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"5\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Administration and complications of red cell transfusion in infants and children",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?11/25/11672/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?11/25/11672/contributors\">",
"     Jun Teruya, MD, DSc",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?11/25/11672/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?11/25/11672/contributors\">",
"     Donald H Mahoney, Jr, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?11/25/11672/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?11/25/11672/contributors\">",
"     Alison G Hoppin, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?11/25/11672/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Jan 16, 2013.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Transfusions of red blood cells are given to children in a wide variety of clinical settings. This includes children with anemia due to congenital or acquired disease, blood loss from trauma or surgery, or (in the case of premature infants) blood sampling. On the other hand, red cell transfusion has significant risks, including volume overload, transmission of infectious agents, and various immunologic consequences including transfusion reactions. Many of these complications can be avoided with careful administration of red cell transfusions.",
"   </p>",
"   <p>",
"    The administration and complications of red cell transfusion in infants and children will be reviewed here. The indications for red cell transfusion in infants and children and the appropriate selection of red blood cell product are discussed elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?18/23/18808?source=see_link\">",
"     \"Indications for red blood cell transfusion in infants and children\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?27/11/27832?source=see_link\">",
"     \"Red cell transfusion in infants and children: Selection of blood products\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     ADMINISTRATION",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Patient identification",
"    </span>",
"    &nbsp;&mdash;&nbsp;As the infectious risks of transfusion continue to decline, more attention is being paid to other preventable hazards of transfusion, including known causes of transfusion-related deaths [",
"    <a class=\"abstract\" href=\"UTD.htm?11/25/11672/abstract/1\">",
"     1",
"    </a>",
"    ]. High on this list is a hemolytic transfusion reaction due to a misidentified patient or specimen, which occurs with a frequency greater than that of transfusion-associated transmission of human immunodeficiency virus (HIV) or hepatitis C (HCV) [",
"    <a class=\"abstract\" href=\"UTD.htm?11/25/11672/abstract/1,2\">",
"     1,2",
"    </a>",
"    ]. It is not uncommon to have two patients on the same hospital floor with the same last name but different blood types, both of whom require blood transfusion.",
"   </p>",
"   <p>",
"    As a result, all patients in the hospital, including children, should have armbands or similar methods of identification. These should be examined explicitly at the time specimens are drawn for blood bank testing, and again immediately before each unit of blood is transfused. Careful attention should be paid to the labeling requirements of specimens for the blood bank [",
"    <a class=\"abstract\" href=\"UTD.htm?11/25/11672/abstract/3,4\">",
"     3,4",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Catheter size",
"    </span>",
"    &nbsp;&mdash;&nbsp;One of the major practical concerns in administering blood to children, particularly small infants, is the size of the intravenous line through which blood can be transfused. Blood under minimal pressure can be transfused through a 22 gauge needle or catheter but will flow very slowly. Higher rates of flow can be achieved with pressure devices. Minimal hemolysis is caused by pressures of up to 300 mmHg and catheter sizes as small as 22 gauge [",
"    <a class=\"abstract\" href=\"UTD.htm?11/25/11672/abstract/5\">",
"     5",
"    </a>",
"    ]. Ordinary pump or roller infusion devices, commonly used to administer intravenous fluids so that accurate measurement is possible, can be used with blood products without risk of increased hemolysis [",
"    <a class=\"abstract\" href=\"UTD.htm?11/25/11672/abstract/6\">",
"     6",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Filters",
"    </span>",
"    &nbsp;&mdash;&nbsp;Blood must always be administered through a filter to remove small aggregates and blood clots that may have formed during storage [",
"    <a class=\"abstract\" href=\"UTD.htm?11/25/11672/abstract/7\">",
"     7",
"    </a>",
"    ]. The usual filter is 170 to 260 microns. These devices do not provide leukoreduction.",
"   </p>",
"   <p>",
"    Because of the small volumes of many pediatric transfusions, leukocyte reduction filters may be used at the bedside if the unit has not been leukoreduced previously. However, such filtration is most often performed near the time of collection and in the blood bank. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?24/5/24665?source=see_link&amp;anchor=H15#H15\">",
"     \"Leukoreduction to prevent complications of blood transfusion\", section on 'Prestorage versus poststorage leukoreduction'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?27/11/27832?source=see_link&amp;anchor=H5#H5\">",
"     \"Red cell transfusion in infants and children: Selection of blood products\", section on 'Leukoreduced red cells'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Volume",
"    </span>",
"    &nbsp;&mdash;&nbsp;The volume of blood to be transfused varies with the clinical situation. The usual transfusion volume is 10 to 15",
"    <span class=\"nowrap\">",
"     mL/kg.",
"    </span>",
"    If the concentration of red cells in the selected red cell product is approximately 65 percent, this volume will usually raise the hemoglobin concentration by 2 to 3",
"    <span class=\"nowrap\">",
"     gm/dL",
"    </span>",
"    or the hematocrit by 6 to 9 percent. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?27/11/27832?source=see_link&amp;anchor=H4#H4\">",
"     \"Red cell transfusion in infants and children: Selection of blood products\", section on 'Packed red cells'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    In neonates, the small volumes require the use of special equipment, which is discussed elsewhere in the program. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?8/53/9048?source=see_link&amp;anchor=H15#H15\">",
"     \"Red blood cell transfusions in the newborn\", section on 'Administration'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Infusion duration",
"    </span>",
"    &nbsp;&mdash;&nbsp;Blood issued for transfusion should be infused within four hours. If the transfusion will take longer because of slow flow or other issues, the blood bank can divide the unit into smaller aliquots so that each can be transfused within four hours. In special circumstances, such as for the operating room or a remote clinic, the blood bank may issue red cell units in coolers that have been validated to maintain the appropriate storage temperature.",
"   </p>",
"   <p>",
"    A transfusion rate of approximately 2.5",
"    <span class=\"nowrap\">",
"     mL/kg",
"    </span>",
"    per hour usually avoids circulatory overload. Thus, a transfusion of 10",
"    <span class=\"nowrap\">",
"     mL/kg",
"    </span>",
"    of packed red cells usually is transfused over a four-hour period. Patients with cardiovascular instability may need to be transfused more slowly. More rapid infusion is appropriate when the degree of blood loss compromises tissue perfusion.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Compatible fluids",
"    </span>",
"    &nbsp;&mdash;&nbsp;Blood should be transfused only in the presence of compatible fluids. Incompatible products may cause red cell hemolysis or impair the anticoagulant properties of standard solutions used for red cell products.",
"   </p>",
"   <p>",
"    No fluid should be administered with blood unless it has been specifically labeled and tested for this use [",
"    <a class=\"abstract\" href=\"UTD.htm?11/25/11672/abstract/8\">",
"     8",
"    </a>",
"    ]. The most compatible solution is isotonic (0.9 percent) saline. If a single line is being used, the tubing should be flushed carefully before and after blood administration if a potentially incompatible fluid has been infused. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?41/14/42214?source=see_link&amp;anchor=H3#H3\">",
"     \"Transfusion reactions caused by chemical and physical agents\", section on 'Addition of drugs and diluents to blood products'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Many drugs and solutions are completely incompatible with red cells, including the following:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Five percent dextrose solutions can cause blood clumping and hemolysis [",
"      <a class=\"abstract\" href=\"UTD.htm?11/25/11672/abstract/8\">",
"       8",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Ringer's lactate solutions or other calcium-containing solution must be avoided, because calcium in these products will reverse the anticoagulation provided by standard citrate-containing solutions and will lead to the transfusion of blood that contain clots [",
"      <a class=\"abstract\" href=\"UTD.htm?11/25/11672/abstract/8,9\">",
"       8,9",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Blood warmers",
"    </span>",
"    &nbsp;&mdash;&nbsp;Red cells are preserved in the blood bank at 1 to 6&ordm;C. For a slow transfusion, this temperature may not pose a problem. However, the use of a blood warmer is recommended in the following clinical settings:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Unstable infants",
"     </li>",
"     <li>",
"      Patients who require rapid transfusion of a large amount of blood (&gt;15",
"      <span class=\"nowrap\">",
"       mL/kg/hour)",
"      </span>",
"     </li>",
"     <li>",
"      Patients who require exchange transfusions",
"     </li>",
"     <li>",
"      Patients with cold agglutinin disease",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    If the blood requires warming, it is warmed at the time of transfusion using an approved and calibrated device. These devices must be monitored, since excessive warming can cause hemolysis. Blood should never be warmed in an uncontrolled way. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?41/14/42214?source=see_link&amp;anchor=H4#H4\">",
"     \"Transfusion reactions caused by chemical and physical agents\", section on 'Thermal hemolysis'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Exchange transfusion",
"    </span>",
"    &nbsp;&mdash;&nbsp;Red cell exchange can be performed with an automated apheresis instrument, such as the COBE Spectra (Gambro, Lakewood, CO), unless the patient is very small. The automated controls of these instruments are quite accurate in providing the desired target hemoglobin value, and their utility has been demonstrated in a number of studies [",
"    <a class=\"abstract\" href=\"UTD.htm?11/25/11672/abstract/10,11\">",
"     10,11",
"    </a>",
"    ]. Red cell priming of the instrument is recommended if the extracorporeal volume is more than 10 to 15 percent of the estimated total blood volume [",
"    <a class=\"abstract\" href=\"UTD.htm?11/25/11672/abstract/12\">",
"     12",
"    </a>",
"    ]. The instrument should be primed with red cells, for example, in small children (body weight &lt;10 to 20 kg) or patients with severe anemia [",
"    <a class=\"abstract\" href=\"UTD.htm?11/25/11672/abstract/12\">",
"     12",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Most instruments require two sites of vascular access for draw and return; this can be problematic in children who have poor venous access. In emergent settings, double lumen central catheters, commonly used for hemodialysis, can be placed in the femoral vein. For long-term venous access for repeated exchanges, a surgically-created fistula or surgically implanted central venous catheter may be required.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Informed consent",
"    </span>",
"    &nbsp;&mdash;&nbsp;Except in emergent situations, specific informed consent for transfusion should be obtained and is required by the Joint Commission [",
"    <a class=\"abstract\" href=\"UTD.htm?11/25/11672/abstract/13\">",
"     13",
"    </a>",
"    ]. Parents or guardians are generally able to give this consent, although the additional assent of the child should also be considered. Teenagers in some states are able to give consent for their own medical treatment under certain circumstances. The benefits and risks, notably infectious risks, of transfusion should be disclosed. (See",
"    <a class=\"medical medical_patient\" href=\"UTD.htm?26/12/26820?source=see_link\">",
"     \"Patient information: Blood donation and transfusion (Beyond the Basics)\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    When the parent is unable or unwilling to give consent, and physicians feel that transfusion is medically necessary, guidance of the courts is often sought, with the appointment of a guardian specifically to give this permission.",
"   </p>",
"   <p>",
"    The treatment of children of Jehovah's Witnesses should be individualized [",
"    <a class=\"abstract\" href=\"UTD.htm?11/25/11672/abstract/14\">",
"     14",
"    </a>",
"    ]. In general, the church is opposed to storage of blood for transfusion, but local groups and individuals within these groups take different positions about what kinds of hematologic support may be acceptable. In cases in which the child is placed at substantial medical risk because of parental nonconsent, court approval is often sought for transfusion. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?10/46/10986?source=see_link\">",
"     \"The approach to the patient who refuses blood transfusion\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?5/52/5961?source=see_link&amp;anchor=H4#H4\">",
"     \"Indications for red cell transfusion in the adult\", section on 'Transfusion in the perioperative or intensive care unit setting'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The option of directed donation should be offered in any elective transfusion, and the option of autologous transfusion should be disclosed whenever it is a possibility. State law may include the options of these forms of donation in the consent form. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?10/51/11061?source=see_link\">",
"     \"Directed (designated) blood donation programs\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?11/54/12134?source=see_link\">",
"     \"Preoperative autologous blood donation\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h1\">",
"     COMPLICATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Undesirable sequelae of transfusion may be divided into infectious and noninfectious categories. Although the public has focused on infectious risks, the noninfectious risks of transfusion, primarily transfusion reactions, have become more frequent [",
"    <a class=\"abstract\" href=\"UTD.htm?11/25/11672/abstract/15\">",
"     15",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The following is a brief review of the different complications from blood transfusions, each of which is discussed in detail elsewhere.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h2\">",
"     Infection",
"    </span>",
"    &nbsp;&mdash;&nbsp;All donated blood is extensively screened for transfusion-transmitted infections; as a result, the risk of acquiring infection is extremely low (",
"    <a class=\"graphic graphic_table graphicRef69661 \" href=\"UTD.htm?30/59/31676\">",
"     table 1",
"    </a>",
"    ). Currently, each unit of blood administered in the United States is screened for a number of infections, including HIV, hepatitis B and C viruses, human T-cell leukemia virus, West Nile virus, Trypanosoma cruzi, and Treponema pallidum.",
"   </p>",
"   <p>",
"    Residual risk remains largely from \"window period\" donations, during the time when antigen",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    antibody are of such low level as to be undetectable by current techniques. A more complete discussion on the screening for transfusion-transmitted infection is found elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?39/41/40601?source=see_link&amp;anchor=H8#H8\">",
"     \"Laboratory testing of donated blood\", section on 'Infectious disease screening'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The risk of bacterial contamination of blood products is much greater than the risk of viral transmission. Bacterial contamination of blood products can occur at the time of collection or because the donor had occult bacteremia at the time of donation. Temperature elevation, hypotension, or other signs of sepsis should be investigated carefully in a patient who has received a transfusion. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?11/14/11498?source=see_link&amp;anchor=H19#H19\">",
"     \"Blood donor medical history\", section on 'Bacterial infection'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?10/14/10471?source=see_link\">",
"     \"Transfusion transmitted bacterial infection\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Other rare infectious transfusion risks in the United States include the parasites of malaria, Chagas disease, and babesiosis. Screening by history of blood donors, including geography, is used to reduce the risk of transfusion of any of the parasitic or prion diseases. In 2006, a test for Chagas disease was approved by the FDA. Although testing is not mandated, most blood suppliers have started screening for Chagas disease. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?11/14/11498?source=see_link\">",
"     \"Blood donor medical history\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h2\">",
"     Transfusion reaction",
"    </span>",
"    &nbsp;&mdash;&nbsp;In children, the rate of transfusion reaction is approximately 1 percent, as illustrated in a multicenter study from the Pediatric Health Information System of 44,632 hospitalized children (18 years of age or younger) who received RBC transfusions [",
"    <a class=\"abstract\" href=\"UTD.htm?11/25/11672/abstract/16\">",
"     16",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    These reactions are briefly reviewed here and are discussed in greater detail elsewhere.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Acute hemolytic &mdash; Acute hemolytic transfusion reactions usually result from the mistransfusion of ABO-incompatible red cells. This complication is best prevented, rather than treated, by meticulous attention to patient and sample identification. Treatment is supportive. (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Patient identification'",
"      </a>",
"      above and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?11/31/11769?source=see_link&amp;anchor=H7#H7\">",
"       \"Immunologic blood transfusion reactions\", section on 'Acute hemolytic reactions'",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?11/31/11769?source=see_link&amp;anchor=H10#H10\">",
"       \"Immunologic blood transfusion reactions\", section on 'Treatment'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Febrile &mdash; Febrile reactions not due to hemolysis are usually related to the presence of cytokines produced by passenger leukocytes. Treatment includes stopping the transfusion and excluding a hemolytic reaction or sepsis as the cause of fever. Antipyretic therapy is given for symptomatic relief. These reactions are reduced with leukoreduction. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?11/31/11769?source=see_link&amp;anchor=H3#H3\">",
"       \"Immunologic blood transfusion reactions\", section on 'Febrile nonhemolytic reactions'",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?11/31/11769?source=see_link&amp;anchor=H10#H10\">",
"       \"Immunologic blood transfusion reactions\", section on 'Treatment'",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?27/11/27832?source=see_link&amp;anchor=H5#H5\">",
"       \"Red cell transfusion in infants and children: Selection of blood products\", section on 'Leukoreduced red cells'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Delayed hemolytic &mdash; Delayed hemolysis results when the patient produces an antibody days following a blood transfusion or by anamnestic response. It presents 2 to 10 days following transfusion as jaundice",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      an unexpected fall in hemoglobin. A delayed hemolytic transfusion reaction is confirmed by repeat antibody screening of the patient's plasma, which demonstrates the presence of a specific alloantibody that was not previously present. Positive direct antiglobulin test for IgG with a positive eluate against the corresponding antigen will confirm the diagnosis. Among many red cell antibodies, anti-Jka and anti-Jkb are known to cause delayed hemolysis more often than other antibodies. Subsequent red cell transfusions should utilize blood that tests negative for the newly identified antigen. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?11/31/11769?source=see_link&amp;anchor=H11#H11\">",
"       \"Immunologic blood transfusion reactions\", section on 'Delayed hemolytic reactions'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Allergic and anaphylactic reactions &mdash; An anaphylactic, allergic, or anaphylactoid reaction to a blood transfusion can vary in severity from mild hives and itching to fatal anaphylaxis. While more common with plasma and platelet transfusions, these reactions also may occur following red cell transfusion. Treatment is supportive. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?11/31/11769?source=see_link&amp;anchor=H16#H16\">",
"       \"Immunologic blood transfusion reactions\", section on 'Urticarial (allergic) reactions'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Transfusion-associated lung injury &mdash; The presence of transfusion-associated acute lung injury (TRALI) should be suspected when dyspnea, bilateral noncardiogenic pulmonary edema, hypotension, and fever occur within six hours of completion of transfusion. TRALI is the leading cause of transfusion-related mortality in the United States. It is due primarily to the interaction between leukocytes from the recipient and anti-HLA antibodies or anti-granulocyte antibodies from the donor. This is the reason multiparous female donors are disqualified from donating plasma and platelet components. Treatment is supportive. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?27/39/28282?source=see_link\">",
"       \"Transfusion-related acute lung injury (TRALI)\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h2\">",
"     Circulatory overload",
"    </span>",
"    &nbsp;&mdash;&nbsp;Circulatory overload secondary to transfusion may occur in children, although it is more common in adults. Manifestations may begin near the end or within six hours of the transfusion. Patients should be monitored closely during this time period for suggestive signs and symptoms, including dyspnea, orthopnea, tachycardia, and a wide pulse pressure, often with hypertension.",
"   </p>",
"   <p>",
"    Patients deemed to be at risk for volume overload (such as those with impaired cardiac function) can be transfused at a slower rate of 1",
"    <span class=\"nowrap\">",
"     mL/kg",
"    </span>",
"    per hour compared to the normal rate of 2.5",
"    <span class=\"nowrap\">",
"     mL/kg",
"    </span>",
"    per hour. Diuretic therapy, such as",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?5/26/5544?source=see_link\">",
"     furosemide",
"    </a>",
"    (0.5 to 1",
"    <span class=\"nowrap\">",
"     mg/kg",
"    </span>",
"    per dose), is given to treat symptoms or, patients considered at high risk, for prophylaxis. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?41/14/42214?source=see_link&amp;anchor=H2#H2\">",
"     \"Transfusion reactions caused by chemical and physical agents\", section on 'Transfusional volume overload (TACO)'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h2\">",
"     Metabolic toxicity",
"    </span>",
"    &nbsp;&mdash;&nbsp;Metabolic toxicities from red cell transfusion include the following [",
"    <a class=\"abstract\" href=\"UTD.htm?11/25/11672/abstract/17-23\">",
"     17-23",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Hypocalcemia",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      hypoglycemia in newborns due to the infused citrate in the preservative solution.",
"     </li>",
"     <li>",
"      Hyperkalemia in patients who receive large volumes of blood (eg, exchange or massive transfusions) or irradiated blood (radiation increases cellular leakage of potassium). Children who receive large quantities of blood infused through a central line, as in exchange transfusions or massive transfusions, are at particular risk for hyperkalemia [",
"      <a class=\"abstract\" href=\"UTD.htm?11/25/11672/abstract/24-28\">",
"       24-28",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?20/37/21081?source=see_link&amp;anchor=H9#H9\">",
"       \"Use of red blood cells for transfusion\", section on 'Potassium leakage'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Clinically significant accumulation of",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?42/60/43975?source=see_link\">",
"       mannitol",
"      </a>",
"      (a component of preservative solutions) in neonates who receive large volumes of blood may result in an osmotic diuresis.",
"     </li>",
"     <li>",
"      Clinically significant accumulation of adenine (a component of preservative solutions) in neonates who receive large volumes of blood may cause nephrotoxicity.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h2\">",
"     Graft-versus-host disease",
"    </span>",
"    &nbsp;&mdash;&nbsp;Transfusion-associated graft-versus-host disease (TA-GVHD) is caused by viable, reproducing competent donor lymphocytes that are transfused into a patient who either does not recognize these cells as foreign or does not have the capacity to destroy them. It can be prevented by use of irradiated products when transfusing patients at risk for TA-GVHD. It is particularly important to consider the possibility of undiagnosed immune deficiency in children who require red blood cell transfusion. Premature and low body weight babies are particularly at risk for TA-GVHD. Irradiated blood products may prevent TA-GVHD. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?6/35/6710?source=see_link\">",
"     \"Transfusion-associated graft-versus-host disease\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?27/11/27832?source=see_link&amp;anchor=H8#H8\">",
"     \"Red cell transfusion in infants and children: Selection of blood products\", section on 'Irradiated red cells'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h2\">",
"     Iron overload",
"    </span>",
"    &nbsp;&mdash;&nbsp;Iron overload can be a significant problem in children who are transfused chronically. As an example, the main cause of death in patients with thalassemia major is cardiac (heart failure, fatal arrhythmia) due to deposition of transfused iron in the heart. Children who are at risk for iron overload can be treated with iron chelation therapy. Iron chelation therapy can reduce the damage produced by the life-long need for red cell transfusions in these children. In addition, exchange transfusion rather than simple transfusion has been used in children with sickle cell disease, partly to reduce the risk of iron overload. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?37/13/38106?source=see_link&amp;anchor=H11#H11\">",
"     \"Clinical manifestations and diagnosis of the thalassemias\", section on 'Cardiopulmonary complications'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?37/60/38856?source=see_link&amp;anchor=H11#H11\">",
"     \"Iron overload syndromes other than hereditary hemochromatosis\", section on 'Transfusional iron overload'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?39/0/39946?source=see_link&amp;anchor=H19#H19\">",
"     \"Overview of the management of sickle cell disease\", section on 'Transfusion therapy'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h1\">",
"     MEASURES TO REDUCE TRANSFUSION",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h2\">",
"     Erythropoietin",
"    </span>",
"    &nbsp;&mdash;&nbsp;Use of",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?16/51/17208?source=see_link\">",
"     recombinant human erythropoietin",
"    </a>",
"    (EPO) to increase the patient's endogenous production of red cells has been investigated, but its role in reducing blood transfusions in infants and children remains limited.",
"   </p>",
"   <p>",
"    The possible efficacy of EPO has been studied in the following clinical settings:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Premature infants &mdash; Although EPO has been reported to reduce the number of transfusions in premature infants, it does not generally eliminate the need for transfusion. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?20/19/20792?source=see_link&amp;anchor=H14#H14\">",
"       \"Anemia of prematurity\", section on 'Erythropoietin'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Children with cancer &mdash; Reports vary on whether EPO is effective in reducing blood transfusions in children with cancer [",
"      <a class=\"abstract\" href=\"UTD.htm?11/25/11672/abstract/29-32\">",
"       29-32",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Children with chronic renal failure &mdash; EPO is a standard therapy for the anemia associated with chronic renal failure, which is due to reduced EPO production by the kidney. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?31/17/32026?source=see_link&amp;anchor=H17#H17\">",
"       \"Overview of the management of chronic kidney disease in children\", section on 'Anemia'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Children with Diamond-Blackfan anemia &mdash; Erythropoietin is not effective in treating the anemia associated with this inherited congenital bone marrow failure syndrome. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?12/24/12680?source=see_link&amp;anchor=H4#H4\">",
"       \"Recombinant hematopoietic growth factors in inherited bone marrow failure syndromes\", section on 'Diamond-Blackfan anemia'",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h2\">",
"     Artificial oxygen carriers",
"    </span>",
"    &nbsp;&mdash;&nbsp;\"Artificial blood\" (ie, oxygen therapeutics or oxygen carriers), are substances that can fulfill some of the oxygen-carrying function of the red cell and have been under investigation as a measure to reduce transfusion. They consist of either noncellular hemoglobin solutions stabilized to prevent immediate removal by the kidneys or perfluorocarbon emulsions capable of transporting dissolved oxygen. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?23/32/24073?source=see_link\">",
"     \"Oxygen carriers as alternatives to red cell transfusion\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17472421\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Hemolytic transfusion reaction due to a misidentified patient or specimen is an important cause of transfusion-related death. The transfusion recipient should be positively identified by checking an identification armband or similar method at the time specimens are drawn for blood bank testing and again before each unit of blood is transfused. (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Patient identification'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The usual transfusion volume in children is 10 to 15",
"      <span class=\"nowrap\">",
"       mL/kg;",
"      </span>",
"      this volume is expected to raise the hemoglobin concentration by 2 to 3",
"      <span class=\"nowrap\">",
"       gm/dL.",
"      </span>",
"      To avoid volume overload, the transfusion should be given slowly, at approximately 2.5",
"      <span class=\"nowrap\">",
"       mL/kg/hour",
"      </span>",
"      (10",
"      <span class=\"nowrap\">",
"       mL/kg",
"      </span>",
"      over four hours). If the transfusion will take longer than four hours because of slow flow or other issues, the blood bank can issue the transfusion in smaller aliquots so that each can be given over less than four hours. Of note, the shelf life of packed red cells after spiked is four hours. (See",
"      <a class=\"local\" href=\"#H6\">",
"       'Volume'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H7\">",
"       'Infusion duration'",
"      </a>",
"      above.) &nbsp; &nbsp; &nbsp;",
"     </li>",
"     <li>",
"      Use of a blood warmer is recommended for unstable infants, exchange transfusions, patients who require rapid transfusion of large amounts of blood, or for patients with cold agglutinin disease. (See",
"      <a class=\"local\" href=\"#H9\">",
"       'Blood warmers'",
"      </a>",
"      above.) &nbsp; &nbsp; &nbsp;",
"     </li>",
"     <li>",
"      Currently, each unit of blood administered in the United States is screened for a number of infections, including HIV, hepatitis B and C viruses, human T-cell leukemia virus, West Nile virus, Trypanosoma cruzi, and Treponema pallidum. Residual risk remains largely from \"window period\" donations, during the time when antigen",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      antibody are of such low level as to be undetectable by current techniques. (See",
"      <a class=\"local\" href=\"#H13\">",
"       'Infection'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The rate of transfusion reaction in children is approximately one percent. Types of transfusion reactions are: acute hemolytic; febrile; delayed hemolytic; allergic and anaphylactic; and transfusion-related lung injury. The following types of transfusion reaction may be difficult to recognize because they are delayed (see",
"      <a class=\"local\" href=\"#H14\">",
"       'Transfusion reaction'",
"      </a>",
"      above):",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Delayed hemolysis presents 2 to 10 days following transfusion as jaundice",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      an unexpected fall in hemoglobin. It results when the patient produces an antibody during the days following a blood transfusion or by anamnestic response.",
"     </li>",
"     <li>",
"      Transfusion-associated lung injury (TRALI) is an important cause of transfusion-related mortality, and should be suspected if a patient develops dyspnea, pulmonary edema, hypotension, and fever within six hours of a transfusion. &nbsp;",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Transfusion-associated graft-versus-host disease (TA-GVHD) is almost universally fatal and can be prevented by use of irradiated products when transfusing patients at risk. Risk factors for TA-GVHD include congenital immunodeficiency, immunosuppressive treatments such as chemotherapy, organ transplant recipients, and anticipated hematopoietic transfusion. (See",
"      <a class=\"local\" href=\"#H17\">",
"       'Graft-versus-host disease'",
"      </a>",
"      above.) &nbsp;",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/25/11672/abstract/1\">",
"      Sazama K. Reports of 355 transfusion-associated deaths: 1976 through 1985. Transfusion 1990; 30:583.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/25/11672/abstract/2\">",
"      Strong DM, Katz L. Blood-bank testing for infectious diseases: how safe is blood transfusion? Trends Mol Med 2002; 8:355.",
"     </a>",
"    </li>",
"    <li>",
"     Rossmann SN. Specimen labeling for compatibility testing. American Association of Blood Banks, Bethesda 2002.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/25/11672/abstract/4\">",
"      Lumadue JA, Boyd JS, Ness PM. Adherence to a strict specimen-labeling policy decreases the incidence of erroneous blood grouping of blood bank specimens. Transfusion 1997; 37:1169.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/25/11672/abstract/5\">",
"      Frelich R, Ellis MH. The effect of external pressure, catheter gauge, and storage time on hemolysis in RBC transfusion. Transfusion 2001; 41:799.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/25/11672/abstract/6\">",
"      Ciavarella D, Snyder E. Clinical use of blood transfusion devices. Transfus Med Rev 1988; 2:95.",
"     </a>",
"    </li>",
"    <li>",
"     American Association of Blood Banks. Standards for blood banks and transfusion services, 26th ed, American Association of Blood Banks, Bethesda, MD 2009. p.42.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/25/11672/abstract/8\">",
"      Ryden SE, Oberman HA. Compatibility of common intravenous solutions with CPD blood. Transfusion 1975; 15:250.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/25/11672/abstract/9\">",
"      Dickson DN, Gregory MA. Compatibility of blood with solutions containing calcium. S Afr Med J 1980; 57:785.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/25/11672/abstract/10\">",
"      Lawson SE, Oakley S, Smith NA, Bareford D. Red cell exchange in sickle cell disease. Clin Lab Haematol 1999; 21:99.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/25/11672/abstract/11\">",
"      Adams DM, Schultz WH, Ware RE, Kinney TR. Erythrocytapheresis can reduce iron overload and prevent the need for chelation therapy in chronically transfused pediatric patients. J Pediatr Hematol Oncol 1996; 18:46.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/25/11672/abstract/12\">",
"      Kim HC. Therapeutic pediatric apheresis. J Clin Apher 2000; 15:129.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/25/11672/abstract/13\">",
"      Sazama K. Practical issues in informed consent for transfusion. Am J Clin Pathol 1997; 107:S72.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/25/11672/abstract/14\">",
"      Bennett DR, Shulman IA. Practical issues when confronting the patient who refuses blood transfusion therapy. Am J Clin Pathol 1997; 107:S23.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/25/11672/abstract/15\">",
"      Sazama K, DeChristopher PJ, Dodd R, et al. Practice parameter for the recognition, management, and prevention of adverse consequences of blood transfusion. College of American Pathologists. Arch Pathol Lab Med 2000; 124:61.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/25/11672/abstract/16\">",
"      Slonim AD, Joseph JG, Turenne WM, et al. Blood transfusions in children: a multi-institutional analysis of practices and complications. Transfusion 2008; 48:73.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/25/11672/abstract/17\">",
"      Jackson JC. Adverse events associated with exchange transfusion in healthy and ill newborns. Pediatrics 1997; 99:E7.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/25/11672/abstract/18\">",
"      Roseff SD, Luban NL, Manno CS. Guidelines for assessing appropriateness of pediatric transfusion. Transfusion 2002; 42:1398.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/25/11672/abstract/19\">",
"      Jain R, Jarosz C. Safety and efficacy of AS-1 red blood cell use in neonates. Transfus Apher Sci 2001; 24:111.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/25/11672/abstract/20\">",
"      Strauss RG, Sacher RA, Blazina JF, et al. Commentary on small-volume red cell transfusions for neonatal patients. Transfusion 1990; 30:565.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/25/11672/abstract/21\">",
"      Rock G, Poon A, Haddad S, et al. Nutricel as an additive solution for neonatal transfusion. Transfus Sci 1999; 20:29.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/25/11672/abstract/22\">",
"      Strauss RG, Burmeister LF, Johnson K, et al. Feasibility and safety of AS-3 red blood cells for neonatal transfusions. J Pediatr 2000; 136:215.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/25/11672/abstract/23\">",
"      Luban NL, Strauss RG, Hume HA. Commentary on the safety of red cells preserved in extended-storage media for neonatal transfusions. Transfusion 1991; 31:229.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/25/11672/abstract/24\">",
"      Brown KA, Bissonnette B, MacDonald M, Poon AO. Hyperkalaemia during massive blood transfusion in paediatric craniofacial surgery. Can J Anaesth 1990; 37:401.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/25/11672/abstract/25\">",
"      Carvalho B, Quiney NF. 'Near-miss' hyperkalaemic cardiac arrest associated with rapid blood transfusion. Anaesthesia 1999; 54:1094.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/25/11672/abstract/26\">",
"      Hall TL, Barnes A, Miller JR, et al. Neonatal mortality following transfusion of red cells with high plasma potassium levels. Transfusion 1993; 33:606.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/25/11672/abstract/27\">",
"      Horsey PJ. Hyperkalaemia associated with transfusion of plasma reduced blood. Anaesthesia 2000; 55:294.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/25/11672/abstract/28\">",
"      Baz EM, Kanazi GE, Mahfouz RA, Obeid MY. An unusual case of hyperkalaemia-induced cardiac arrest in a paediatric patient during transfusion of a 'fresh' 6-day-old blood unit. Transfus Med 2002; 12:383.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/25/11672/abstract/29\">",
"      Wagner LM, Billups CA, Furman WL, et al. Combined use of erythropoietin and granulocyte colony-stimulating factor does not decrease blood transfusion requirements during induction therapy for high-risk neuroblastoma: a randomized controlled trial. J Clin Oncol 2004; 22:1886.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/25/11672/abstract/30\">",
"      Ludwig H, Sundal E, Pecherstorfer M, et al. Recombinant human erythropoietin for the correction of cancer associated anemia with and without concomitant cytotoxic chemotherapy. Cancer 1995; 76:2319.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/25/11672/abstract/31\">",
"      Le&oacute;n P, Jim&eacute;nez M, Barona P, Sierrases&uacute;maga L. Recombinant human erythropoietin for the treatment of anemia in children with solid malignant tumors. Med Pediatr Oncol 1998; 30:110.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/25/11672/abstract/32\">",
"      Porter JC, Leahey A, Polise K, et al. Recombinant human erythropoietin reduces the need for erythrocyte and platelet transfusions in pediatric patients with sarcoma: a randomized, double-blind, placebo-controlled trial. J Pediatr 1996; 129:656.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 5938 Version 6.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1003-201.65.114.212-1237D62C13-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f11_25_11672=[""].join("\n");
var outline_f11_25_11672=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H17472421\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      ADMINISTRATION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Patient identification",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Catheter size",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Filters",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Volume",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Infusion duration",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Compatible fluids",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Blood warmers",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Exchange transfusion",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Informed consent",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      COMPLICATIONS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      Infection",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      Transfusion reaction",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      Circulatory overload",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      Metabolic toxicity",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      Graft-versus-host disease",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      Iron overload",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      MEASURES TO REDUCE TRANSFUSION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      Erythropoietin",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      Artificial oxygen carriers",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H17472421\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"PEDS/5938\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PEDS/5938|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?30/59/31676\" title=\"table 1\">",
"      Infection risk of blood products",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?20/19/20792?source=related_link\">",
"      Anemia of prematurity",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?11/14/11498?source=related_link\">",
"      Blood donor medical history",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?37/13/38106?source=related_link\">",
"      Clinical manifestations and diagnosis of the thalassemias",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?10/51/11061?source=related_link\">",
"      Directed (designated) blood donation programs",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?11/31/11769?source=related_link\">",
"      Immunologic blood transfusion reactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?18/23/18808?source=related_link\">",
"      Indications for red blood cell transfusion in infants and children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?5/52/5961?source=related_link\">",
"      Indications for red cell transfusion in the adult",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?37/60/38856?source=related_link\">",
"      Iron overload syndromes other than hereditary hemochromatosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?39/41/40601?source=related_link\">",
"      Laboratory testing of donated blood",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?24/5/24665?source=related_link\">",
"      Leukoreduction to prevent complications of blood transfusion",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?31/17/32026?source=related_link\">",
"      Overview of the management of chronic kidney disease in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?39/0/39946?source=related_link\">",
"      Overview of the management of sickle cell disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?23/32/24073?source=related_link\">",
"      Oxygen carriers as alternatives to red cell transfusion",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?26/12/26820?source=related_link\">",
"      Patient information: Blood donation and transfusion (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?11/54/12134?source=related_link\">",
"      Preoperative autologous blood donation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?12/24/12680?source=related_link\">",
"      Recombinant hematopoietic growth factors in inherited bone marrow failure syndromes",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?8/53/9048?source=related_link\">",
"      Red blood cell transfusions in the newborn",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?27/11/27832?source=related_link\">",
"      Red cell transfusion in infants and children: Selection of blood products",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?10/46/10986?source=related_link\">",
"      The approach to the patient who refuses blood transfusion",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?41/14/42214?source=related_link\">",
"      Transfusion reactions caused by chemical and physical agents",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?10/14/10471?source=related_link\">",
"      Transfusion transmitted bacterial infection",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?6/35/6710?source=related_link\">",
"      Transfusion-associated graft-versus-host disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?27/39/28282?source=related_link\">",
"      Transfusion-related acute lung injury (TRALI)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?20/37/21081?source=related_link\">",
"      Use of red blood cells for transfusion",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f11_25_11673="Apical 4 chamber view";
var content_f11_25_11673=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F75034%7ECARD%2F77446%7ECARD%2F56587%7ECARD%2F68826&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=3\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F75034%7ECARD%2F77446%7ECARD%2F56587%7ECARD%2F68826&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=3\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Apical four-chamber echocardiographic view",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 352px; height: 311px; background-image: url(data:image/jpeg;base64,/9j/4AAQSkZJRgABAQAAAQABAAD/2wBDAAYEBQYFBAYGBQYHBwYIChAKCgkJChQODwwQFxQYGBcUFhYaHSUfGhsjHBYWICwgIyYnKSopGR8tMC0oMCUoKSj/2wBDAQcHBwoIChMKChMoGhYaKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCj/wAARCAE3AWADASIAAhEBAxEB/8QAHwAAAQUBAQEBAQEAAAAAAAAAAAECAwQFBgcICQoL/8QAtRAAAgEDAwIEAwUFBAQAAAF9AQIDAAQRBRIhMUEGE1FhByJxFDKBkaEII0KxwRVS0fAkM2JyggkKFhcYGRolJicoKSo0NTY3ODk6Q0RFRkdISUpTVFVWV1hZWmNkZWZnaGlqc3R1dnd4eXqDhIWGh4iJipKTlJWWl5iZmqKjpKWmp6ipqrKztLW2t7i5usLDxMXGx8jJytLT1NXW19jZ2uHi4+Tl5ufo6erx8vP09fb3+Pn6/8QAHwEAAwEBAQEBAQEBAQAAAAAAAAECAwQFBgcICQoL/8QAtREAAgECBAQDBAcFBAQAAQJ3AAECAxEEBSExBhJBUQdhcRMiMoEIFEKRobHBCSMzUvAVYnLRChYkNOEl8RcYGRomJygpKjU2Nzg5OkNERUZHSElKU1RVVldYWVpjZGVmZ2hpanN0dXZ3eHl6goOEhYaHiImKkpOUlZaXmJmaoqOkpaanqKmqsrO0tba3uLm6wsPExcbHyMnK0tPU1dbX2Nna4uPk5ebn6Onq8vP09fb3+Pn6/9oADAMBAAIRAxEAPwD5UooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooq1Ba+aitvxk4wBk0AVaK9J8BfC6TxSAZ9SlsBjJH2JpT14wNy5zXaaj+z/ZWMSyT+L5UVugk0kq2fTHm0AeBUV1PjXwovhmWOEXc11MSd/wDopjRR7NuOT7YFc4sQx87bG5wCPagCGinkKD94kfSpYoFdctJtPUjHQfXNAFeirDW4yu19wIzkDtTTEoYgvyOoA5z6daAIaKsfZiOroCOuT09KSKEPnLkcgZxkZ+uaAIKKtG127tzkEDkY5B9DzTZLfauQ/P8AdOAf59OKAK9FPdAqoQ2dwz9KZQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUowepxQAlFWBHEwXBcE5DHqBQtv+8KkE+mOg+pxQBXruPhxof8AbeowC5SSS2gO/bGuT178/WuStLQ3NwqLvK7wDtXJwe9eyeGFttB0iO2to5pLxSWdsHehOSMDIFAH0H4OtPDNjZRhbd4pxwPMYMwBH6CtrxDZaHqdjtM8S5XaMDdgfTnv3r58t/GM8mY447dSmGIkGWPuDnk/yqe58YPbI5mKxkAAL5hYsfQHpgn8aALnxG8CWclu8treJIB8u1VycjtnBANfPGqaU+mz3UV1MI5omwoKNmTPXBxj869ik8aNOSW075JHyVDHGR7YxWf4i0rS/Elj5mlW93DcAgs1zETgkdM7TkccGgDxok4OC23p/hUiSbARyGX7oOeD6+xq/Pot3bahLbTosBQMQ1wfLUge571nlGTKtnaP85oAdv2ksrNjIIOTke/B600sWUtzkdBk8e9KdpxtYhiQeOc+/wBaYVKsc4GODg0ASE4RtpCgdR3+g79qcJip5fHBIGOPp16dqijwZAOgY44pwRim4beW29QOf8OnNACmQtGiA5OSSWx/nFS5JzvPAxkMMN1z+XNVlO1fr/n19KkVmLKNw555IOfr7UARy4DYA4HHTB/GmVJL977249Cc5yajoAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKmtEV51VyQDnkdQccVDT4nMbhgWBHdTgigCWZ9uAqqAO27OAe1NDlpMcBiwxjpxxTxj5WwqrtClse36k969M+HPgFr7y9Svbcuh+ZYHAC7PXPegBfACW+ij7S0kTvJhceUWf2+hz07VuajHJqeoy3K3FxFAoHz7TkfgP4h3FJ4k0q2tLll0+3tox9x8LuK+nbrTNTki0zwyiCJYr5xl5SpB6/3cYDf5zQBkSamu9YEDuF4V48hnHfv19ayNU1NGgEHlShjkoQ/THXndjn9Kxk165t9Sa4Z453j3BW+bGe233Pes/UNSnuJ3aVsCRic4OB2OOaANG01JwplWWRlGcB2GF/X9a3tI1q8tQ6tIFLkJ8rgnGB14PHXpiuN0m6aCYxIod3BT5sn8ByKveU8M6tdbYA4ypj+ZUyOvU8UAdb4k0aXUrJZ5rjzHVT5YZ1474xjOfSvO3tJFn8lUzLu8sKMk7v7uMda7OwVJ0kigG4IuPMkfHmH0BzzUfiDSW1BY5rWCYTqMZ28YA6YxyffPagDjZbeeCUpLE8UikqQwxg+n1pqqXKmTdg9Mck/Sl8t0Em4BSvyncPwx9aRSCuHVtw4GB79KAFVQWLc7ck/Lwe/So/4QQSSMgj0H+TSDG0/y9aceQRgeuQOvXp7UAKAWZSCzSHn/JpFcjGzbwep70Pk4LDHGenX/wCtSHdtbJ5zyMc/jQAsz7jwzEZOA3ao6cT2znHem0AFFFFABRRRQAUUUUAFFFFABRRRQAUUVIsMjuqquWYZA9RQBHRTlUscCkx16ce9ACUUpFPSKR8bI3bOcYUnOKAI6KdtPHv0pCMEg4yPQ5oASinAc44/OgIefu9M9RQA2ilxxnjH1p5iYIWO3A/2hn8qAI6KXFO8t8A7Tz096AGVJDkyKAMk8Y9c03acA4wDwCa0ND0yfUtRit4hwzBWOR8oPf6UAdB4E0B9d1eNT5/lK4JEafIR0xnp2/HFfVWmaTb2WmG0uI5IRBEGJc4UoByeoOevHtXO+BdN07RNLgg02K3ubqPBLOAM4ycnH4YrpPFeol9JMk9nJFK67FAXd2z3HU5PFAHm/iARXuo/ZrchI4pSIhGfLYcZzyTnNc18RTpwQPfrJJKU8sFpgzZ9P589K0be2a91AW9r5rzOMJnLsvchVGM+9ct490/VbSYLfqki4/1casNnqByePUnvQB5tdRwbz5RJQ4Cg/e44x0/Wq5YHa0nOMAYGAcfhT7k5lORgkZIGcDngcnp71Cdu75dhznrxj+lAElqyC43sSMH+Ae/b0rS+1S6jKkUpUe5Yrj+mfasksEb5CCMDgjOfr+NXrK2mmJdSo3cdO/Ht1oA39CvRYXLvEFebaRG3mfJ6HHPP/wBeut0+/WUwztesEjzykgTk9UGScg+v1rgDdG2lCIis28OjsuM4HQcD0GRXrfhf7NrunvcXAtbNIUBWPjMreqr1A596AOC8Q6INSt5tStJUba2ZIwQM+nf9a428uZ7iTfd3EkxChQGbJ4P3TXth1QaZH5FvoolWUHe8ZbaFxyenA9+teX+IdJkaSS+t7O4Fs7EjfkkcevHy570Ac24Xls5GeuMZ/wAKTKjBUc993NW5pyLaOJobYNHldwX529zz27fhVQltqnJwOnsaAAJubCMD6Z4/ClBHLDAx6jj6UnCk8Z6j5h0pOSO2KABvTBGOx7U2lNJQAUUUUAFFFFABRRRQAUUUUAFFFFABXX61ous6Ta2l7q2jz2dtMD5Ek0ZAkXrn6DPFchXpvxI8aaX4i0jSrew022iubdT50yw+WST25Y5HvxzQBw95qIktliisrS3RiH+RSWOOxJPQ9fwqs7BWeRgGZ14Lc7cj0x9fpUTud+Y8g7eeMHH+fSnFdgJ/hJzxkj2z7UAOWdkQRpIVhbqM8/j7+lPlklaLyhM5RRlgSSAen51F92QKG8rI/wA5p8Pl+SokcA8j73TrQBCwCyMFXC453DJAOKfMHbK/MDnoT19D9aayEgYQg9MEe3060qOFVlYc4OAe2M9fxoAA6liFjBX6c+n+f51MyoQVRG+VuSpGfb+tUwDjg8nt6/5/pUuR7sCMYHGenHTtxQAKSUZd5/d55zxjpgfXNMfBIAGSRwATxSM7EZPptH4U52bYwwoXOeMfpQAOGJDNgqRxzx/kVJkNCQQMDJGF5/D2460wy7uWG5gMA5wR/jTerbVK89ScAf8A1qALUGcokTMJGwoUZ5/Toe9e3/CnwPFNbxSSzLFdNiRpd2Ao5wAMjK9a8l8K6f5t7byy4MYbeucgH15xXt2giOznE13E6QM+EdBynT0GcUAelX2lR6Hp7S28KS8hXIfaSvPIGefpXG63rlwikp9sggT7wm2uD9PQ/wCeK6fT/ElqsTp9pjmNvlk83OBx09fp9K4bxZ4hk1LU0geXyrYg7gAMEk+uc/TNAEHw98VwJ4jkim09JnibKui4ZQB95TjAPc+tUfid4oEmrO6Sh2fBkDYwwGePu8Y70eAoY7TxK8unXsgj2s37yHzCcdhzkGp9Y0ybVNdvbm5ls7SNx8806gEAdMD29KAPEtd3G4MkYjCsd25AcEfljHNY2CASASoxnNd94qsI7ZjHa3P2iAZIdbdVU993uO2PauKmj2bjtLMCGOR+ZPHQ0AVgAW2jHPduMVbtmmGCkuxeB1AGB9T7GoNpVz8jAAjqSAufWpIsHPleZ3HIyBnt1oAvaXdQwyTPcW8V4rjAjcgA49s5ruPCbW11q8EkVvpUMX3gZZDt9DkZz+Gea4C1LxPJNPG+MYznAIPbJNdRoZWGN7lp4555cboXP3QDgNw31xxQB6l4ggsLq6MtrYGcsCiSQJxKwHUYHTtj8a5++jns7Rrcv5gdMi2eA7Rn/gPT/OKtaJq11f2jReZJ5kDbR5aD93kdevBHpVeaDTbO7RnnuJpS2XLHJBHsf5UAeUa7pM9hPl7eaNHPBcH+eBVHzIRbGOaCQ3AI2yeZgBfTbjn65r0DXrm11H7QjyNbWIyyKEBbd2yMVwN7bCEts3bM8ZGCKAKuaUE8kFumPwqWBYDFM07yKwH7sIoIY+hORioQMkD14oAVieN2eB39KbRRQAUUUUAFFFFABRRRQAUUUUAFFFFABV+UANkEZzwoA+hJ9jVCrc6SpMf9lsjJ9x+lACSKcuzhiqgAAkdPTio1YqpLHJycqcf1p6IoYk/LtXk9m4PvUsKRNvCnaxGQG/D+dAFUPkAHII7jr1707KncJPvZznGO/Of896fNA0K7l3EfdJOOD3GKgJ4AOOPSgB77s8AgZ4yMEegzTSSVJYn8uv8AnNKAQeoUjv1H6Uj4LYChPXrxQA7J2jaQQvOPT+tMBHcfkaBjHJOfpSg8rjcT2x/SgB2447HdyQB0/wAOlNyCcHoe5/h5pAQGzzj2PNKOTlchuvFAADjPTB9eas2FsbieIYBBPbuc9DVb74AHX/P5V0/hsK6CNrlYmDblXkI2PfPJoA6DRdIVLiG1nSSNHTK+YflPPqM4HtXVR3MOl3EEVpJHJMpJdSSAPxC8rWJJI1w/7q9eTZhjEJNxc+oBOBg9qrWsRZpDbKom3DejyLu92y3bjoKAOh1PWboXokjSFfM+cmMHcvGOcjp6Ae9V/DbWuqasVt5mlvcFhE24DPfOcfhWNqM07QMZYVEiKQDCVOBjq2B0/GrXg3XI47yIPbWgn3gb5QSV78BRmgDtLa4lOpqIrWOC8BKBlViFI47Nyao6nqdrFfH+2Jxd3Cn5t03lgkdtueo9O9dRpGvyXGtxRWEsb3sYwo8oxgjuDkflTPHlpr2pyTXNxpVtMzYdpIrf5wF9fmH6UAbup+H9H1bwrbazbWkNva+VvcvAoZvcDPHv618/XfhS51641uXQUgW30a1N9cPLJgmMZyV45PHT2r2qHx55XggWGoXUKyIcCJIQXI91LYHPbNcN8OdX0G11Dxxaa5q8ekR63pZt4LiWLcoZs5O1SfXOMigDzODwzqV/4PvvFECQyaZp9xHb3CeZ+9jL4wxXH3CSBn1Psaj8T+GNR8MwaO+omJG1WyW+hiSTc6xPkLvGBgnGe/55x6J4Kv8Awp4N8V6l4e1LxDFrHhDXtN8i9u7aCRFglBYodpBJZccEA48wehrj/in4lj8XeO9T1OzULp+4WtmpHCQIuxML/DnG72LGgDk1dwvLymPPyAHrjgVr6Zqlpb2/ltBcPdkY3F/kz15HtzWGeMrkA4wRjjOcf5NSR+Y0m5M7n6ED8+MUAeo/Dm8h/teBdbkvFtycM4clSfViD16da6vxhFDf3kn9l7TaQJuaYy7AB/eAz8x/KvGNLZrZ/MmJRSQXUOQSM4wR2ODxX0Do1zpt3pELWdjFDBHtQvOp3yt3Oe5x2oA8g8RXaXUcUcMLx2kXVvQeucnJPpXPXts9wu5ysSqDjJztz0HBOf6V9C3egaj4t06aG0khtrBVz5iR7Rgf3eeT0zXgPiKw+w3slvH5h2PtJXPT/Yyec96AOdmUK+Bj8DkfgaksoRcXKRmaGAHP7ybhR9cA06RCyEHJZRgYBIx6Dn+lVyAB15FAA4AdgGVhnqo4NNp4QlwiAsx4wB1Pt60SxSQuUlRo3HVWGDQAyiiigAooooAKKKKACiiigAopSP1pKACtJ1znBCrn5iRk8nt6+lZtbNyV3OrZBznAY59z78igCs5G39yoyDklfx5prOMIqIyuq5DE5A//AF/pSyBdq+WGjI+UkDoPx/nULFyJeSMMPmHA44oAdBK0ezcWUbiMdByMHimtHlg0JynPUjKj0x+NQ7gAQUAYH/PBoVgMZzj6/wCe1AC7+ML90c+me3rSNjPBHAx060pw2SAoBPU9jSlCh2lTvzwSOPwoAjOehGCOOlSbWKM5I64ODz0/lUeP0p6AbSWUkDuOn0NAAygbenrz/I03PPPPalPzHdwTnG2nKuSGVSUJAIx+JAoAtWcSAHzVwMck5H4dK2454IwvyJKmMtsYjg9+g5rHtDCMl4RIG6ZPIHp07etbNm9oq5mURqMAMmRuGeh+X8aANe1EduIp4ZZtygZZs5bPTI3dRVnWb9XwyTwBkYAuoKgH1IzyfasyE3Ck/Y3MkR+bJJVT9flAzWfdXaoxivGV8ncyljn8fegB11fTwlydwLDcWA4HqxGeevSqlreATGKUZAPy7MFgOpw2Dyf0qA3BMkm4MFcdckn/AHgCc5/SpdPkiFyhy6plVJjPIJyfx560Ae7fBq3gEZM+jrcDAP70/MFz6heR71tePdGS51Nmkj1FbRwHZuqhfTp27ZqP4XBNHc3Fteq+5fL2MRGCCOjEk8c/Wm+PriCAXCRQm4jkIDKjiTnrgnGQKAPN9d0Jrm0ml0y6We3hOG3x7GOOxYd68yvA/wBocSHadxChQck/hjmus1fV5LeOaGJRGjMdiBANo47beenWuQuJbqV1MhkOAcA9h6dOvWgCnuJ6cAdBnp9KUnJ4wO3B6dffpQEkBXKuOeOKPKII53AjgqM54oAlEgHRQTjZgnj3HXp70RTKh3ldxJxnIBH0FMXIYc4DcDOcEc/pmnp8zknDBeOD2/PpQA3aJSzLksWJIJAyM9h/npXpnhTX7ODSFsbczI4/dyMIdwPcYOMBq8yfaScKB8oIyfp710fgy8kNwLKOGBlmYBlI5f04zz+FAHrNzqFpp2jTrb6xKHlxmKIbdx9OnB68V5Dq0s805EWVSQAkjPT0XivU9J0uw0PUUuvENvHdTybREmwDDemM8Hir/iDwjZGwl1TU7qCzimDNFb/LvY9gOPzA/OgDwW5K79ztIduRyeG9McdKhdAVJXGR1Azz7j24ra8Q2yC4X7HA4jIJV3TDSYPYY4FZSR+YzNLuClc5Axkeo46CgCuozlAASf4qbwD6/Wp7lIhIfILuuOuMc+vTpUR4GAQfcd6AFljeMDfG655ywxnNNznqcYH51LPdXFwFE88soUBV3uWwB0Az2qCgBxGcYABPvS5yCxUHtnPf1puecnn696UsT1/H3oAEBLDGfXjqKCflxk49O1IaAcHI60ABozxjt/Kl5IAySM8DPek7UAOcg8qgXPPemU4/d9Pw602gAq5cs/3EyQTnOOc+1U6nuuJcF94x27e1AEZJLDODjtnjHpQWwMDOPrnimnk0A0AB6+lJRTugIyPyoAMkY57etOOc43ADGRg8DIzim+hI4Ht1o4A6nnqBQAd8Z4PWkPJo6kkk0HHGCaAHJ8zqCVHP3m6VabaqBFJUEbQ5OD7456dahQozEBeeTzjn9OPpVliJVYkAN0JzjqeDkD7tAD4vLQsHmyhyM44I9Bz0zWg0mYo0juGlDAERkg7fYA9utV40jJiXzODn5Twc+gHTFStaOJd/lyqvzDcqjIOOo54HFADk8+2UnzUX737sjIOeuBjFfQfwnu4rb4W+GmfXrXQvteuyWzCbTReC9LEfuSSP3ecY3ZA96+cyY0gjVoVLrhQ4P6e/1qwdZvorK2sI724Flaz/AGqKHfhI5eMsgH8XHUdKAPbJ/DNn4sn+IvhPTdEttP1+z1mK+09UwpETMsT4YdECnfjplx6VwnxcvtP/AOE+ksNGht4tN0iJNMgMYA80xZDsxGMkuTk9eBXLW/i7XbXxFNrkGq3SavKCr3qsDI+QAVJ78Y/KsyCOS8u3CRPK2/cdq5Zj9cfn60AfQPwGvvtV99n1DVGt94zFDtOxgOwOfu/41q/Eezt/DWoS2gtPMgmO9pIhtYAnOSxbpz1ryPwfr194fu0hvU2Qk58qRDEceoOKveNNc0+6kLxed8+MrtYKTxkBj1H4UAcx43nhW4DWzzHBAO9gxGPfPauRIaUK2TK/Q+wrc1a8N3sCSMqIAFUZAAPUdfw/lXdfDr4Wz+LPCMniDStRs7y5s7wRSaRJlWmUEFl37hguOgxg8/NnoAeZW+j6hPpFzq0FjPLpls6xT3CqSkbN0BPY/wD1qpsAQT19CBjd9OOK+yPF1hoXh7Wr+4gtIU8KamIdL8RacEEaWnmKPs94qYwgGQpOBzz1Br53+IGn+CtPt4tM8LXl3quqwzsLvVZP3Vu6gEbETnpgfN6jqQRgA8+BHDZ2twRx3z/KkYjdghRzkntj/CpHLrLvDNncMMBz/wDr9qjkHJJ/A4xkUAIqs4IUE4568Ct3wxNdWc8s8e5ARhiOGPNYjMxQKdmM5GAo6/8A6q19HthKVdo5Zdn8CHCkccnj3oA9ct9fgXSEi020vLmcgfNtLs3chjnj2P0rIhk1R5jfatDdM6gmP7V823A+oCnnr3qWPVLeKySQahHDFAvEKheR7/LyP1rM17xBqWuaUY4VijsIv+WshK7V7cYGaAMbW9UXVriZ2gVCTje5AOPU88e3auXuJIANrO0r5ywAwpOMbuvX270txKZMRSOPL+982cjtz7dcYqpOQsjbfMC5GVfO78ff0oAlZzuJATGcheN2fXHr7VUYAHAORUpIBPysGz3/AJ/WkwRxJuxu+Y5/l79aAIif0qY3MhtlgKxbFJIPlLu5/wBrGf1qI43e1NoAXJ/pSVPHLEttKjwb5WxskLkbB3471BQApxnjpRmkpc0AByeTnnvSoNxx37CkJJ680Z/WgBSCFHBAPc96bTy2VxgDnPA60ygAp7EhnB4J4P50ynMxY5Ykn3NACDHOaM8Y7UlL2oAByaXgDBAz65ptPAXb3LA8gensaAG44z2o9amkUEt91QMnB4wfT36UwIxQEA8njjrQA1TjJzg4qTIGDgnB7nBPH1pVjYf8syRjkMMfrU8UQ2jCKVByN3c+5Hb0+tAETpJKw4OT95m7n39KtSGFByvJ564ywx1/GnHCLIJH3gADDHqPft6VHGS7jYzY27sE5A684z7c0AbGjm282JLtyhc7sqoKjPfGK63UNCvPsB+wSC5i/hlVjkfTgfjXBaekizf6tGbbwcjAHHrXX6NeaaJIvtpkt5VkDB1GV46ZwOKAOXv7O7t7jaYJI3JBDFW4Hc5rOSJ2VcZwM5x2zk5XnpxzXqnizxBa3FmltNAkwAxG6qDjr04rzadI0xsGd+SoABPHYDstAEEBKfOko24ycjg88ge1XHukZvPjIikH8QOM4PrmqI3q2WYAEbskHGOgP6imOGJK9R1Ibvzj/wDUKAOt8OtL4jmW0vtVWMSYGZQpY9hkjmtPxT8P59LX/iWzSaizcfJAduPTNclopeKaMvLCvzDIeTGeO5yOfxr1G0SzuoY3W5iFzkDZHehVPuQSf50AcLpug6lpWoWN9rOh3N3psMyy3FtIpQTRgjcu4DgevFfRXjDxB4U0K3gvLY2dw97CYJbTStqi9tCoZJPkGIWhkbCMfmwp6k8ee+I/EU9tp8WnxJbokwwSswOMepGfyrzzUtRis1jntGtraYncY4o1bcR/F/8AWoA1Nc8Tal4ju0n8S6jI9wLaO2YeUUWSOMkq0oHDnLk5Pc9qw7qHTZXbyZ5Wd2wZACFY9Pmx09q0/h3p9t4w8aW665cpBpFnE+o6jNMQubePBZQBycnC4GTgk9q9u1Xw7oHimaG51IaAz/b31OeXSwpCaQg2wxy4IDSSEIFJGcE4+6RQB886t4Za2IEF5FduyjcI1LFc9N3fd6Y//XUPhnWEJlfT7pFXne0ZwvHUn19vavefGPwne28TeKte0OW18MaDpUQltxLFlbmQRhpNo6qmTgHn5uFHpg+IPGXiCy8P2dlqWnXlpd3lusqiTavmRt91sDqeDx7c0AeMS6Y8apExJkztCFQOvpz174zXU6f4LuI9KN3f6pp9rjhbYzq0kg9eGwO/Fb/h/RZdavYITZSyXU5wCg+6T7+vXJFepQ/DHSvCNh9v1m7hjmkHFvMpbIHpg5yKAPnm3uI7a5KWyDAGRgowPqec810V7oWrXem/arxF0+xCBh5rqGA/vY68g8VreJ9Z0+4vjLaW7sFb5ZEjKq3vjjpXIT3U2rPJHdX1xECciNnYqExztLNyfagDm72CJLh/s7x7E78MADwD05/pmqnJGEVcLnnGTz7966ptDjjhaW3jkfOT9oZuEHYg5x+NYF3tR1SFUUA44YMQfbnmgClt2hwc8YzzjnPSk67mYg55J/p060+VEGQHU4GeDnb14Hr9ajwATnGOwzmgBcA44LHPO3j+lR07Az1yKONoHegBDyamtBbmXF48qRYPMSBjntwSKhIwcHrSUAFFSW8ayzJG8qQqxwZHztX3OAT+QomRY5GVJUlAONyA4PvyAaAI6XJ9T6UpGcng+uBTaAFJycnrSUUUAFLjjPakpTyaAEpwOSSee/Pem0pFADwmSfutxwB1P0pythtvBAz6kD6e1R7T749uacjndkZB/h29jQBPtUqV+Qk8Lg5CjryakjKsWdsqcg7h6enT6Go4xF5pJ2kEgEY4z6VoRwoFOW+boMsD2z19KAIFVUQqyMRw2NvA6deO/p79qcq4Y7RznBGPXn+tKT5YZpACP4D24qv5rglM7WJxxzzjjPFADnZgsu4yABs7myefQ9s1I821D5nynkYJ5579c5x2qNpXLqY9p2sVA6c/4+9JKxKuM5bILBl+YHH86ALWlXBinVWeNVGPlb5h+PP+eK6mPOowiOYwJF0Eowc++2uShVdxBiDMR8rensOeTzXbeBvCV14rstVu7fVrDTLHTI0e5udQmaJRvJC9M9x378dxQBx2pxm1mKxFGTAJI5JH17VSNwvPChyM7iOT/wDWxXd698PtYsvGWjeGt9jcXWrLFJaXNtKZIJYpCQJA2M7RgknGcDIrG+IXgy+8DeIpNJv3gmkREnhniB2TxsMhlz6NlT7j8wDBR8rn5sk8D1/Tp0pZHJlUEupB4+Xj3HToeo/Gotkbly0n3TkAAHAH9Pap7dVSQsqqCrDA3Zx/+vt6ZoA7X4eaNHc37vqOm3bx7cK8a71H/wBfmvRFjisb6a2hksIIztAF0hcD8N2Q3X9aqaLP4VHhxX1USJcKp2CK4BO49uF61x11rE1pcyf2NHcGCQ4QuckcdPu9fWgCHxpePBqFxHm1nQnG+Hcqg9sfN+dcPcK0kijzVMgHzAsOuOPrV/Vr68v5na4kWRmBOQ3HPbge2TWNMoWbYAsgx1yensc9KACG5khnRk2Blz1AYHPrng9a3NB8T3uiyCWwu5ImE0E8kOSYp2ikDp5qg4cBumfWudZiWG0FfQZ6UinG0noD69KAPf8Aw98Tbfx1e6fonjO5SyttQ1D7TrF3NIFglij+aC0jH/LOLIGcnrkk5Y10es6deaj8SrzUfG0NrFbXBAsVMqvE9sPuCNgDkYIOeOWPFfMcXzD95JsAHysGyVHoBmt3R9QmguoHS6iKW/CiVjtA67V9BnnPvQB9u+FrfSdL04nTHtFVWODtAYDGcZK545riPFttH4nvpY3SW4RQfNlGX2ntjA4+lch8MvifoiSeRrT75XUZh2BkckdNxP5Zr1TRNZXxH5ttpnh8WllJ827Cp5w/4DQB4lrPgy5to3ttHtbi4eXnzQdiK/TjK8DrnNee6t4cv9Duf9KljeaU5kVQSiMMYy2MH6jFe+fEzSPsIjS3a4xvBVLZwQD6tgE8eleJeNVmTILRyLty4TahB9SGGf8AGgBtxqAtdNEdzK11MUHyoSixr/nua4C+uzLP5pAycj5W6D2579/xp86zBW2lfKHG8jg++SKoEAnczLzkcAj+lAAJMA4UA54wTwOcj6c05drRqBw5bGc9B6fTmm7OMqMjg8g8+tLJlgCTjBxgjp/n+tADQMjOF5OBz/8AXoBwvbPUeopTkLjggHOMfTn6Gm87f9nNACGkp3IyD+VNoAdtO3djjOM0g6+tBpKAJ7q3ktnCzKqllDAK4bg8joTURABIByOxptPeN0VGdGVXGVJGAw9qAGUUpyODnjtSUAFOY5JPQk9B0ptOwFcgtx0yOaAG09doI3AnrmkC8ZJGPrSDgdTmgBygZGVZh3wcf0pYgCeRnnoOvelSPLYbOckYH+fXFPWIcqxB4yCO/rzjsKAHhlCHar/J1G485z6dBSvKWUEOyErk7W6j86axLLs2gA85Axz/AIH0/wAKVwqOq4YEAsDnOD/hxQA1pt775Ms/Rjntn9aYzuIlXaAoORxnrUhRFjJGRgg5zzj1/wDrjNJvCgEH5gBg8np1HFADo03HcFUY4GCMden196GKiRlOTIuV54P8utNVAA7gK3GXA6KO3fmmeZtLAopYcZB4x0x/9egC0kpUDYJcngAHIB78Y+93r0n4XeM4PC/h3xrG0kX9oX9rCtjHNb+eksiSNuBUgr0bPPH14FeXJKVYoBtzxj29Pr71OkzlQF2u3c7Rz04HHH170Ae8n4peGZfHt14xksdQnvYdDjtLSzlBQNcklZCjAkRoFOMjrljjNcz8SvF+geMfA/h2Sws10nVtLkazj0/zZLhvsZUbG81gMgMuMEk9a85EjSIm75XI+XC9cdhgVRkZfM42hgM5BOAPb29qAF3hD8oGceZkLnPvyeKZI0gZWZlbaAdy847UsMuxAp2qAecEjHt79/ypHMYhyoAU9Dgk980ASbmYjdJhsKoGQCDnsOn41J5lxFIwV/LJJUAkDd7e3/16rbGADDhmxgL3Hbv0ppBKA4wpGcfjwDz0oAllLYaRzyw6LwDjg8Y4/rVTIJxjPrt79fyqxnacyLkP/C3Gfrzkf/WqJ1YeZk+5yBnOf060AMwBgEEAjv8Az+lI2O3Xuexpxyq4BXBAJx/nrSNwBkYOO1ACs5dRuJPUZJqWGSPcpkDlFHKKevt9PWoojt3HarDGMkdM96awCkjIPoRQB3eja3pNtblLfS/MlGAC7twT/wAC6e9eyeEvF08Fksep6l/Z1lGuxDJKWP8A46xP0zivnCwiDzL50giUjHCEsfccc9q9J8OXEcO5bfS7m8kbje0GfxbK8+2KAPQvFPiLTZ4YZbLUb5Zs4M0pwuD/ABEb8fT1rzPXLTT7+aS6n1wkqAWGAWJ9Qd3LY6Cuxn0W3urQyz6dLCScxpJIwJP+0OmfSuB8UrptqjxPEIz0AZiQD3zt6t7/AJ0Acrq4t/KC2txNMu7J3bcgepAPWqK7bZ2bau7A25IYj8M09pjB5ghcrFJg7gDn9e9Lc3ME+AlniYqFdjIzc45YDjB475FAFN2V2JORxngDr/hQShC/K2QMHB60hUDuT6kDj2pCBgYz70AC4yM8e/XmgqQSCOR1pB70lABTht2853Z6dsU2nc7c8Y6UADY/hJP1GKTjHvRmkoAKmknkkhjjeaV1ThUYkqo9uahooAXPGO1JVg3UpshaEp5IfzAPLXduxj72M/hnFV6ACnEenPGTjtTac+NxwQfpQAIeenr071NvXyyFBU9A27B56jGenXmogwwflHXP/wBb6VI6lY0Lt2yoPf8A+tQAjMMABnOR8wzx16fSnO5WJU3Egjnnke1C4Pyxrkntzhv/AK3+FMdShIXcAOckEE0AOMhuJGadsuxyWOBQGwGBIVioXnn+Qpgy7HALDnqcc460rEd2+fdyQP1zQA6Nz5gVUBP90jk+o9u9X9Pi+0I5OFIyQT37du9UiygbY1G4cg4wR9c0sc3lSAx4TgYIIOPXtQB0ej6Ct1I6B5I9y4+VScjHJ57VHr/hyWwG9JfPQZG3oQB269PeodN1WS3lMsbOjE/I6fh146V2+meI7XVz9i1yP94Fyk8RCtjqBtA5zQB5a3mF1UqWyBwD1HbvTkdedpbB45/iAH8Qz/8Arr26y+GWka+GS31aGxuDztdjIHz27Y/CuI8W/DrWPDJQ3KRzxdPMTJG0Z6jFAHIx3CjbllkUgFiwHbofXjPTvVYSozscAHIb2J6/hU0NvlzGxaMngO6tj8fTpxUcsDRTAlg54wRnBPTmgCPZulUsCxbnr27HNSBUB2uyrjBOSMcjB4x/ninFg7gyrllbGR3J5688/pT1LfZ2TCEH5tzLll47HPB4HtQBGVZgHIDM3CqV6gd8+lMZ2kdUwpOc5PTr6/3abllgbhccjBPIz/8AqqLAy2eeMgr0oAsNlSfNVuoyW4DfX19q9Y8Z6Dc33wY+Gcuk6TcXE7Jfee9palyR5q4LlR7cZ9DXkOApJUZwM4bnHTn9a6PTPH3izSNPh0/S/EWp2tlCpVIIbhgiAkk4A46kn8aAPoLwH4Oii+F9j4R1EaZFdeJbWa9uTcXKR3UM52m02xk7mGEJI7En3z8vXlvPZXk9reRvDcwSNHLG4w0bqcMCPXIOav3mtavPqsOqXWpXUupRFNl08jGWNkxsw3UYwMYqhcTzaheTXF3NJPd3EhkkkkYs0jsckk9ySetAEKscgAkegHrUkL4dSODnAUDPHtk1HhSOoHPXPH5UpCruGSRjKnGMn/OaAO78GaXpjziTUgVVTuR4XBbPfjcMAd69Qt/FOhaNEitOhiC7FYTE7RnqeentXzw7sPlVmUE53MeT71o2rxG3G5ZWnIzsjY7vwPNAHrutfECxnS5ttwvjghX2opH5nn6mvG9XvXuZmWRFTaThdoyvPQkdeMc024v7go0QUQLzkJlSfrz/AJyapE8DcT04JoAN4KgMCSOO3T8v1o455B+nce3FHy7iWBAxnH+e1LvHPAP1H6UAIcgdiD7UgHTg89B60mRjGMEd/WnbuD3z6j+tACMOTzu7k0h4HQ5pc8n+LPc0gODkdaAEpcnpk46UlFADgeCOn9aQdfWjFB4GCMUAJRS8EnsPege9ACk5AFNoooAKXjHvSU5uuc5zzmgBtS+YdoCrgAc55zTCRngcUhJY5JJPqaAHqf7wDEY69unWhnO9mAIDc4z1/wAmk3EHkYI/DB9aTJU8Ed+aAA/c4+7n9acMbcsDt/r/AI009s5wMcZqQuMgICRjbz1IoAHJOVUfN0bOMk/5FCI2VLBcN0DcA8deKZuwQBggHPKjmpGYsFMoU4+UYIH+RQBft2D23lptDk5Z2c/NgdOtX00aT7OJ5bWfaPnZ4vmX6+x9j71gRs4kO3C8n7w6f4V2fgvxRc6JOwZt1u33lcbh6nsec0AdF4G8XRadex2+oDfHtCgyryg9cgdfavT9Y07T/EukgaXqFm45bypZVBbPv2rEsbrwR4iy99EYLk5LNGHBkc98Y6/hite1+H+mzTC60C+WSRCrKkm5GXj1JxnvigDxnxV4T1PRbyU3Nm0cTAbTGfMDf8CwM9M+1UtFi+13CwsiySMQgUYLD/6/XntX0hcaWk1q1nqk7WckQ2NLKC0ZJHbmvGvEvhq/0uR57S5S7gVjsMD4yM9kznFAHoPhv4Radeack5gMEjrgmWQTfoRgV57498Dw6NftDGiqE4EjAoGPJ6AYBqHwx8QfEXhdZUcytEePLEu1cf7Wc4FWtd+ItpqyyRXmn2UkjH5nEYJI6bc56enFAHlV9E0MwA+9nkpnGT6cCqyFkcFR83bj1rS1CaxnmaaKKWIE4AUDjH44pDjyfKAsyzcK4xuH14oAzy7BRgn13Z798fnSxu5KANypwoP16UOMyAbcHoRkDkdfpTD0BI6igCUNhztb5R0xnH69s4zUbL8xUDBB59qUbCnHByBzz+P+fWkG3b1x7f16UABG0fdBGetSBswIhIxuJxkD8T6VHjDAH5eh+YUmGx0OBz0oAczDnPIxxxjHvxSbz0DELuzwKQhshSDkdsUg5wADmgAJycnrQD69KSl455+mKAFOTzx602ilOM8dKAFU4ORjjnmkzQDjkdex9KUHtkgd6AExxntSUUUAKevpSUUUAKaBwaSlGO/T+dABmjNGOM9qSgAopcfLnI+lJQAU4Dc2ADzwOabSkYOKAHBCTjIB75OKQjPT7o70nGPepANyE/LgD2B/zxQA6VGBHLFWPTkkH396au4lRsfAOAFJ+9/jStwNrINx+6B+H555pWceYwUuckkYOMZoAFAZvmI+pPDU6TADBuHVcYGf5/j3pNo/hbjorH8/8mlfzMnaBwMnHTHt7UARv8pcMu0n0P8AnimEYHXnOKnlydrqAO7HH+eKjX5l5YnA6YJ49PpQAsUgjzjBHow+9/hxVlBh1EeEkXgbjgA9f1+tVOWHL5zyc54+tOK+WGwS2PYjb7n+lAF2yupoJlInCOo4BXJ9hn15r17wJ4x1G1hWO8jEsQHzSR7W5+pBxivGIZikjZc5J5DjOfXnsa6XQtWghQrseIc7kRiS7Dvhmxn2oA9o1Txlc28e5FjljVQVjbAOfUEjHpWfpnjRdRvGt7mCJrnq25RnHXIIXGK861PU4LtZHubmQMcBAygsPXAztBrM0O3D3ckkExkIJZjJ8px2Y8/oKAPctS0OyubGRYIo4HYF2kjygyPdgQR9K8Q17RrmK9uUu1liiLFhK8TYb8hz7VtN4jv7FEgN/P5XPCvDtx7buce1Vb/xLa3lvHGG3TE4zIV57enGR+VAHJ3emrHlY7hSoxkNkEH0I9aptCfMK27M7ZwoUH05/Hitx5omMYksFQE4BRlbt6/1qBLOJnkQ+UGJ2KBCxOD9O/vQBjSKQ4bDfMcccZ9fx5prqcLgZz0Pc1Yu7R45yAj7CeMptzUByTsz0GD82B+tADd3HAA57E0A4DFid3BAI61cs7N7pkSBHklfkqqEjHqMfjn/ADj0TwZ8KtZ1u4iYWUqRhgS0ox68hcdB6UAec29q05Dq0UYJ6k8LWvZQaPZMz6kbiUg5UwKMenB3Dqe/ava/E3wpt/DekG71PWhYKBjzCTGuc9OByO1eHa5BAskwhuxcY/j3cnHTPtQAmpajpzkpp9hhcY3yklv5msiZ1kCbI1Ttwf8AP5moySMgZUEDIz1pCCM5B44NAATSk4yAQQQO1Jn9aV2LHJLHOM5OaAEPJpRyMc/nSZ4x2/nSlicjcSM55oAQYzz0pKXjHvTpHMjlnwWPtigBlFFL2oASiiigAoopScnJ60AJRRRQAUUppKACnZ54JGB3NNqRxtxjb1OO+f6UAR07IBPHHbPahzk9APpScdj+dADkkeP7jEU5cIN2AytwVzzjP/1qYq73CjjPHNSqGU/OSp5ySM8ntzxQAiOm7CpkngZP6UxMEgbc/j7U8Bc9ckjJA4z7f5xQEOQCSRggYU598UALM5dSWVOSOQOenSmPgY2fdx1/DmnFXibbv25JA7d+vtTtygiRGHy8EZwec9PagBg8vaoORkckc053VlCt0Awpz0+tN3FwcnGFxn15oK43FSMADnkUAN5IyAMDsO1TEEbACRhcjH1/mfWmquVOV4BxjqR+HvSS4LEMVBxnjJx1+UUATpO235SAWPUEgk8Drjj+VSQXt3BlYbhgG+ZSp5Jx6/zqgNu3nduz0HpTxtJwob5hwCAcn60AW5ma7U5LFsbgxGAQOpFErKY/l2OVzhgD+JJqAyrsKrzu+8SPxz161oHTrcIDBdyyEENgxhcf+PHntQAQNcyOn2mNkRAFBbcFAPPOK7fwP/YYuWOpXG95DtaO3Zs8e7EY/CsPQzqMEyxzC2MH8P2nbKnPOMHrn9K9M0DwJqPiKQCM+E4jtyMxJGcemVU56UAP1fwhp+qWyvpEWoTt1Adoypx2PPH+elefXfg65+0GNdLvFkX5ZCyhRx9T1r6I8MfDbxX4dJlSTRryIr/qLcmP9SuD+dbMn+gzeZ4mSWz3nOzy0dWPQAkUAeS+BPAHix4ozDZrFZScYdN3HPJIPB4r6C8JeG59Lth+7tYZvvEqjgk/ixqK1+IfhuOGKGK/VigxgoV6deAMCnXXxG8PFF8qaacHn93GDj86AMb4keHv7e0ua3mhuTOqlopDeRhFPqAevrg18aeMNIudG1A20kquEY/KrBsE9sj7x9fTpX0p8TviNp17E0NpayxFhwZgFxxw2BnB+tfOes2dxqszTWTRSKhL7UkbOOORkACgDlTlWIPBHBoBJIHBHTn606aNoZCkgwwppOe3XrQAh4NBHcdKmtoXnLImMgZPOOO5NNmjaNiHYbxwV7igCKil64HA96UggZoAbS8Y6c0Y46ijPGO1ACUvQcg89KBjPPSkoAKKKKACiiigAooooAXHGe1JRRQAU5m3NuYkknmm045yQeOelACHGeOlOPzHOCsefqBRxwvLc9j1pcEAFQR35HIH1oARRhS3rwDml3txhiPl2/h6UpG3dt2jHfdkmmZwxI/DHSgBwx3yRjnb9KVWBySoJzkjHX8e1LGA/L7cDJ5OM9OKRcIVdMEc8MP096ABmLn5vmJ/DPFNPzLgY+X25I9TSZ6Y4I70ZBOTknPPNADvlbCruPXjHU/5/lStwAhPK9c4OPpSh4wV+VxgY3AgHv8A/WpUZUPylm44IbBHrQAhZVChcZHORzj2/lSFhyw9hg/ypvUgJu4Hc/nQjbenGRgmgBvbNK3XnqOOuacH2bccgZ79f/re1KBkkcAAcnnnp1oAWJygYBlwcEgjOfanNNuMY2qoHdDgn3JPekRlAJkjEmO+Txz3xRtDEoyMsg4HXPXv+FAG5pd1ZQxKLi2i80NjDKxxnjqOMV0ema4YJhJa2823ghIpCgAx6Y4HtXBTbzGDI7bRwFII3fT86tW9wVhaQybW42gs3bsOaAPsj4QeJLnUbdRqYEahdpVg3y/j0r0mGPSoblpGvlkdjwktyGC57AZr4Y8K67qIcQKZwjcYSRvx6sCBivePA+marNb+aZLW3hUbj5u2U568/MT/AI0Ae63TaM8Z+0vYFCMEsyD9a8Y+Iw0bT5J7q01VxcE5EEEhYN9AO/pVLxlqPiWISW2lWdvMnGbhYY8DnPOT0/lXl+va9cLut9ZisI5ehkliZSo6HlTQBznibxgMSW9tZRAk8yyIQwI9z3rjZ9Y1C5Yh7qYK3BVWOP51Z11oJ7hpkvYJlJwFijZSBn3H61m3IiwjQmQgjkvgfkB9KAIv3khVfmY/wjr+VOjQeaoc5HU7PmJ9qYRzt464zmpkhlJVsDJOFywHT/P40AStLGqBIY2OcnMnp16dAPf2qmeuSOvNOfJJLYz1P50ygApSMHB61bOn3Y09L54JFsmfYsxXgnvj16VVGD1oAXhs8gYHTFNxxkUEYz0496BQAlFFFABRRRQAUUUUAFFFFABRRRQAVLNuDtlSuSevp/WoqtTSKZHEgk4ztGcEe3/16AIN5GNvy47gmk5PzNkjPr1pzgErtZTkc9sH0oUlSuFyemPX8KAGkAZ5HH605VKMpK59jg5qwqhMqzffB5ORu+uf89KicBWIyoBGSMHqc/ljNADSFyOT5Z6Z6j3oI+UDawyM4zx9aUsSx5yBkqScYPr/APWpAxTPA56FeMH60ANGQV+7xz0zj603GMg8EdjTkxkDBzz0PJ9qfGhM6BQrEtgDsecd+3vQBGASOBnJ4oOVb0I9OMUMMEZHHoP6U5sE5ypx9enpQAjEHbnPuc5zzQnzfKFBY9MmhyQed2CO/U/40byFCjp16dfr60AOlTY59Qe+MHv/AIcU7y8IGOO2SR93/GogWK7R064p6ysrbs5JOTmgBikgcAcc9AalCkcna27IBxnOP89abvRpCXTCn+71FNZyScDap7f5+lADe1Svkj5hlzkn/PbH+elM+XkDk54bOKehVmG8ksx539Cc9SetAGhpiRTzKZ0MoJz/AKvnj3/pX0D8N4LWS2Edro05ZQMywxhW+ufXtXh+i2bXc0aWEFt5pyQDO2Tj8Md67LTItf0+ASpFcWQYhfNhnDLkdiCeD7470AdV4/u0sNwt/wDhJLWTuqXQC8+gA5968Y1XV3md4y942D/y8TCTHr27/pXQeKr26nl/0zXGZ+ux/wD6w4ri53UuAwV8cFl4zQBGnJO3+LjH49K2tI0Vb+QK9zYWysR8014g2jPcZrEIIHQEH5sgUqMYzzzkZ4P8/wDCgDodc0TTNNdVh1u3uyRgmFQ4zn1DfrWAxDMcyP5edu7bx+VRrwQcjr3Gat3Vys0CgvI7+6quOnUjk0AVGGD3x1GRim0pOTk9aSgBcnjk8dPakoooAUn9KSilzxjtQAlFFFABRRRQAUUUUAKAT05oAyPekpRjPPSgBKKXjHQ5+tJQAVJKpDsTjr/nio6tsp3SFiQcj5sA8Y9PyoArEnoeM84xinqybxndgevepo4sHcMFs5GRxnPX6UjKryjbGFDHJx0/DuB70ARSPubn7pOcnPP1/wDrUw9Tuzuz3qxIm9sEYwpwVGQcHr7DrUbxlc7Qdh5w3BHbmgCIjA5/KnKQuT+XPNOwrY2kb8k9P6VKqJhGXli33umPbHTNAEeRuDKCpBHt9MehpMMQ0ZYnaeg59v607yyuQMFhg4Xt+PrUkSsrhnAkHYj6HpQBWLEjnn09qQn9KuIFEgBPzY428c4yMe35VG8W3aBncwJIH0PT29qAIM5GW54wBnpRuwCF6c8460+QKxTYAu7+dOZWXBIClTnIGcfUj3oAiyDy2SSeeaOM5wdualEahH3hlOAQSOh9/r0oQBWyYmIPygHjn60ARqQAQR9ff6cUhA45HuauFF3NuzuIwNy557YPr69qhEauWwCTz9wcf/q9aAICMf4+tGKtRw5l+Q/MOoI7jnOPSomjJCj5QvXOOg9T7UARHHOAfalBK8gkN2INSuhUAE7SPvfKQRn19qjxg9eMZPbigBXkkdQHd2UdMkkUztmnbSCAV5zyMH8qTqM8Aj9aAEHBpKkHONuS/baKZ26/hQArAA4FNpw+6CDyDngdPxpBjPPSgA7UlKaPSgBKUmlUH3HbNIQR14oASilAyccficUrKQASMAjigBtFOzxgZ2+me9ICR04oASiinMCMcHkZ5FADaXH6UlKCR04oAMHnPBFJT/ut8vX25xRs6DILHPA5oAb2zSU5gOqkkd+O9NoAK9T0v4OeOtWtoruy8PsYXAZZJLiKPcvqMuDXllbdt4o1e0UrY3tzaKcfLBPIgGD6BqAPRz8CPiB986DEZO+L2Ac+3z8CqH/CnfHyXssa+GbpWiyd6yx7T3IDbvm69BXKjx/4nAG3W9SUgg5F7N/8XQPH3iYCIf2xf4iO5P8ASZRg+/zc8+uaAL/i3wJ4i8MafbXms2LW8U3ylzjKk8bWx34xiuejsZnRGWGYbeQWjYA9hz/KtfTfiJ4m07Ujf2+os12WLl5kEoJ/3WyP0rso/wBon4gIMG8sGHvZpx+VAHJ6R8PvE+swCfTPD+qXMTHaJVtyACOvJxz05rT/AOFSeN1yV8LapwM8opx+vWs+/wDip4zvdTmv5NevIbiX732aRoF6AdEIHQVGPih42AwPFGsf+Bsp/wDZqAL9x8MfHkELyP4T1PykyMLHlsHp0ySfpRafC3xdL54k0G/s3jBlVLiMx+YAOQgPUjPbNULf4n+NoZFceJ9Wkxxtmu3kU/UMSPxpLr4meLru0ht7vW7ydYZDIjyyMzgnr82c49ulAGCtt5DsjBPMT5T0yCCc9/zpXjjfCptDBcYHJ446+nWuwk+MHieTw7Nosi6S1nMpR/8AQIwxB69BjPvjNQeG/ir4h8O2ItNOh0cRDoX06JmH44zQBU0bwJ4s1WFLqz8N6vPb4zGws3KHjsfTPpViT4Z+MUn8qTwpq5ZgMBLRjgeuR9Kbe/FfxrdXktwPEN/bmR95jtp3ijB9kUgD6YqQ/F3xybT7P/wkmoY3l9/ntvz6bs5x7dKAFf4c+MIwZpvCmtkd3e1ck59QKqReC9bfSLrUmsWjtICY5fPcI49flYg/jirNt8XPHVvv2+JNRfcCP3k7NjPcZPBovfip4nvdah1S4mtHuIohCENshiZc5wyY2t9SM0Ac3HbldqscY+XjDHOOg9+a3rPwR4qls3u7fw1qktntJMwtHwAMnI47V1Vn+0F4ttYgkdl4fwOAfsG3H/fLAVzg+LnjUXzXK65cqGdnMCsRCc9vL+7j2xQAtt8OvGNxGs0XhfWniOGU/YnG7vnn+VOPw08aRlWbwlrZBHGLYtg9cnHvUNz8WfHM87ynxLqSFjnbHOyKPooOAPamxfFfxzHu/wCKm1Rtwwd1y5/Ec8UASwfC3xpOHjPhu+hkSMyH7TH5Iwf7u7AJ9uo9K5C9t/s5eKX5JYyQY9wO09/rXUyfFPxlNbxQ3OuXdwsUvnIZpC5VsY6k8j2PHtW9p3x08VWEPlw2ugn/AGjpyA9MZ+XGTQBwGl6Fqur3X2fStOvb6f7pit4Wdl57gA4rcb4Z+NYghl8K60FkYKMWrEn2xitbXPjP4y1aGNFvLfT2QlvN0+EQSH6sOay4vij44iSZR4p1dhKuw77p3Kj/AGck4PuOaAGS/DLxrFBJLJ4V1pVTqfsjf4ZrD0jRby/1OCzERhaV9peZdqpjg7iemD61tr8TPGoY7/FGsSqRgpLdu6n6gnBrbufjV4wudLuLCaXTWguIjDIfsEQZlPB5A6+9AHEa/o9xomoSWd6oSWPrgg5Hr/LFRaRpGo6zqEdjpNlcXl3IcJFAhdjxntXdaL8aPF2kW6w20mmuFUKGlsY2Y46EtjJxjvUniH43eNNc042c95bWyZBElpbiKRSOhVxyp+mKAMWP4ZeNJXVI/Cus7myRm3YDA4649atN8IfHw4/4RbUs4z9wY/n+lUbz4k+L7wP52v34LBQWjlMZG3pgrjH4de9Vz4+8WGMo3iPV2UkH5r2UkfQ7sj6CgDYt/g/49mUsPC+ohRwd4VCPwJyaz/GXgjVfCd5FaX8bM88YaIIN2e5HSq7+PfFDS+Ydc1AP/s3LqOmOgOOlTeGPiJ4n8MTNLoupyQSN1LqJc9f7+fWgDITQdWcArpl85x1Fs5/pXZWHwZ+IF9YR3sHh2R4pCAN9xEGYHuVL5x09KuH4/fEYrt/tyPGMf8ecOfz2VwyeKtbS6kuU1O8WeRizOJnG7JOcjOO/pQB6Db/s/fERwN2k2sY6/PeRfnwxqtF8DfHTXssTWNpAyMV3SX8Qycdvmyevp+VeenV7wkfvpMDsJX/+KouNZv7i3WC4uppYF+7HJIzBfpk8UAdzr/wo1TSdOQebHd60jhJ9OsmWaRAfusApJb39M1Sg+EPj6bATwvqIBIGZEVP5muRtdWvbS8+12lzNb3X/AD1hldH/ADBzW5/wsXxptZf+Es13a3Ufb5cf+hUAdRpvwX1jzVj8Q6xoPhyZlLrBqd2I5WUHGQuMEfjWs/wS0yIFp/iT4UWNV3SFZwxX043f4V5He6ld38olv55bqUZG+aRnbHpkmoFnK4xHFgf7PX/OKAPZJvg9oQtxLD8TPD7wJ8srKuSjngAgMeD6nH0NVn+EcOnWMEOs65YxapeoXtHiu0MDY48t2PKk5BB6du1eSGbJBMaEjuQf19aTzhx+7j46DB/xoA7/AMffC3UPBnhm21i81XR7uKe5W28qyuDK6sUZsngDjYRweprzuns+VwFVR7ZplABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQB/9k=);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Apical four-chamber view from a&nbsp;two-dimensional&nbsp;echocardiogram. The display shows the apex at the top of the screen with the left ventricle (LV) to the viewer's right.",
"    <div class=\"footnotes\">",
"     aML: anterior mitral leaflet; LA: left atrium; pML: posterior mitral valve leaflet; RA: right atrium; RV: right ventricle.",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Two-dimensional transthoracic echocardiogram (2D TTE) parasternal long axis view",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 401px; height: 299px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    This parasternal long axis echocardiogram was obtained in systole; the aortic valve is open and the mitral is closed.",
"    <div class=\"footnotes\">",
"     RV: right ventricle; IVS: interventricular septum; NCC: noncoronary cusp of the aortic valve; PW: posterior left ventricle wall; RCC: right coronary cusp of the aortic valve; aML: anterior mitral valve leaflet; pML: posterior mitral valve leaftlet; dAo: descending aorta.",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Two-dimensional transthoracic echocardiogram (2D TTE) right ventricular (RV) inflow view",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 402px; height: 291px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    The parasternal&nbsp;right ventricular (RV)&nbsp;inflow view&nbsp;from the two-dimensional echocardiogram shows the RV and atrium (RA) and the septal and&nbsp;anterior leaflets of the tricuspid valve (TV). The entrance of the coronary sinus into the RA is separated from the entrance of the inferior vena cava by the eustachian valve (EV).",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Short axis plane echocardiogram of left ventricle",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 384px; height: 267px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    The short axis image of the left ventricle (LV), at the level of the mitral valve, shows the tips of the mitral leaflets.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f11_25_11673=[""].join("\n");
var outline_f11_25_11673=null;
var title_f11_25_11674="Orbital cellulitis";
var content_f11_25_11674=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"4\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Orbital cellulitis",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?11/25/11674/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?11/25/11674/contributors\">",
"     Christopher Gappy, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?11/25/11674/contributors\">",
"     Steven M Archer, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?11/25/11674/contributors\">",
"     Michael Barza, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?11/25/11674/contributors\">",
"     Section Editors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?11/25/11674/contributors\">",
"     Stephen B Calderwood, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?11/25/11674/contributors\">",
"     Morven S Edwards, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?11/25/11674/contributors\">",
"     Jonathan Trobe, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?11/25/11674/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?11/25/11674/contributors\">",
"     Anna R Thorner, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?11/25/11674/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   May 29, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Orbital cellulitis is an infection involving the contents of the orbit (fat and ocular muscles). It must be distinguished from preseptal cellulitis (sometimes called periorbital cellulitis), which is an infection of the anterior portion of the eyelid. Neither infection involves the globe itself. &nbsp;",
"   </p>",
"   <p>",
"    Although preseptal and orbital cellulitis may be confused with one another because both can cause ocular pain and eyelid swelling and erythema, they have very different clinical implications. Preseptal cellulitis is generally a mild condition that rarely leads to serious complications, whereas orbital cellulitis may cause loss of vision and even loss of life. Orbital cellulitis can usually be distinguished from preseptal cellulitis by its clinical features (ophthalmoplegia, pain with eye movements, and proptosis) and by imaging studies; in cases in which the distinction is not clear, clinicians should treat patients as though they have orbital cellulitis. Both conditions are more common in children than in adults, and preseptal cellulitis is much more common than orbital cellulitis.",
"   </p>",
"   <p>",
"    The pathogenesis, microbiology, clinical manifestations, complications, diagnosis, and treatment of orbital cellulitis will be reviewed here. Preseptal cellulitis is discussed separately. Orbital infections caused by fungi, mainly the Mucorales (which cause mucormycosis) and Aspergillus spp, and, much more rarely, Mycobacterium tuberculosis are also presented separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?27/6/27751?source=see_link\">",
"     \"Preseptal cellulitis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?6/46/6890?source=see_link\">",
"     \"Mucormycosis (zygomycosis)\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?33/51/34616?source=see_link\">",
"     \"Epidemiology and clinical manifestations of invasive aspergillosis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?5/40/5767?source=see_link\">",
"     \"Tuberculosis and the eye\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     TERMINOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Preseptal cellulitis and orbital cellulitis involve different anatomic sites, with preseptal cellulitis referring to infections of the soft tissues anterior to the orbital septum, and orbital cellulitis referring to infections posterior to it (",
"    <a class=\"graphic graphic_figure graphicRef68971 \" href=\"UTD.htm?18/7/18550\">",
"     figure 1",
"    </a>",
"    ). Orbital cellulitis involves the muscle and fat located within the orbit. Orbital cellulitis does not involve the globe. (See",
"    <a class=\"local\" href=\"#H459379838\">",
"     'Anatomy'",
"    </a>",
"    below and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?27/6/27751?source=see_link&amp;anchor=H83430261#H83430261\">",
"     \"Preseptal cellulitis\", section on 'Anatomy'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    There is some debate regarding the appropriate terminology for these infections. Some clinicians use the term &ldquo;periorbital cellulitis&rdquo; rather than &ldquo;preseptal cellulitis&rdquo; or use the terms interchangeably. We prefer the term &ldquo;preseptal cellulitis&rdquo; to make a clear distinction between this infection and the more serious infection, &ldquo;orbital cellulitis.&rdquo; Orbital cellulitis is sometimes referred to as &ldquo;postseptal cellulitis&rdquo;; we favor the term &ldquo;orbital cellulitis,&rdquo; and will use it throughout this topic.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H459379838\">",
"    <span class=\"h1\">",
"     ANATOMY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Basic familiarity with the anatomy of the eye is fundamental to understanding the pathogenesis, clinical manifestations, and complications of orbital cellulitis. The orbit is a cone-shaped structure, lying horizontally, with its apex in the skull. It is surrounded by paranasal sinuses, namely, the frontal (lying superior), ethmoid (medial) and maxillary (inferior) sinuses (",
"    <a class=\"graphic graphic_figure graphicRef71411 \" href=\"UTD.htm?20/4/20547\">",
"     figure 2",
"    </a>",
"    ). The orbit is lined by periosteum. The ethmoid sinuses are separated from the orbit by a paper-thin layer called the lamina papyracea, which contains many perforations for nerves and blood vessels as well as some natural fenestrations termed Zuckerkandl&rsquo;s dehiscences. The most common route of infection of the orbit is by extension from the ethmoid sinuses, presumably through these perforations.",
"   </p>",
"   <p>",
"    The orbital septum is a membranous sheet that extends from the periosteum of the orbit to the tarsal plate and forms the anterior boundary of the orbital compartment (",
"    <a class=\"graphic graphic_figure graphicRef68971 \" href=\"UTD.htm?18/7/18550\">",
"     figure 1",
"    </a>",
"    ). The superior and inferior orbital veins drain blood directly into the cavernous sinus (",
"    <a class=\"graphic graphic_figure graphicRef61214 \" href=\"UTD.htm?0/51/821\">",
"     figure 3",
"    </a>",
"    ). Because of this communication and because the inferior orbital veins are valveless, infection can pass readily from the orbit to intracranial structures [",
"    <a class=\"abstract\" href=\"UTD.htm?11/25/11674/abstract/1\">",
"     1",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H459379483\">",
"    <span class=\"h1\">",
"     EPIDEMIOLOGY AND PATHOGENESIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Orbital cellulitis is much more common in young children than in older children or adults. Orbital cellulitis is an uncommon complication of bacterial rhinosinusitis, but rhinosinusitis is the source of most cases of orbital cellulitis; coexisting rhinosinusitis is present in 86 to 98 percent of cases of orbital cellulitis [",
"    <a class=\"abstract\" href=\"UTD.htm?11/25/11674/abstract/2-5\">",
"     2-5",
"    </a>",
"    ]. Ethmoid sinusitis and pansinusitis are the forms of rhinosinusitis most likely to lead to orbital cellulitis. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?38/48/39688?source=see_link\">",
"     \"Acute sinusitis and rhinosinusitis in adults: Clinical manifestations and diagnosis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?11/0/11273?source=see_link&amp;anchor=H13#H13\">",
"     \"Acute bacterial rhinosinusitis in children: Clinical features and diagnosis\", section on 'Complications'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    As has been noted above, the ethmoid sinuses are separated from the orbit by the lamina papyracea, a thin structure with many fenestrations. Computed tomography (CT) scanning often shows the predominant site of inflammation to be the medial aspect of the orbit, adjacent to the ethmoid sinuses, and subperiosteal abscesses most often occur in the same location (",
"    <a class=\"graphic graphic_figure graphicRef71411 \" href=\"UTD.htm?20/4/20547\">",
"     figure 2",
"    </a>",
"    ). (See",
"    <a class=\"local\" href=\"#H459379838\">",
"     'Anatomy'",
"    </a>",
"    above and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?27/6/27751?source=see_link&amp;anchor=H83430261#H83430261\">",
"     \"Preseptal cellulitis\", section on 'Anatomy'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Although bacterial rhinosinusitis is the most common cause of orbital cellulitis, other potential causes are:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Ophthalmic surgery, including strabismus surgery [",
"      <a class=\"abstract\" href=\"UTD.htm?11/25/11674/abstract/6\">",
"       6",
"      </a>",
"      ], blepharoplasty [",
"      <a class=\"abstract\" href=\"UTD.htm?11/25/11674/abstract/7\">",
"       7",
"      </a>",
"      ], radial keratotomy [",
"      <a class=\"abstract\" href=\"UTD.htm?11/25/11674/abstract/8\">",
"       8",
"      </a>",
"      ], and retinal surgery.",
"     </li>",
"     <li>",
"      Peribulbar anesthesia [",
"      <a class=\"abstract\" href=\"UTD.htm?11/25/11674/abstract/9,10\">",
"       9,10",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Orbital trauma with fracture or foreign body [",
"      <a class=\"abstract\" href=\"UTD.htm?11/25/11674/abstract/11,12\">",
"       11,12",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Dacryocystitis [",
"      <a class=\"abstract\" href=\"UTD.htm?11/25/11674/abstract/13,14\">",
"       13,14",
"      </a>",
"      ]. (see",
"      <a class=\"medical medical_review\" href=\"UTD.htm?28/42/29350?source=see_link&amp;anchor=H15#H15\">",
"       \"Nasolacrimal duct obstruction (dacryostenosis) in children\", section on 'Acute dacryocystitis'",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Infection of the teeth [",
"      <a class=\"abstract\" href=\"UTD.htm?11/25/11674/abstract/15\">",
"       15",
"      </a>",
"      ], middle ear [",
"      <a class=\"abstract\" href=\"UTD.htm?11/25/11674/abstract/16\">",
"       16",
"      </a>",
"      ], or face.",
"     </li>",
"     <li>",
"      An infected mucocele that erodes into the orbit [",
"      <a class=\"abstract\" href=\"UTD.htm?11/25/11674/abstract/17\">",
"       17",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Fungal rhinosinusitis can also lead to orbital cellulitis. (See",
"    <a class=\"local\" href=\"#H147596967\">",
"     'Fungi and mycobacteria'",
"    </a>",
"    below and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?8/36/8775?source=see_link\">",
"     \"Fungal rhinosinusitis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H459379521\">",
"    <span class=\"h1\">",
"     MICROBIOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;The causative organisms of orbital cellulitis are often difficult to identify. Cultures from the orbit are only obtained if surgical intervention is needed, usually to drain an abscess. Sinus cultures obtained during surgery can be used to guide antimicrobial therapy [",
"    <a class=\"abstract\" href=\"UTD.htm?11/25/11674/abstract/18\">",
"     18",
"    </a>",
"    ], but may not accurately reflect the pathogen(s) in the orbit. Blood cultures are sometimes positive in children, the percentages ranging from 0 to 33 percent in various retrospective series [",
"    <a class=\"abstract\" href=\"UTD.htm?11/25/11674/abstract/19-23\">",
"     19-23",
"    </a>",
"    ]. They are rarely positive in adults. In one series of patients with orbital cellulitis, blood cultures were positive in 33 percent of children younger than four years of age but in only 5 percent of adults [",
"    <a class=\"abstract\" href=\"UTD.htm?11/25/11674/abstract/20\">",
"     20",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H147596960\">",
"    <span class=\"h2\">",
"     Bacteria",
"    </span>",
"    &nbsp;&mdash;&nbsp;The most commonly identified pathogens in orbital cellulitis are Staphylococcus aureus and streptococci (",
"    <a class=\"graphic graphic_table graphicRef77104 \" href=\"UTD.htm?35/15/36094\">",
"     table 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?11/25/11674/abstract/2-4,24\">",
"     2-4,24",
"    </a>",
"    ]. In one series of 94 children admitted to a tertiary care children&rsquo;s hospital with orbital cellulitis between 2004 and 2009, members of the Streptococcus anginosus (milleri) group were the most commonly identified pathogens (15 percent) followed by S. aureus (9 percent), group A beta-hemolytic streptococci (Streptococcus pyogenes, 6 percent), and Streptococcus pneumoniae (4 percent) [",
"    <a class=\"abstract\" href=\"UTD.htm?11/25/11674/abstract/3\">",
"     3",
"    </a>",
"    ]. Only one patient had methicillin-resistant S. aureus (MRSA) infection but one would expect an increasing proportion of MRSA infections given the rising prevalence of community-acquired MRSA (CA-MRSA) among strains of S. aureus. Cases of neonatal and infantile orbital cellulitis caused by CA-MRSA have been reported [",
"    <a class=\"abstract\" href=\"UTD.htm?11/25/11674/abstract/25\">",
"     25",
"    </a>",
"    ]. &nbsp;",
"   </p>",
"   <p>",
"    Uncommon causes of orbital cellulitis include Haemophilus influenzae and nonspore-forming anaerobes [",
"    <a class=\"abstract\" href=\"UTD.htm?11/25/11674/abstract/24,26\">",
"     24,26",
"    </a>",
"    ], Aeromonas hydrophila [",
"    <a class=\"abstract\" href=\"UTD.htm?11/25/11674/abstract/27\">",
"     27",
"    </a>",
"    ], Pseudomonas aeruginosa [",
"    <a class=\"abstract\" href=\"UTD.htm?11/25/11674/abstract/28\">",
"     28",
"    </a>",
"    ] and Eikenella corrodens [",
"    <a class=\"abstract\" href=\"UTD.htm?11/25/11674/abstract/29\">",
"     29",
"    </a>",
"    ]. H. influenzae type b, formerly an important cause of orbital cellulitis in children, has become rare with the widespread use of the vaccine [",
"    <a class=\"abstract\" href=\"UTD.htm?11/25/11674/abstract/24,30,31\">",
"     24,30,31",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Some cases of orbital cellulitis are polymicrobial, often with a combination of aerobic and anaerobic bacteria. As an example, in a study of 20 children with orbital cellulitis who had positive cultures from specimens obtained during surgery (from an orbital or subperiosteal abscess",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    a paranasal sinus), seven (35 percent) had more than one organism isolated [",
"    <a class=\"abstract\" href=\"UTD.htm?11/25/11674/abstract/4\">",
"     4",
"    </a>",
"    ]. Two small studies have observed polymicrobial infections in all patients [",
"    <a class=\"abstract\" href=\"UTD.htm?11/25/11674/abstract/32,33\">",
"     32,33",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H147596967\">",
"    <span class=\"h2\">",
"     Fungi and mycobacteria",
"    </span>",
"    &nbsp;&mdash;&nbsp;Although most cases of orbital cellulitis are caused by bacteria, fungi, especially Mucorales (which causes mucormycosis) and Aspergillus spp can cause life-threatening, invasive orbital infections. Mucormycosis and invasive aspergillosis should be considered in patients with defects in host defenses. Mucormycosis primarily affects patients with diabetic ketoacidosis and sometimes in patients with renal acidosis. Aspergillus infection of the orbit occurs in patients with severe neutropenia or other immune deficiencies, including HIV infection. These infections are discussed briefly below and more fully elsewhere. (See",
"    <a class=\"local\" href=\"#H19539607\">",
"     'Diagnosis'",
"    </a>",
"    below and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?6/46/6890?source=see_link\">",
"     \"Mucormycosis (zygomycosis)\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?8/36/8775?source=see_link\">",
"     \"Fungal rhinosinusitis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?33/51/34616?source=see_link\">",
"     \"Epidemiology and clinical manifestations of invasive aspergillosis\"",
"    </a>",
"    .)",
"    <br/>",
"    <br/>",
"    Fungal causes of orbital cellulitis have been reported rarely in apparently immunocompetent infants [",
"    <a class=\"abstract\" href=\"UTD.htm?11/25/11674/abstract/34\">",
"     34",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Rarely, fungal pathogens other than the Mucorales or Aspergillus spp [",
"    <a class=\"abstract\" href=\"UTD.htm?11/25/11674/abstract/35\">",
"     35",
"    </a>",
"    ] or mycobacteria (especially Mycobacterium tuberculosis) cause orbital infections. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?5/40/5767?source=see_link\">",
"     \"Tuberculosis and the eye\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h1\">",
"     CLINICAL MANIFESTATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;It is important to distinguish preseptal from orbital cellulitis because the two conditions have very different clinical implications (",
"    <a class=\"graphic graphic_table graphicRef62818 \" href=\"UTD.htm?5/36/5711\">",
"     table 2",
"    </a>",
"    and",
"    <a class=\"graphic graphic_table graphicRef55123 \" href=\"UTD.htm?28/42/29356\">",
"     table 3",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?11/25/11674/abstract/2-5,36\">",
"     2-5,36",
"    </a>",
"    ]. Both orbital cellulitis and preseptal cellulitis cause ocular pain and eyelid swelling with erythema (",
"    <a class=\"graphic graphic_picture graphicRef57604 \" href=\"UTD.htm?9/28/9670\">",
"     picture 1",
"    </a>",
"    ); in some cases of orbital cellulitis, eyelid erythema is absent. Only orbital cellulitis causes swelling and inflammation of the extraocular muscles and fatty tissues within the orbit, leading to pain with eye movements, proptosis, and ophthalmoplegia with diplopia. Chemosis (conjunctival swelling) may occasionally occur in severe cases of preseptal cellulitis, but is more common with orbital cellulitis. In both conditions, but especially in orbital cellulitis, there may be fever and peripheral leukocytosis with a predominance of neutrophils [",
"    <a class=\"abstract\" href=\"UTD.htm?11/25/11674/abstract/2,37\">",
"     2,37",
"    </a>",
"    ]. In a retrospective study that included 262 children, fever occurred more commonly in those with orbital cellulitis than in those with preseptal cellulitis (94 versus 47 percent) [",
"    <a class=\"abstract\" href=\"UTD.htm?11/25/11674/abstract/2\">",
"     2",
"    </a>",
"    ]. Rarely in orbital cellulitis, there may be visual impairment, and even blindness, arising from inflammation or ischemia of the optic nerve [",
"    <a class=\"abstract\" href=\"UTD.htm?11/25/11674/abstract/38\">",
"     38",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The frequencies with which the signs and symptoms of orbital and preseptal cellulitis have been reported in different studies are summarized in the table (",
"    <a class=\"graphic graphic_table graphicRef62818 \" href=\"UTD.htm?5/36/5711\">",
"     table 2",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H459379581\">",
"    <span class=\"h1\">",
"     COMPLICATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Although it is much less common than preseptal cellulitis, orbital cellulitis is a far more consequential infection because it can be sight- or even life-threatening [",
"    <a class=\"abstract\" href=\"UTD.htm?11/25/11674/abstract/36,39\">",
"     36,39",
"    </a>",
"    ]. It can be complicated by subperiosteal abscess, orbital abscess, vision loss, cavernous sinus thrombophlebitis,",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    brain abscess [",
"    <a class=\"abstract\" href=\"UTD.htm?11/25/11674/abstract/18,36\">",
"     18,36",
"    </a>",
"    ]. The most common complications of orbital cellulitis are subperiosteal abscess and orbital abscess. These complications may develop rapidly; therefore, close monitoring is indicated, with daily checks of visual acuity and assessment of the pupillary light reflex. A sluggish or absent pupillary light reflex or a relative afferent pupillary defect indicates optic nerve involvement. Any worsening of the patient&rsquo;s symptoms or signs should lead to a contrast-enhanced computed tomography (CT) scan of the orbits and sinuses (or repeat CT if one was done earlier) to detect an abscess. (See",
"    <a class=\"local\" href=\"#H459379685\">",
"     'Imaging studies'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    Orbital cellulitis results in loss of vision in 3 to 11 percent of patients and in death in 1 to 2 percent of patients [",
"    <a class=\"abstract\" href=\"UTD.htm?11/25/11674/abstract/39\">",
"     39",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Rare complications include cavernous sinus thrombosis and central retinal artery occlusion [",
"    <a class=\"abstract\" href=\"UTD.htm?11/25/11674/abstract/40,41\">",
"     40,41",
"    </a>",
"    ]. These complications are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?22/38/23145?source=see_link&amp;anchor=H2#H2\">",
"     \"Septic dural sinus thrombosis\", section on 'Septic cavernous sinus thrombosis'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?3/50/3882?source=see_link\">",
"     \"Central and branch retinal artery occlusion\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H459379606\">",
"    <span class=\"h2\">",
"     Subperiosteal abscess",
"    </span>",
"    &nbsp;&mdash;&nbsp;Subperiosteal abscess is a fairly common complication of orbital cellulitis, occurring in 15 to 59 percent of cases in various retrospective series (",
"    <a class=\"graphic graphic_table graphicRef62818 \" href=\"UTD.htm?5/36/5711\">",
"     table 2",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?11/25/11674/abstract/2-4,42\">",
"     2-4,42",
"    </a>",
"    ]. It is difficult to distinguish subperiosteal abscess from simple orbital cellulitis on clinical grounds, although marked displacement of the globe is suggestive of abscess. Orbital imaging or surgery is necessary to make the diagnosis (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef61952 \" href=\"UTD.htm?32/43/33461\">",
"     image 1",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    In some patients, a subperiosteal abscess, arising by extension from a sinus infection, precedes orbital cellulitis [",
"    <a class=\"abstract\" href=\"UTD.htm?11/25/11674/abstract/43\">",
"     43",
"    </a>",
"    ] or occurs without orbital cellulitis. The abscess can present with minimal symptoms [",
"    <a class=\"abstract\" href=\"UTD.htm?11/25/11674/abstract/44\">",
"     44",
"    </a>",
"    ] until it ruptures into the orbit.",
"   </p>",
"   <p>",
"    Subperiosteal abscesses in younger children tend to lie medially in the orbit [",
"    <a class=\"abstract\" href=\"UTD.htm?11/25/11674/abstract/45\">",
"     45",
"    </a>",
"    ], to be amenable to antibiotic treatment without surgery (when small or in the form of poorly organized phlegmons) [",
"    <a class=\"abstract\" href=\"UTD.htm?11/25/11674/abstract/18,32,45\">",
"     18,32,45",
"    </a>",
"    ], and to contain a single aerobic species [",
"    <a class=\"abstract\" href=\"UTD.htm?11/25/11674/abstract/32\">",
"     32",
"    </a>",
"    ]. Nonmedial abscesses in older children, and abscesses located superiorly (near the frontal sinus) appear to be at highest risk for intracranial abscess. Abscesses in older patients usually contain mixtures of aerobic and anaerobic microbes [",
"    <a class=\"abstract\" href=\"UTD.htm?11/25/11674/abstract/33,46\">",
"     33,46",
"    </a>",
"    ] and are more likely to require drainage than those in children.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H459379613\">",
"    <span class=\"h2\">",
"     Orbital abscess",
"    </span>",
"    &nbsp;&mdash;&nbsp;Like subperiosteal abscess, orbital abscess is difficult to distinguish from uncomplicated orbital cellulitis. It has been reported in up to 24 percent of cases of orbital cellulitis (",
"    <a class=\"graphic graphic_table graphicRef62818 \" href=\"UTD.htm?5/36/5711\">",
"     table 2",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?11/25/11674/abstract/2-5,37\">",
"     2-5,37",
"    </a>",
"    ]. Patients with orbital abscess typically have more severe signs (proptosis, ophthalmoplegia) and symptoms (pain with eye movements) than those with uncomplicated orbital cellulitis [",
"    <a class=\"abstract\" href=\"UTD.htm?11/25/11674/abstract/37\">",
"     37",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In a retrospective cohort study that included 298 otherwise healthy children admitted to a pediatric emergency department who underwent CT scanning for suspected acute periorbital (preseptal) or orbital cellulitis, six (2 percent) were found to have an orbital abscess [",
"    <a class=\"abstract\" href=\"UTD.htm?11/25/11674/abstract/37\">",
"     37",
"    </a>",
"    ]. Proptosis, pain with external ocular movement, and ophthalmoplegia were associated with the presence of an orbital abscess, although 51 percent of patients with abscess did not have these findings. On multivariate analysis, other factors associated with orbital abscess were a peripheral absolute neutrophil count (ANC) &gt;10,000 per microL, absence of conjunctivitis, periorbital edema, age &gt;3 years, and previous antibiotic therapy. (See",
"    <a class=\"local\" href=\"#H459379685\">",
"     'Imaging studies'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H459379620\">",
"    <span class=\"h2\">",
"     Extraorbital extension",
"    </span>",
"    &nbsp;&mdash;&nbsp;Infection may rarely extend to the orbital apex, causing visual loss, or intracranially, causing epidural or subdural empyema, brain abscess, meningitis, cavernous sinus thrombosis, or dural sinus thrombosis [",
"    <a class=\"abstract\" href=\"UTD.htm?11/25/11674/abstract/18\">",
"     18",
"    </a>",
"    ]. The visual loss associated with orbital cellulitis is thought to result from any of the following processes [",
"    <a class=\"abstract\" href=\"UTD.htm?11/25/11674/abstract/38\">",
"     38",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Optic neuritis as a result of inflammation from nearby infection",
"     </li>",
"     <li>",
"      Ischemia resulting from thrombophlebitis along the orbital veins",
"     </li>",
"     <li>",
"      Pressure resulting in central retinal artery occlusion",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Intracranial complications may be heralded by severe headache, protracted vomiting, mental status changes and, in patients with cavernous sinus thrombosis, cranial nerve palsies. Bilateral cranial nerve palsies can be a sign of bilateral cavernous sinus thrombosis.",
"    <br/>",
"    <br/>",
"    Intracranial extension may be more common in patients with frontal sinus involvement [",
"    <a class=\"abstract\" href=\"UTD.htm?11/25/11674/abstract/18,47\">",
"     18,47",
"    </a>",
"    ]; of note, frontal sinusitis does not occur in young children since the frontal sinuses do not develop until at least six years of age, and do not develop fully until mid-adolescence. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?11/0/11273?source=see_link&amp;anchor=H2#H2\">",
"     \"Acute bacterial rhinosinusitis in children: Clinical features and diagnosis\", section on 'Anatomy'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H194021169\">",
"    <span class=\"h1\">",
"     DIFFERENTIAL DIAGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The differential diagnosis of orbital cellulitis includes a range of infectious and noninfectious diseases. Although orbital cellulitis is most commonly caused by bacteria, in patients with certain risk factors, fungal pathogens (and occasionally tuberculosis) should be considered. As noted below, it is critical to distinguish preseptal cellulitis from the more serious orbital cellulitis. (See",
"    <a class=\"local\" href=\"#H19539607\">",
"     'Diagnosis'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    Diseases that should be considered in the differential diagnosis of orbital cellulitis include:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Preseptal cellulitis (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?27/6/27751?source=see_link\">",
"       \"Preseptal cellulitis\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Mucormycosis or aspergillosis involving the orbit (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?6/46/6890?source=see_link\">",
"       \"Mucormycosis (zygomycosis)\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?33/51/34616?source=see_link\">",
"       \"Epidemiology and clinical manifestations of invasive aspergillosis\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Cavernous sinus thrombosis (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?22/38/23145?source=see_link&amp;anchor=H2#H2\">",
"       \"Septic dural sinus thrombosis\", section on 'Septic cavernous sinus thrombosis'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Herpes simplex or varicella zoster virus infections involving the eye (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?33/12/33992?source=see_link\">",
"       \"Herpes simplex keratitis\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?2/20/2378?source=see_link&amp;anchor=H11#H11\">",
"       \"Clinical manifestations of varicella-zoster virus infection: Herpes zoster\", section on 'Herpes zoster ophthalmicus'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Tuberculosis involving the orbit (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?5/40/5767?source=see_link\">",
"       \"Tuberculosis and the eye\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Endophthalmitis (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?24/18/24873?source=see_link\">",
"       \"Bacterial endophthalmitis\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?38/12/39112?source=see_link\">",
"       \"Treatment of endogenous endophthalmitis due to Candida species\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?35/16/36102?source=see_link\">",
"       \"Treatment of exogenous endophthalmitis due to Candida species\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?2/55/2937?source=see_link\">",
"       \"Treatment of endophthalmitis due to molds\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Tumors (eg, neuroblastoma [",
"      <a class=\"abstract\" href=\"UTD.htm?11/25/11674/abstract/48\">",
"       48",
"      </a>",
"      ], rhabdomyosarcoma [",
"      <a class=\"abstract\" href=\"UTD.htm?11/25/11674/abstract/49\">",
"       49",
"      </a>",
"      ])",
"     </li>",
"     <li>",
"      Orbital pseudotumor (idiopathic orbital inflammation) and Tolosa-Hunt syndrome [",
"      <a class=\"abstract\" href=\"UTD.htm?11/25/11674/abstract/50,51\">",
"       50,51",
"      </a>",
"      ] (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?23/28/24006?source=see_link\">",
"       \"Tolosa-Hunt syndrome\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Posterior scleritis [",
"      <a class=\"abstract\" href=\"UTD.htm?11/25/11674/abstract/52\">",
"       52",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Periocular dermoid cyst [",
"      <a class=\"abstract\" href=\"UTD.htm?11/25/11674/abstract/53\">",
"       53",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Granulomatosis with polyangiitis (Wegener&rsquo;s disease) of the orbit [",
"      <a class=\"abstract\" href=\"UTD.htm?11/25/11674/abstract/54\">",
"       54",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Trauma, including insect bites",
"     </li>",
"     <li>",
"      Allergic response &nbsp;[",
"      <a class=\"abstract\" href=\"UTD.htm?11/25/11674/abstract/55,56\">",
"       55,56",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Hordeolum (stye)",
"     </li>",
"     <li>",
"      Severe conjunctivitis [",
"      <a class=\"abstract\" href=\"UTD.htm?11/25/11674/abstract/57,58\">",
"       57,58",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Mucocele",
"     </li>",
"     <li>",
"      Thrombosed orbital varix",
"     </li>",
"     <li>",
"      Graves&rsquo; disease",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Certain findings are suggestive of the following serious conditions:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Cavernous sinus thrombosis should be suspected if signs of orbital inflammation (redness and swelling of the eyelids, ophthalmoplegia, decreased visual acuity) also occur in the contralateral eye. The second eye may become involved a day or two after the first eye. The cranial nerves III, IV, V",
"      <sup>",
"       1",
"      </sup>",
"      , V",
"      <sup>",
"       2",
"      </sup>",
"      , and VI pass through the cavernous sinus and account for many of the manifestations. In addition, there may be decreased visual acuity due to edema of the optic disc and there may be numbness over the upper face due to involvement of V",
"      <sup>",
"       1",
"      </sup>",
"      and",
"      <sup>",
"      </sup>",
"      V",
"      <sup>",
"       2",
"      </sup>",
"      . These patients often have sphenoid and posterior ethmoid sinusitis. This topic is discussed in greater detail elsewhere. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?22/38/23145?source=see_link\">",
"       \"Septic dural sinus thrombosis\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Mucormycosis and aspergillosis arise by spread from the upper airway, especially the posterior ethmoid or sphenoid sinuses. Accordingly, they sometimes present as the &ldquo;orbital apex syndrome&rdquo; with ophthalmoplegia and progressive visual loss, but otherwise minimal signs of inflammation (eg, mild eyelid swelling, little or no fever). They may begin in indolent fashion, but may progress quickly to involve critical structures in the eye, nose, and brain. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?6/46/6890?source=see_link&amp;anchor=H7#H7\">",
"       \"Mucormycosis (zygomycosis)\", section on 'Rhino-orbital-cerebral mucormycosis'",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?33/51/34616?source=see_link&amp;anchor=H625354431#H625354431\">",
"       \"Epidemiology and clinical manifestations of invasive aspergillosis\", section on 'Rhinosinusitis'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Endophthalmitis should be considered if visual acuity is reduced and the red reflex cannot be seen due to vitreous haze.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19539607\">",
"    <span class=\"h1\">",
"     DIAGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The diagnosis of orbital cellulitis is suspected clinically and can be confirmed by computed tomography (CT) scanning. During the initial evaluation, it is critical to distinguish preseptal cellulitis from the more serious orbital cellulitis. It is also important to look for complications of orbital cellulitis, such as subperiosteal abscess, orbital abscess, visual loss, and intracranial extension. Although both preseptal cellulitis and orbital cellulitis typically cause eyelid swelling with or without erythema, the presence of ophthalmoplegia, pain with eye movement,",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    proptosis occur only with orbital cellulitis. Another finding that is more common with orbital cellulitis, and rare or absent with preseptal cellulitis, is chemosis. Fever is more common with orbital cellulitis than with preseptal cellulitis [",
"    <a class=\"abstract\" href=\"UTD.htm?11/25/11674/abstract/2,4\">",
"     2,4",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    It is important for an ophthalmologist to evaluate patients with suspected orbital cellulitis in order to evaluate the extraocular movements and visual acuity, and to assess for proptosis. In patients with extensive rhinosinusitis, an otolaryngologist should generally be consulted as well. (See",
"    <a class=\"local\" href=\"#H6817810\">",
"     'Surgery'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H459379685\">",
"    <span class=\"h2\">",
"     Imaging studies",
"    </span>",
"    &nbsp;&mdash;&nbsp;The goals of imaging studies are to support the diagnosis of orbital cellulitis and to search for an abscess or other complications requiring surgical drainage. (See",
"    <a class=\"local\" href=\"#H6817810\">",
"     'Surgery'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H194021484\">",
"    <span class=\"h3\">",
"     Imaging modalities",
"    </span>",
"    &nbsp;&mdash;&nbsp;CT scanning and magnetic resonance imaging (MRI) are useful for the diagnosis of orbital cellulitis and its complications. There are no controlled trials comparing these modalities and the choice is usually based on the availability of the test and on the clinical experience of the physicians involved. CT scanning of the orbits and sinuses is used most commonly to evaluate for possible orbital cellulitis and its complications. MRI is superior to CT scan in following the progression of soft tissue disease [",
"    <a class=\"abstract\" href=\"UTD.htm?11/25/11674/abstract/59\">",
"     59",
"    </a>",
"    ], but may not be readily available and may require sedation in young children.",
"   </p>",
"   <p>",
"    When cavernous sinus thrombosis is suspected, an imaging study that includes venography should be performed, such as magnetic resonance (MR) venography or CT venography. These modalities are discussed in detail separately. MR venography is used most commonly, and would show nonfilling of the cavernous sinus in patients with cavernous sinus thrombosis. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?7/26/7594?source=see_link&amp;anchor=H16#H16\">",
"     \"Etiology, clinical features, and diagnosis of cerebral venous thrombosis\", section on 'Diagnosis'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H194021491\">",
"    <span class=\"h3\">",
"     Imaging findings",
"    </span>",
"    &nbsp;&mdash;&nbsp;In preseptal cellulitis, inflammation is confined to the eyelids. In orbital cellulitis, inflammation of extraocular muscles, fat stranding, and anterior displacement of the globe are common findings. It is important to note that some cases of orbital cellulitis will have subtle abnormalities by CT scan. There is almost always evidence of rhinosinusitis, most commonly ethmoid sinusitis, and the most intense inflammatory response in the orbit is often seen adjacent to the ethmoid sinus.",
"   </p>",
"   <p>",
"    Subperiosteal abscesses and orbital abscesses appear as low-density collections on CT scan. Subperiosteal abscesses lie between the periosteum and the wall of the bony sinus (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef61952 \" href=\"UTD.htm?32/43/33461\">",
"     image 1",
"    </a>",
"    ). Both types of abscesses, but especially subperiosteal abscesses, are often found adjacent to the ethmoid sinus (",
"    <a class=\"graphic graphic_figure graphicRef71411 \" href=\"UTD.htm?20/4/20547\">",
"     figure 2",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H194021498\">",
"    <span class=\"h3\">",
"     Indications for imaging",
"    </span>",
"    &nbsp;&mdash;&nbsp;Whether every patient with suspected orbital cellulitis should have a CT scan is controversial [",
"    <a class=\"abstract\" href=\"UTD.htm?11/25/11674/abstract/19,26,60,61\">",
"     19,26,60,61",
"    </a>",
"    ]. Clinicians may be reluctant to obtain a CT scan due to concern about exposure of the pediatric patient to radiation. Guidelines for the management of orbital cellulitis from the United Kingdom offer the following indications for CT scanning: inability to assess vision; proptosis, ophthalmoplegia, bilateral edema, or deteriorating visual acuity; lack of improvement after 24 hours of administration of intravenous antibiotics; &rdquo;swinging&rdquo; fevers not resolving within 36 hours; or signs or symptoms of central nervous system (CNS) involvement [",
"    <a class=\"abstract\" href=\"UTD.htm?11/25/11674/abstract/60\">",
"     60",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In the study of CT scanning in children with suspected acute preseptal or orbital cellulitis described above, the presence of edema beyond the eyelid margin or an absolute neutrophil count (ANC) &gt;10,000",
"    <span class=\"nowrap\">",
"     cell/microL",
"    </span>",
"    were independent risk factors for an orbital abscess; the authors concluded that the presence of either of these findings should necessitate an expedited evaluation, including emergent CT scanning [",
"    <a class=\"abstract\" href=\"UTD.htm?11/25/11674/abstract/37\">",
"     37",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H459379613\">",
"     'Orbital abscess'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    In addition, CT scanning should be done in all patients in whom surgical drainage is being considered [",
"    <a class=\"abstract\" href=\"UTD.htm?11/25/11674/abstract/5\">",
"     5",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Based on the studies and guidelines described above, we recommend that patients with suspected orbital cellulitis with any of the following features undergo a contrast-enhanced CT scan of the orbits and sinuses:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Proptosis",
"     </li>",
"     <li>",
"      Limitation of eye movements",
"     </li>",
"     <li>",
"      Pain with eye movements",
"     </li>",
"     <li>",
"      Double vision",
"     </li>",
"     <li>",
"      Vision loss",
"     </li>",
"     <li>",
"      Edema extending beyond the eyelid margin",
"     </li>",
"     <li>",
"      ANC &gt;10,000",
"      <span class=\"nowrap\">",
"       cell/microL",
"      </span>",
"     </li>",
"     <li>",
"      Signs or symptoms of CNS involvement",
"     </li>",
"     <li>",
"      Inability to examine the patient fully (usually patients less than one year of age)",
"     </li>",
"     <li>",
"      Patients who do not begin to show improvement within 24 to 48 hours of initiating appropriate therapy",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19539755\">",
"    <span class=\"h2\">",
"     Microbiologic studies",
"    </span>",
"    &nbsp;&mdash;&nbsp;Despite the low yield, we recommend obtaining blood cultures from patients with suspected orbital cellulitis before the administration of antibiotics. If surgery is performed, the material obtained should be examined by Gram stain and, in patients with risk factors for a fungal",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    mycobacterial etiology, by special stains for fungi and mycobacteria. Cultures should be done for ordinary bacterial pathogens and, depending on the circumstances, fungi and mycobacteria.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H24\">",
"    <span class=\"h1\">",
"     TREATMENT",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6817758\">",
"    <span class=\"h2\">",
"     Antibiotic regimens",
"    </span>",
"    &nbsp;&mdash;&nbsp;Most patients with uncomplicated orbital cellulitis can be treated with antibiotics alone [",
"    <a class=\"abstract\" href=\"UTD.htm?11/25/11674/abstract/4,5,62\">",
"     4,5,62",
"    </a>",
"    ]. Even in patients who are initially treated with antibiotics alone, an ophthalmologist and an otolaryngologist should be consulted because the physical examination requires ophthalmologic",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    otolaryngologic expertise and surgery is sometimes required. (See",
"    <a class=\"local\" href=\"#H6817810\">",
"     'Surgery'",
"    </a>",
"    below.)",
"    <br/>",
"   </p>",
"   <p>",
"    There are no randomized controlled trials evaluating empiric antibiotic regimens for the treatment of orbital cellulitis. Treatment regimens are usually empiric and designed to address the most common pathogens because, in the absence of surgical intervention, reliable culture results are difficult to obtain.",
"   </p>",
"   <p>",
"    The usual choices are a parenterally administered broad-spectrum regimen aimed at S. aureus (including methicillin-resistant S. aureus [MRSA]), S. pneumoniae and other streptococci, as well as gram-negative bacilli. When intracranial extension is suspected, the regimen should also include coverage for anaerobes. Prompt treatment is important because delayed intervention can lead to loss of vision",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    other serious complications [",
"    <a class=\"abstract\" href=\"UTD.htm?11/25/11674/abstract/12,18,38\">",
"     12,18,38",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Appropriate antibiotic regimens for empiric treatment in patients with normal renal function include a combination of:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <a class=\"drug drug_general\" href=\"UTD.htm?41/41/42649?source=see_link\">",
"       Vancomycin",
"      </a>",
"      (in children: 40 to 60",
"      <span class=\"nowrap\">",
"       mg/kg",
"      </span>",
"      IV per day in three or four divided doses, maximum daily dose 4 g; in adults: 30 to 60",
"      <span class=\"nowrap\">",
"       mg/kg",
"      </span>",
"      IV per day in two or three divided doses; the appropriate dose in adults requires measurement of a trough concentration of vancomycin)",
"      <strong>",
"       plus",
"      </strong>",
"      one of the following:",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      <a class=\"drug drug_general\" href=\"UTD.htm?10/17/10521?source=see_link\">",
"       Ceftriaxone",
"      </a>",
"      (in children: 50",
"      <span class=\"nowrap\">",
"       mg/kg",
"      </span>",
"      per dose IV once or twice per day [the higher dose should be used if intracranial extension is suspected], maximum daily dose 4",
"      <span class=\"nowrap\">",
"       g/day;",
"      </span>",
"      in adults: 2 g IV every 24 hours [2 g IV every 12 hours if intracranial extension is suspected])",
"      <strong>",
"       or",
"      </strong>",
"     </li>",
"     <li>",
"      <a class=\"drug drug_general\" href=\"UTD.htm?34/57/35735?source=see_link\">",
"       Cefotaxime",
"      </a>",
"      (in children: 150 to 200",
"      <span class=\"nowrap\">",
"       mg/kg",
"      </span>",
"      IV per day in three doses, maximum daily dose 12 g; in adults: 2 g IV every four hours)",
"      <strong>",
"       or",
"      </strong>",
"     </li>",
"     <li>",
"      <a class=\"drug drug_general\" href=\"UTD.htm?1/8/1160?source=see_link\">",
"       Ampicillin-sulbactam",
"      </a>",
"      (in children: 300",
"      <span class=\"nowrap\">",
"       mg/kg",
"      </span>",
"      IV per day in four divided doses in children, maximum daily dose 12 g",
"      <a class=\"drug drug_general\" href=\"UTD.htm?12/51/13112?source=see_link\">",
"       ampicillin",
"      </a>",
"      -sulbactam [8 g ampicillin component]; in adults: 3 g IV every six hours)",
"      <strong>",
"       or",
"      </strong>",
"     </li>",
"     <li>",
"      <a class=\"drug drug_general\" href=\"UTD.htm?23/41/24216?source=see_link\">",
"       Piperacillin-tazobactam",
"      </a>",
"      (in children: 240",
"      <span class=\"nowrap\">",
"       mg/kg",
"      </span>",
"      per day in three divided doses, maximum daily dose 16 g of",
"      <a class=\"drug drug_general\" href=\"UTD.htm?34/13/35030?source=see_link\">",
"       piperacillin",
"      </a>",
"      component; in adults: 4.5 g IV every six hours)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    In patients with suspected intracranial extension who are being treated with",
"    <a class=\"drug drug_general\" href=\"UTD.htm?10/17/10521?source=see_link\">",
"     ceftriaxone",
"    </a>",
"    or",
"    <a class=\"drug drug_general\" href=\"UTD.htm?34/57/35735?source=see_link\">",
"     cefotaxime",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?19/38/20065?source=see_link\">",
"     metronidazole",
"    </a>",
"    (in children: 30",
"    <span class=\"nowrap\">",
"     mg/kg",
"    </span>",
"    IV or orally per day in divided doses every 6 hours; in adults: 500 mg IV or orally every 8 hours) should be added to include coverage for anaerobes. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?31/43/32438?source=see_link\">",
"     \"Treatment and prognosis of brain abscess\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Like",
"    <a class=\"drug drug_general\" href=\"UTD.htm?41/41/42649?source=see_link\">",
"     vancomycin",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?20/10/20646?source=see_link\">",
"     daptomycin",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?14/3/14393?source=see_link\">",
"     linezolid",
"    </a>",
"    and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?26/42/27301?source=see_link\">",
"     telavancin",
"    </a>",
"    also are active against MRSA, but there is little experience using them for orbital or intracranial infections. Moreover, linezolid concentrations in the central nervous system (CNS) have been inconsistent in children and, accordingly, linezolid is",
"    <strong>",
"     not",
"    </strong>",
"    recommended for children with CNS infections [",
"    <a class=\"abstract\" href=\"UTD.htm?11/25/11674/abstract/63\">",
"     63",
"    </a>",
"    ]. Therefore, unless there is a contraindication to its use (eg, allergy), vancomycin is the preferred agent for MRSA coverage of orbital cellulitis.",
"   </p>",
"   <p>",
"    Adults and children with a serious allergy to penicillins",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    cephalosporins can be treated with a combination of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?41/41/42649?source=see_link\">",
"     vancomycin",
"    </a>",
"    &nbsp;and either",
"    <a class=\"drug drug_general\" href=\"UTD.htm?34/45/35536?source=see_link\">",
"     ciprofloxacin",
"    </a>",
"    &nbsp;or",
"    <a class=\"drug drug_general\" href=\"UTD.htm?32/46/33504?source=see_link\">",
"     levofloxacin",
"    </a>",
"    . In adults, ciprofloxacin is given at a dose of 400 mg IV twice daily (or 500 to 750 mg orally twice daily) and levofloxacin&nbsp;is given at a dose of 500 to 750 mg IV or orally once daily. In children, ciprofloxacin is given at a dose of 20 to 30",
"    <span class=\"nowrap\">",
"     mg/kg",
"    </span>",
"    per day divided every 12 hours with a maximum dose of 1.5 grams orally daily or 800 mg IV daily. Limited information regarding levofloxacin use in pediatric patients is available. Some centers recommend a dose for infants &ge;6 months and children &lt;5 years of 10",
"    <span class=\"nowrap\">",
"     mg/kg",
"    </span>",
"    per dose every 12 hours, and for children &ge;5 years of 10",
"    <span class=\"nowrap\">",
"     mg/kg",
"    </span>",
"    per dose every 24 hours (maximum daily dose 500 mg).",
"    <br/>",
"    <br/>",
"    Desensitization to a penicillin or cephalosporin may be considered in patients with a history of an IgE-mediated (anaphylactic) reaction to these agents. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?22/46/23274?source=see_link&amp;anchor=H1969477#H1969477\">",
"     \"Allergy to penicillins\", section on 'Desensitization'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    If a pathogen is retrieved on cultures of blood or orbital or subperiosteal aspirates, or from sinuses from cultures obtained by endoscopic sinus surgery, treatment should be modified accordingly. For example, if a methicillin-susceptible strain of S. aureus (MSSA) is recovered, treatment should be changed from",
"    <a class=\"drug drug_general\" href=\"UTD.htm?41/41/42649?source=see_link\">",
"     vancomycin",
"    </a>",
"    to",
"    <a class=\"drug drug_general\" href=\"UTD.htm?8/15/8437?source=see_link\">",
"     oxacillin",
"    </a>",
"    or",
"    <a class=\"drug drug_general\" href=\"UTD.htm?1/36/1608?source=see_link\">",
"     nafcillin",
"    </a>",
"    (in children: 100 to 200",
"    <span class=\"nowrap\">",
"     mg/kg/day",
"    </span>",
"    in divided doses every six hours, maximum daily dose 12 g; in adults: 2 g IV every four hours) because these agents are more rapidly bactericidal for MSSA than vancomycin. Because these infections are often polymicrobial, broad-spectrum therapy is usually continued until anaerobic culture data are available, usually for approximately five days after collection.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H57656628\">",
"    <span class=\"h2\">",
"     Response to therapy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients should begin to show improvement within 24 to 48 hours of initiating appropriate therapy; if this does not occur, repeat imaging should be performed to search for an abscess or another indication for surgery. (See",
"    <a class=\"local\" href=\"#H6817810\">",
"     'Surgery'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6817802\">",
"    <span class=\"h2\">",
"     Duration and switch to oral therapy",
"    </span>",
"    &nbsp;&mdash;&nbsp;There have been no controlled trials to define the optimal duration of antimicrobial therapy in orbital cellulitis or when to switch from intravenous to oral treatment. For patients with uncomplicated orbital cellulitis (ie, without abscess or other complications) whose infection responds well, it is reasonable to switch to oral therapy. We generally switch to oral therapy after the patient is afebrile and the eyelid and orbital findings have begun to resolve substantially, which usually takes three to five days.",
"    <br/>",
"    <br/>",
"    If there are no definitive culture data, appropriate empiric oral regimens include:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <a class=\"drug drug_general\" href=\"UTD.htm?32/21/33104?source=see_link\">",
"       Clindamycin",
"      </a>",
"      (for adults: 300 mg every eight hours; for children: 30 to 40",
"      <span class=\"nowrap\">",
"       mg/kg",
"      </span>",
"      per day in three to four equally divided doses, not to exceed 1.8 grams per day) alone [",
"      <a class=\"abstract\" href=\"UTD.htm?11/25/11674/abstract/64\">",
"       64",
"      </a>",
"      ]. &nbsp;",
"     </li>",
"     <li>",
"      Either",
"      <a class=\"drug drug_general\" href=\"UTD.htm?32/21/33104?source=see_link\">",
"       clindamycin",
"      </a>",
"      <strong>",
"       or",
"      </strong>",
"      <a class=\"drug drug_general\" href=\"UTD.htm?4/58/5034?source=see_link\">",
"       trimethoprim-sulfamethoxazole",
"      </a>",
"      (for adults: 1 to 2 double strength tablets every 12 hours; for children: 10 to 12",
"      <span class=\"nowrap\">",
"       mg/kg",
"      </span>",
"      per day of the",
"      <a class=\"drug drug_general\" href=\"UTD.htm?25/36/26182?source=see_link\">",
"       trimethoprim",
"      </a>",
"      component divided every 12 hours)",
"      <strong>",
"       PLUS",
"      </strong>",
"      one of the following:",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      <a class=\"drug drug_general\" href=\"UTD.htm?41/10/42152?source=see_link\">",
"       Amoxicillin",
"      </a>",
"      (for adults: 875 mg orally every 12 hours; for children: 80 to 100",
"      <span class=\"nowrap\">",
"       mg/kg",
"      </span>",
"      per day in divided doses every eight hours)",
"      <strong>",
"       or",
"      </strong>",
"     </li>",
"     <li>",
"      <a class=\"drug drug_general\" href=\"UTD.htm?41/10/42152?source=see_link\">",
"       Amoxicillin",
"      </a>",
"      -clavulanic acid (for adults: 875 mg every 12 hours; for children: 45",
"      <span class=\"nowrap\">",
"       mg/kg",
"      </span>",
"      per day divided every 12 hours)",
"      <strong>",
"       or",
"      </strong>",
"     </li>",
"     <li>",
"      <a class=\"drug drug_general\" href=\"UTD.htm?26/44/27333?source=see_link\">",
"       Cefpodoxime",
"      </a>",
"      (for adults: 400 mg every 12 hours; for children: 10",
"      <span class=\"nowrap\">",
"       mg/kg",
"      </span>",
"      per day divided every 12 hours, not to exceed 200 mg per dose)",
"      <strong>",
"       or",
"      </strong>",
"     </li>",
"     <li>",
"      <a class=\"drug drug_general\" href=\"UTD.htm?5/21/5461?source=see_link\">",
"       Cefdinir",
"      </a>",
"      (for adults: 300 mg twice daily; for children: 7",
"      <span class=\"nowrap\">",
"       mg/kg",
"      </span>",
"      twice daily, not to exceed 600",
"      <span class=\"nowrap\">",
"       mg/day)",
"      </span>",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The recommendation to use",
"    <a class=\"drug drug_general\" href=\"UTD.htm?32/21/33104?source=see_link\">",
"     clindamycin",
"    </a>",
"    alone is based primarily on published susceptibility data rather than on clinical efficacy data for patients with orbital cellulitis. However, the drug has shown good efficacy for skin and soft tissue infections caused by staphylococci and streptococci [",
"    <a class=\"abstract\" href=\"UTD.htm?11/25/11674/abstract/64\">",
"     64",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?4/7/4216?source=see_link&amp;anchor=H703095#H703095\">",
"     \"Treatment of skin and soft tissue infections due to methicillin-resistant Staphylococcus aureus in adults\", section on 'Clindamycin'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?32/32/33290?source=see_link\">",
"     \"Evaluation and management of suspected methicillin-resistant Staphylococcus aureus skin and soft tissue infections in children\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    In adults and children who have serious allergies to penicillins and cephalosporins, appropriate alternatives to the agents listed above are",
"    <a class=\"drug drug_general\" href=\"UTD.htm?34/45/35536?source=see_link\">",
"     ciprofloxacin",
"    </a>",
"    or",
"    <a class=\"drug drug_general\" href=\"UTD.htm?32/46/33504?source=see_link\">",
"     levofloxacin",
"    </a>",
"    . In adults, ciprofloxacin is given at a dose of 500 to 750 mg orally twice daily and levofloxacin&nbsp;is given at a dose of 500 to 750 mg orally once daily. In children, ciprofloxacin is given at a dose of 20 to 30",
"    <span class=\"nowrap\">",
"     mg/kg",
"    </span>",
"    per day divided every 12 hours with a maximum dose of 1.5 grams orally daily. Limited information regarding levofloxacin use in pediatric patients is available. Some centers recommend a levofloxacin dose for infants &ge;6 months and children &lt;5 years of 10",
"    <span class=\"nowrap\">",
"     mg/kg",
"    </span>",
"    per dose every 12 hours, and for children &ge;5 years of 10",
"    <span class=\"nowrap\">",
"     mg/kg",
"    </span>",
"    per dose every 24 hours (maximum daily dose 500 mg). When a fluoroquinolone is used, it should be combined with",
"    <a class=\"drug drug_general\" href=\"UTD.htm?32/21/33104?source=see_link\">",
"     clindamycin",
"    </a>",
"    or",
"    <a class=\"drug drug_general\" href=\"UTD.htm?4/58/5034?source=see_link\">",
"     trimethoprim-sulfamethoxazole",
"    </a>",
"    to cover MRSA. Desensitization to a penicillin or cephalosporin or may be considered in patients with a history of an IgE-mediated (anaphylactic) reaction to these agents. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?22/46/23274?source=see_link&amp;anchor=H1969477#H1969477\">",
"     \"Allergy to penicillins\", section on 'Desensitization'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    For patients with uncomplicated orbital cellulitis, we suggest that antibiotics be continued until all signs of orbital cellulitis have resolved, and for a total of at least two to three weeks. A longer period (at least four weeks), is recommended for patients with severe ethmoid sinusitis and bony destruction of the sinus [",
"    <a class=\"abstract\" href=\"UTD.htm?11/25/11674/abstract/26,65\">",
"     26,65",
"    </a>",
"    ]. The management of the complications of orbital cellulitis is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?22/38/23145?source=see_link\">",
"     \"Septic dural sinus thrombosis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?31/43/32438?source=see_link\">",
"     \"Treatment and prognosis of brain abscess\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?16/40/17033?source=see_link\">",
"     \"Epidural abscess\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6817810\">",
"    <span class=\"h2\">",
"     Surgery",
"    </span>",
"    &nbsp;&mdash;&nbsp;The main indications for surgery are a poor response to antibiotic treatment, worsening visual acuity or pupillary changes, or evidence of an abscess, especially a large abscess (&gt;10 mm in diameter) or one that fails to respond promptly to antibiotic treatment [",
"    <a class=\"abstract\" href=\"UTD.htm?11/25/11674/abstract/66,67\">",
"     66,67",
"    </a>",
"    ]. In some cases, drainage of affected sinuses is also required to control the infection. The results of cultures and susceptibility testing from samples obtained during surgery can be used to tailor therapy.",
"    <br/>",
"    <br/>",
"    Medial subperiosteal abscesses in children often respond to medical therapy without surgery [",
"    <a class=\"abstract\" href=\"UTD.htm?11/25/11674/abstract/32,45\">",
"     32,45",
"    </a>",
"    ]. In one series of 68 children with subperiosteal abscess, only 21 (31 percent) underwent surgery [",
"    <a class=\"abstract\" href=\"UTD.htm?11/25/11674/abstract/42\">",
"     42",
"    </a>",
"    ]. Those undergoing surgery had, on average, larger abscesses (&gt;10 mm in diameter). Another study also found the volume of the abscess to be an important criterion for surgery, with volumes &lt;1250 mm",
"    <sup>",
"     3",
"    </sup>",
"    not requiring surgery [",
"    <a class=\"abstract\" href=\"UTD.htm?11/25/11674/abstract/68\">",
"     68",
"    </a>",
"    ]. In another study in children, the degree of proptosis was the only significant predictor of the need for surgical intervention [",
"    <a class=\"abstract\" href=\"UTD.htm?11/25/11674/abstract/69\">",
"     69",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    We suggest that patients with large abscesses (&gt;10 mm in diameter) be strongly considered for surgery. Patients with smaller abscesses can generally be followed clinically and with repeat imaging unless impairment of vision is a concern. If either the clinical findings or CT scan show no improvement within 24 to 48 hours, surgical drainage is generally indicated. Surgery is almost always indicated in patients with intracranial extension of the infection. Surgery may also be indicated to obtain culture material (eg, in patients with suspected fungal or mycobacterial infection of the orbit).",
"   </p>",
"   <p>",
"    External approaches (through the orbit) and endoscopic transcaruncular surgery have been employed [",
"    <a class=\"abstract\" href=\"UTD.htm?11/25/11674/abstract/70-73\">",
"     70-73",
"    </a>",
"    ]. The transcaruncular approach involves a lower eyelid transconjunctival incision extended medially around the lacrimal caruncle [",
"    <a class=\"abstract\" href=\"UTD.htm?11/25/11674/abstract/71\">",
"     71",
"    </a>",
"    ]. &nbsp;",
"   </p>",
"   <p>",
"    Sinus surgery is indicated for debridement in patients with severe, destructive rhinosinusitis.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H44184571\">",
"    <span class=\"h1\">",
"     OUTCOMES",
"    </span>",
"    &nbsp;&mdash;&nbsp;The outcomes of orbital cellulitis depend on whether complications are present. The majority of patients with orbital cellulitis respond rapidly and completely to appropriate therapy. The most serious complications are cavernous sinus thrombosis, intracranial extension, and vision loss, which can lead to permanent sequelae and, in the case of complications in the former two, death. These complications are rare. (See",
"    <a class=\"local\" href=\"#H459379581\">",
"     'Complications'",
"    </a>",
"    above.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Basics topics (see",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?23/37/24145?source=see_link\">",
"       \"Patient information: Orbital cellulitis (The Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Orbital cellulitis is an infection involving the contents of the orbit (fat and ocular muscles). Preseptal cellulitis and orbital cellulitis involve different anatomic sites, with preseptal cellulitis referring to infections of the soft tissues anterior to the orbital septum and orbital cellulitis referring to infections posterior to it (",
"    <a class=\"graphic graphic_figure graphicRef68971 \" href=\"UTD.htm?18/7/18550\">",
"     figure 1",
"    </a>",
"    ). Although the two entities may initially be confused with one another, it is important to distinguish between them because they have very different clinical implications. Preseptal cellulitis is generally a mild condition that rarely leads to serious complications, whereas orbital cellulitis may cause loss of vision and even loss of life. Orbital cellulitis can usually be distinguished from preseptal cellulitis by its clinical features (ophthalmoplegia, pain with eye movements, and proptosis) and by imaging studies; in cases in which the distinction is not clear, clinicians should treat patients as though they have orbital cellulitis. Both conditions are more common in children than in adults. (See",
"    <a class=\"local\" href=\"#H1\">",
"     'Introduction'",
"    </a>",
"    above and",
"    <a class=\"local\" href=\"#H2\">",
"     'Terminology'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The most common underlying factor that leads to orbital cellulitis is acute sinusitis, particularly ethmoid sinusitis; less common causes are ophthalmic surgery and orbital trauma. (See",
"      <a class=\"local\" href=\"#H459379483\">",
"       'Epidemiology and pathogenesis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Orbital cellulitis is often a polymicrobial infection. The most commonly identified pathogens in orbital cellulitis are Staphylococcus aureus and streptococci (",
"      <a class=\"graphic graphic_table graphicRef77104 \" href=\"UTD.htm?35/15/36094\">",
"       table 1",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H459379521\">",
"       'Microbiology'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The diagnosis of orbital cellulitis is suspected clinically and can be confirmed by contrast-enhanced computed tomography (CT) scanning of the orbits and sinuses. During the initial evaluation, it is critical to distinguish preseptal cellulitis from the more serious orbital cellulitis (",
"      <a class=\"graphic graphic_table graphicRef55123 \" href=\"UTD.htm?28/42/29356\">",
"       table 3",
"      </a>",
"      and",
"      <a class=\"graphic graphic_table graphicRef62818 \" href=\"UTD.htm?5/36/5711\">",
"       table 2",
"      </a>",
"      ). It is also important to evaluate for complications of orbital cellulitis, such as subperiosteal abscess, orbital abscess, visual loss, and intracranial extension. Although both preseptal cellulitis and orbital cellulitis typically cause eyelid swelling with or without erythema, features such as ophthalmoplegia, pain with eye movements,",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      proptosis occur only with orbital cellulitis. (See",
"      <a class=\"local\" href=\"#H14\">",
"       'Clinical manifestations'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H19539607\">",
"       'Diagnosis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The diagnosis of orbital cellulitis is made by a combination of physical examination findings (including formal assessments of extraocular movements, visual acuity, and proptosis), and radiologic assessment with CT scanning. (See",
"      <a class=\"local\" href=\"#H19539607\">",
"       'Diagnosis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      We recommend that patients with suspected orbital cellulitis with any of the following features undergo a contrast-enhanced CT scan of the orbits and sinuses to confirm the diagnosis of orbital cellulitis and detect potential complications:",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Proptosis",
"     </li>",
"     <li>",
"      Limitation of eye movements",
"     </li>",
"     <li>",
"      Pain with eye movements",
"     </li>",
"     <li>",
"      Double vision",
"     </li>",
"     <li>",
"      Vision loss",
"     </li>",
"     <li>",
"      Edema extending beyond the eyelid margin",
"     </li>",
"     <li>",
"      Absolute neutrophil count (ANC) &gt;10,000",
"      <span class=\"nowrap\">",
"       cell/microL",
"      </span>",
"     </li>",
"     <li>",
"      Signs or symptoms of central nervous system (CNS) involvement",
"     </li>",
"     <li>",
"      Inability to examine the patient fully (usually patients less than one year of age)",
"     </li>",
"     <li>",
"      Patients who do not begin to show improvement within 24 to 48 hours of initiating appropriate therapy (see",
"      <a class=\"local\" href=\"#H194021498\">",
"       'Indications for imaging'",
"      </a>",
"      above)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Complications of orbital cellulitis may develop rapidly and include subperiosteal and orbital abscesses, extension to the orbital apex causing vision loss, or intracranial extension causing epidural abscess or subdural empyema, intracranial abscess, meningitis, or cavernous sinus thrombosis. (See",
"      <a class=\"local\" href=\"#H459379581\">",
"       'Complications'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      For patients with orbital cellulitis, we suggest initial empiric antibiotic treatment with parenteral broad-spectrum therapy with activity against S. aureus (including methicillin-resistant S. aureus [MRSA]), streptococci, and gram-negative bacilli; this should include",
"      <a class=\"drug drug_general\" href=\"UTD.htm?41/41/42649?source=see_link\">",
"       vancomycin",
"      </a>",
"      <strong>",
"       plus",
"      </strong>",
"      one of the following:",
"      <a class=\"drug drug_general\" href=\"UTD.htm?1/8/1160?source=see_link\">",
"       ampicillin-sulbactam",
"      </a>",
"      ,",
"      <a class=\"drug drug_general\" href=\"UTD.htm?23/41/24216?source=see_link\">",
"       piperacillin-tazobactam",
"      </a>",
"      ,",
"      <a class=\"drug drug_general\" href=\"UTD.htm?10/17/10521?source=see_link\">",
"       ceftriaxone",
"      </a>",
"      , or",
"      <a class=\"drug drug_general\" href=\"UTD.htm?34/57/35735?source=see_link\">",
"       cefotaxime",
"      </a>",
"      (",
"      <a class=\"grade\" href=\"._grade_5?title=Grade 2B\">",
"       Grade 2B",
"      </a>",
"      ). If ceftriaxone or cefotaxime is employed and there is concern for intracranial extension, we suggest that",
"      <a class=\"drug drug_general\" href=\"UTD.htm?19/38/20065?source=see_link\">",
"       metronidazole",
"      </a>",
"      be added to the regimen to cover anaerobes (",
"      <a class=\"grade\" href=\"._grade_5?title=Grade 2B\">",
"       Grade 2B",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H6817758\">",
"       'Antibiotic regimens'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Signs and symptoms should begin to show improvement within 24 to 48 hours following the initiation of appropriate therapy; if this does not occur, repeat imaging should be performed and surgery should be considered. (See",
"      <a class=\"local\" href=\"#H57656628\">",
"       'Response to therapy'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      For patients with uncomplicated orbital cellulitis, we suggest that antibiotics be continued until all signs of orbital cellulitis have resolved, and for a total of at least two to three weeks (including both intravenous and oral therapy). A longer period (at least four weeks) is recommended for patients with severe ethmoid sinusitis and bony destruction of the sinus. The management of the complications of orbital cellulitis is discussed separately. &nbsp;(See",
"      <a class=\"local\" href=\"#H6817802\">",
"       'Duration and switch to oral therapy'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Although initial treatment may consist of intravenous antibiotics alone, management should be in consultation with an ophthalmologist and an otolaryngologist because the physical examination requires ophthalmic",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      otolaryngologic expertise and surgery is sometimes required. The main indications for surgery are a poor response of the infection to antibiotic treatment, worsening visual acuity or pupillary changes, or evidence of an abscess, especially a large abscess (&gt;10 mm in diameter) or one that fails to respond promptly to antibiotic treatment. (See",
"      <a class=\"local\" href=\"#H6817810\">",
"       'Surgery'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/25/11674/abstract/1\">",
"      Zhang J, Stringer MD. Ophthalmic and facial veins are not valveless. Clin Experiment Ophthalmol 2010; 38:502.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/25/11674/abstract/2\">",
"      Botting AM, McIntosh D, Mahadevan M. Paediatric pre- and post-septal peri-orbital infections are different diseases. A retrospective review of 262 cases. Int J Pediatr Otorhinolaryngol 2008; 72:377.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/25/11674/abstract/3\">",
"      Seltz LB, Smith J, Durairaj VD, et al. Microbiology and antibiotic management of orbital cellulitis. Pediatrics 2011; 127:e566.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/25/11674/abstract/4\">",
"      Nageswaran S, Woods CR, Benjamin DK Jr, et al. Orbital cellulitis in children. Pediatr Infect Dis J 2006; 25:695.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/25/11674/abstract/5\">",
"      Sobol SE, Marchand J, Tewfik TL, et al. Orbital complications of sinusitis in children. J Otolaryngol 2002; 31:131.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/25/11674/abstract/6\">",
"      Weakley DR. Orbital cellulitis complicating strabismus surgery: a case report and review of the literature. Ann Ophthalmol 1991; 23:454.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/25/11674/abstract/7\">",
"      Allen MV, Cohen KL, Grimson BS. Orbital cellulitis secondary to dacryocystitis following blepharoplasty. Ann Ophthalmol 1985; 17:498.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/25/11674/abstract/8\">",
"      McLeod SD, Flowers CW, Lopez PF, et al. Endophthalmitis and orbital cellulitis after radial keratotomy. Ophthalmology 1995; 102:1902.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/25/11674/abstract/9\">",
"      Varma D, Metcalfe TW. Orbital cellulitis after peribulbar anaesthesia for cataract surgery. Eye (Lond) 2003; 17:105.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/25/11674/abstract/10\">",
"      Hofbauer JD, Gordon LK, Palmer J. Acute orbital cellulitis after peribulbar injection. Am J Ophthalmol 1994; 118:391.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/25/11674/abstract/11\">",
"      Malik NN, Goh D, McLean C, Huchzermeyer P. Orbital cellulitis caused by Peptostreptococcus. Eye (Lond) 2004; 18:643.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/25/11674/abstract/12\">",
"      Chaudhry IA, Shamsi FA, Elzaridi E, et al. Outcome of treated orbital cellulitis in a tertiary eye care center in the middle East. Ophthalmology 2007; 114:345.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/25/11674/abstract/13\">",
"      Schmitt NJ, Beatty RL, Kennerdell JS. Superior ophthalmic vein thrombosis in a patient with dacryocystitis-induced orbital cellulitis. Ophthal Plast Reconstr Surg 2005; 21:387.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/25/11674/abstract/14\">",
"      Ataullah S, Sloan B. Acute dacryocystitis presenting as an orbital abscess. Clin Experiment Ophthalmol 2002; 30:44.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/25/11674/abstract/15\">",
"      Allan BP, Egbert MA, Myall RW. Orbital abscess of odontogenic origin. Case report and review of the literature. Int J Oral Maxillofac Surg 1991; 20:268.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/25/11674/abstract/16\">",
"      Rubinstein JB, Handler SD. Orbital and periorbital cellulitis in children. Head Neck Surg 1982; 5:15.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/25/11674/abstract/17\">",
"      Weber AL, Mikulis DK. Inflammatory disorders of the paraorbital sinuses and their complications. Radiol Clin North Am 1987; 25:615.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/25/11674/abstract/18\">",
"      Goytia VK, Giannoni CM, Edwards MS. Intraorbital and intracranial extension of sinusitis: comparative morbidity. J Pediatr 2011; 158:486.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/25/11674/abstract/19\">",
"      Uzc&aacute;tegui N, Warman R, Smith A, Howard CW. Clinical practice guidelines for the management of orbital cellulitis. J Pediatr Ophthalmol Strabismus 1998; 35:73.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/25/11674/abstract/20\">",
"      Schramm VL Jr, Curtin HD, Kennerdell JS. Evaluation of orbital cellulitis and results of treatment. Laryngoscope 1982; 92:732.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/25/11674/abstract/21\">",
"      Swift AC, Charlton G. Sinusitis and the acute orbit in children. J Laryngol Otol 1990; 104:213.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/25/11674/abstract/22\">",
"      Mills R. Orbital and periorbital sepsis. J Laryngol Otol 1987; 101:1242.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/25/11674/abstract/23\">",
"      Dudin A, Othman A. Acute periorbital swelling: evaluation of management protocol. Pediatr Emerg Care 1996; 12:16.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/25/11674/abstract/24\">",
"      McKinley SH, Yen MT, Miller AM, Yen KG. Microbiology of pediatric orbital cellulitis. Am J Ophthalmol 2007; 144:497.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/25/11674/abstract/25\">",
"      Kobayashi D, Givner LB, Yeatts RP, et al. Infantile orbital cellulitis secondary to community-associated methicillin-resistant Staphylococcus aureus. J AAPOS 2011; 15:208.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/25/11674/abstract/26\">",
"      Starkey CR, Steele RW. Medical management of orbital cellulitis. Pediatr Infect Dis J 2001; 20:1002.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/25/11674/abstract/27\">",
"      Chou SY, Tsai CC, Kau SC, et al. Aeromonas hydrophila orbital cellulitis in a patient with myelodysplastic syndrome. J Chin Med Assoc 2004; 67:51.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/25/11674/abstract/28\">",
"      Maccheron LJ, Groeneveld ER, Ohlrich SJ, et al. Orbital cellulitis, panophthalmitis, and ecthyma gangrenosum in an immunocompromised host with pseudomonas septicemia. Am J Ophthalmol 2004; 137:176.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/25/11674/abstract/29\">",
"      Hemady R, Zimmerman A, Katzen BW, Karesh JW. Orbital cellulitis caused by Eikenella corrodens. Am J Ophthalmol 1992; 114:584.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/25/11674/abstract/30\">",
"      Ambati BK, Ambati J, Azar N, et al. Periorbital and orbital cellulitis before and after the advent of Haemophilus influenzae type B vaccination. Ophthalmology 2000; 107:1450.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/25/11674/abstract/31\">",
"      Barone SR, Aiuto LT. Periorbital and orbital cellulitis in the Haemophilus influenzae vaccine era. J Pediatr Ophthalmol Strabismus 1997; 34:293.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/25/11674/abstract/32\">",
"      Harris GJ. Subperiosteal abscess of the orbit. Age as a factor in the bacteriology and response to treatment. Ophthalmology 1994; 101:585.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/25/11674/abstract/33\">",
"      Brook I, Frazier EH. Microbiology of subperiosteal orbital abscess and associated maxillary sinusitis. Laryngoscope 1996; 106:1010.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/25/11674/abstract/34\">",
"      Chawla B, Sharma S, Kashyap S, et al. Primary orbital mycosis in immunocompetent infants. J AAPOS 2011; 15:211.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/25/11674/abstract/35\">",
"      Jones J, Katz SE, Lubow M. Scedosporium apiospermum of the orbit. Arch Ophthalmol 1999; 117:272.",
"     </a>",
"    </li>",
"    <li>",
"     Durand, ML. Periocular infections. In: Principles and Practice of Infectious Diseases, 7th ed, Mandell, GL, Bennett, et al.  (Eds), Churchill Livingstone Elsevier, Philadelphia 2010. p.1569.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/25/11674/abstract/37\">",
"      Rudloe TF, Harper MB, Prabhu SP, et al. Acute periorbital infections: who needs emergent imaging? Pediatrics 2010; 125:e719.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/25/11674/abstract/38\">",
"      Patt BS, Manning SC. Blindness resulting from orbital complications of sinusitis. Otolaryngol Head Neck Surg 1991; 104:789.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/25/11674/abstract/39\">",
"      Osguthorpe JD, Hochman M. Inflammatory sinus diseases affecting the orbit. Otolaryngol Clin North Am 1993; 26:657.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/25/11674/abstract/40\">",
"      Okamoto Y, Hiraoka T, Okamoto F, Oshika T. A case of subperiosteal abscess of the orbit with central retinal artery occlusion. Eur J Ophthalmol 2009; 19:288.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/25/11674/abstract/41\">",
"      Komolafe OO, Ashaye AO. Combined central retinal artery and vein occlusion complicating orbital cellulitis. Niger J Clin Pract 2008; 11:74.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/25/11674/abstract/42\">",
"      Ryan JT, Preciado DA, Bauman N, et al. Management of pediatric orbital cellulitis in patients with radiographic findings of subperiosteal abscess. Otolaryngol Head Neck Surg 2009; 140:907.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/25/11674/abstract/43\">",
"      Harris GJ. Age as a factor in the bacteriology and response to treatment of subperiosteal abscess of the orbit. Trans Am Ophthalmol Soc 1993; 91:441.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/25/11674/abstract/44\">",
"      Filips RF, Liudahl JJ. Asymptomatic posterior orbital cellulitis resulting from ethmoid/maxillary sinusitis. J Am Optom Assoc 1997; 68:55.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/25/11674/abstract/45\">",
"      Greenberg MF, Pollard ZF. Medical treatment of pediatric subperiosteal orbital abscess secondary to sinusitis. J AAPOS 1998; 2:351.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/25/11674/abstract/46\">",
"      Bergin DJ, Wright JE. Orbital cellulitis. Br J Ophthalmol 1986; 70:174.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/25/11674/abstract/47\">",
"      Reynolds DJ, Kodsi SR, Rubin SE, Rodgers IR. Intracranial infection associated with preseptal and orbital cellulitis in the pediatric patient. J AAPOS 2003; 7:413.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/25/11674/abstract/48\">",
"      Russo G, Di Pietro M, La Spina M. Ocular involvement in neuroblastoma: not always metastasis. Lancet Oncol 2004; 5:324.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/25/11674/abstract/49\">",
"      Shields CL, Shields JA, Honavar SG, Demirci H. Primary ophthalmic rhabdomyosarcoma in 33 patients. Trans Am Ophthalmol Soc 2001; 99:133.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/25/11674/abstract/50\">",
"      Jacobs D, Galetta S. Diagnosis and management of orbital pseudotumor. Curr Opin Ophthalmol 2002; 13:347.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/25/11674/abstract/51\">",
"      Sirbaugh PE. A case of orbital pseudotumor masquerading as orbital cellulitis in a patient with proptosis and fever. Pediatr Emerg Care 1997; 13:337.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/25/11674/abstract/52\">",
"      Rubinstein A, Riddell CE. Posterior scleritis mimicking orbital cellulitis. Eye (Lond) 2005; 19:1232.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/25/11674/abstract/53\">",
"      Abou-Rayyah Y, Rose GE, Konrad H, et al. Clinical, radiological and pathological examination of periocular dermoid cysts: evidence of inflammation from an early age. Eye (Lond) 2002; 16:507.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/25/11674/abstract/54\">",
"      Ziakas NG, Boboridis K, Gratsonidis A, et al. Wegener's granulomatosis of the orbit in a 5-year-old child. Eye (Lond) 2004; 18:658.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/25/11674/abstract/55\">",
"      Youssef Z, Pennefather PM, Watts MT. Orbital cellulitis vs allergic reaction to hyaluronidase as the cause of periorbital oedema. Eye (Lond) 2005; 19:691.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/25/11674/abstract/56\">",
"      Patil B, Agius-Fernandez A, Worstmann T. Hyaluronidase allergy after peribulbar anesthesia with orbital inflammation. J Cataract Refract Surg 2005; 31:1480.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/25/11674/abstract/57\">",
"      Hegde V, Smith G, Choi J, Pagliarini S. A case of gonococcal kerato-conjunctivitis mimicking orbital cellulitis. Acta Ophthalmol Scand 2005; 83:511.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/25/11674/abstract/58\">",
"      Ruttum MS, Ogawa G. Adenovirus conjunctivitis mimics preseptal and orbital cellulitis in young children. Pediatr Infect Dis J 1996; 15:266.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/25/11674/abstract/59\">",
"      Eustis HS, Mafee MF, Walton C, Mondonca J. MR imaging and CT of orbital infections and complications in acute rhinosinusitis. Radiol Clin North Am 1998; 36:1165.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/25/11674/abstract/60\">",
"      Howe L, Jones NS. Guidelines for the management of periorbital cellulitis/abscess. Clin Otolaryngol Allied Sci 2004; 29:725.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/25/11674/abstract/61\">",
"      Mair MH, Geley T, Judmaier W, Gassner I. Using orbital sonography to diagnose and monitor treatment of acute swelling of the eyelids in pediatric patients. AJR Am J Roentgenol 2002; 179:1529.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/25/11674/abstract/62\">",
"      Mahalingam-Dhingra A, Lander L, Preciado DA, et al. Orbital and periorbital infections: a national perspective. Arch Otolaryngol Head Neck Surg 2011; 137:769.",
"     </a>",
"    </li>",
"    <li>",
"     Zyvox (linezolid) prescribing information. Pharmacia &amp; Upjohn Company. Revised June 2010. file://www.pfizer.com/files/products/uspi_zyvox.pdf (Accessed on August 19, 2011).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/25/11674/abstract/64\">",
"      Liu C, Bayer A, Cosgrove SE, et al. Clinical practice guidelines by the infectious diseases society of america for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children. Clin Infect Dis 2011; 52:e18.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/25/11674/abstract/65\">",
"      Givner LB. Periorbital versus orbital cellulitis. Pediatr Infect Dis J 2002; 21:1157.",
"     </a>",
"    </li>",
"    <li>",
"     Nelson LB, Olitsky SE. Disorders of the orbit. In: Harley's Pediatric Ophthalmology, Lippincott Williams and Wilkins, Philadelphia 2005. p.389.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/25/11674/abstract/67\">",
"      Youssef OH, Stefanyszyn MA, Bilyk JR. Odontogenic orbital cellulitis. Ophthal Plast Reconstr Surg 2008; 24:29.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/25/11674/abstract/68\">",
"      Todman MS, Enzer YR. Medical management versus surgical intervention of pediatric orbital cellulitis: the importance of subperiosteal abscess volume as a new criterion. Ophthal Plast Reconstr Surg 2011; 27:255.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/25/11674/abstract/69\">",
"      Rahbar R, Robson CD, Petersen RA, et al. Management of orbital subperiosteal abscess in children. Arch Otolaryngol Head Neck Surg 2001; 127:281.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/25/11674/abstract/70\">",
"      Arjmand EM, Lusk RP, Muntz HR. Pediatric sinusitis and subperiosteal orbital abscess formation: diagnosis and treatment. Otolaryngol Head Neck Surg 1993; 109:886.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/25/11674/abstract/71\">",
"      Pelton RW, Smith ME, Patel BC, Kelly SM. Cosmetic considerations in surgery for orbital subperiosteal abscess in children: experience with a combined transcaruncular and transnasal endoscopic approach. Arch Otolaryngol Head Neck Surg 2003; 129:652.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/25/11674/abstract/72\">",
"      Younis RT, Lazar RH, Bustillo A, Anand VK. Orbital infection as a complication of sinusitis: are diagnostic and treatment trends changing? Ear Nose Throat J 2002; 81:771.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/25/11674/abstract/73\">",
"      Tanna N, Preciado DA, Clary MS, Choi SS. Surgical treatment of subperiosteal orbital abscess. Arch Otolaryngol Head Neck Surg 2008; 134:764.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 3414 Version 10.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0604-115.66.252.144-EC2EE36D8B-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f11_25_11674=[""].join("\n");
var outline_f11_25_11674=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H26\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      TERMINOLOGY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H459379838\">",
"      ANATOMY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H459379483\">",
"      EPIDEMIOLOGY AND PATHOGENESIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H459379521\">",
"      MICROBIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H147596960\">",
"      Bacteria",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H147596967\">",
"      Fungi and mycobacteria",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      CLINICAL MANIFESTATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H459379581\">",
"      COMPLICATIONS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H459379606\">",
"      Subperiosteal abscess",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H459379613\">",
"      Orbital abscess",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H459379620\">",
"      Extraorbital extension",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H194021169\">",
"      DIFFERENTIAL DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H19539607\">",
"      DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H459379685\">",
"      Imaging studies",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H194021484\">",
"      - Imaging modalities",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H194021491\">",
"      - Imaging findings",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H194021498\">",
"      - Indications for imaging",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H19539755\">",
"      Microbiologic studies",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H24\">",
"      TREATMENT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6817758\">",
"      Antibiotic regimens",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H57656628\">",
"      Response to therapy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6817802\">",
"      Duration and switch to oral therapy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6817810\">",
"      Surgery",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H44184571\">",
"      OUTCOMES",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H26\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"ID/3414\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ID/3414|DiagnosticImage\">",
"      <a href=\"#\" title=\"DIAGNOSTIC IMAGES\">",
"       DIAGNOSTIC IMAGES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?32/43/33461\" title=\"diagnostic image 1\">",
"      Subperiosteal abscess CT",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ID/3414|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?18/7/18550\" title=\"figure 1\">",
"      The orbital septum",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?20/4/20547\" title=\"figure 2\">",
"      Exposed medial wall of orbit",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?0/51/821\" title=\"figure 3\">",
"      Orbital venous drainage",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ID/3414|PIC\">",
"      <a href=\"#\" title=\"PICTURES\">",
"       PICTURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?9/28/9670\" title=\"picture 1\">",
"      Orbital cellulitis photo",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ID/3414|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?35/15/36094\" title=\"table 1\">",
"      Microbiology of preseptal and orbital cellulitis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?5/36/5711\" title=\"table 2\">",
"      Preseptal and orbital cellulitis studies",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?28/42/29356\" title=\"table 3\">",
"      Clinical features of preseptal and orbital cellulitis",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?11/0/11273?source=related_link\">",
"      Acute bacterial rhinosinusitis in children: Clinical features and diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?38/48/39688?source=related_link\">",
"      Acute sinusitis and rhinosinusitis in adults: Clinical manifestations and diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?22/46/23274?source=related_link\">",
"      Allergy to penicillins",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?24/18/24873?source=related_link\">",
"      Bacterial endophthalmitis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?3/50/3882?source=related_link\">",
"      Central and branch retinal artery occlusion",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?2/20/2378?source=related_link\">",
"      Clinical manifestations of varicella-zoster virus infection: Herpes zoster",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?33/51/34616?source=related_link\">",
"      Epidemiology and clinical manifestations of invasive aspergillosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?16/40/17033?source=related_link\">",
"      Epidural abscess",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?7/26/7594?source=related_link\">",
"      Etiology, clinical features, and diagnosis of cerebral venous thrombosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?32/32/33290?source=related_link\">",
"      Evaluation and management of suspected methicillin-resistant Staphylococcus aureus skin and soft tissue infections in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?8/36/8775?source=related_link\">",
"      Fungal rhinosinusitis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?33/12/33992?source=related_link\">",
"      Herpes simplex keratitis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?6/46/6890?source=related_link\">",
"      Mucormycosis (zygomycosis)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?28/42/29350?source=related_link\">",
"      Nasolacrimal duct obstruction (dacryostenosis) in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?23/37/24145?source=related_link\">",
"      Patient information: Orbital cellulitis (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?27/6/27751?source=related_link\">",
"      Preseptal cellulitis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?22/38/23145?source=related_link\">",
"      Septic dural sinus thrombosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?23/28/24006?source=related_link\">",
"      Tolosa-Hunt syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?31/43/32438?source=related_link\">",
"      Treatment and prognosis of brain abscess",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?38/12/39112?source=related_link\">",
"      Treatment of endogenous endophthalmitis due to Candida species",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?2/55/2937?source=related_link\">",
"      Treatment of endophthalmitis due to molds",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?35/16/36102?source=related_link\">",
"      Treatment of exogenous endophthalmitis due to Candida species",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?4/7/4216?source=related_link\">",
"      Treatment of skin and soft tissue infections due to methicillin-resistant Staphylococcus aureus in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?5/40/5767?source=related_link\">",
"      Tuberculosis and the eye",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f11_25_11675="Chest radiograph findings in vascular rings";
var content_f11_25_11675=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PULM%2F51295&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PULM%2F51295&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Chest radiograph findings in vascular rings",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Lateral",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Anterior tracheal bowing (92 percent)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Retrotracheal opacity (79 percent)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Tracheal narrowing (77 percent)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        All the above (62 percent)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Frontal",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Right aortic arch (85 percent)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Distal tracheal indentation (73 percent)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Right descending aorta (66 percent)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        All the above (49 percent)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Normal (10 percent)",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Data from: Pickhardt PJ, Siegel MJ, Gutierrez FR. Radiology 1997; 203:423.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f11_25_11675=[""].join("\n");
var outline_f11_25_11675=null;
var title_f11_25_11676="NIDA rx drug abusers ciminal justice";
var content_f11_25_11676=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PC%2F54669&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=4\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PC%2F54669&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=4\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    NIDA principles of treatment for drug abusers in the criminal justice system",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td>",
"        Drug addiction is a brain disease that affects behavior",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Recovery from drug addiction requires effective treatment, followed by management of the problem over time",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Treatment must last long enough to produce stable behavioral change",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Assessment is the first step in treatment",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Tailoring services to fit the needs of the individual is an important part of effective drug abuse treatment for criminal justice populations",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Drug use during treatment should be carefully monitored",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Treatment should target factors that are associated with criminal behavior",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Criminal justice supervision should incorporate treatment planning for drug abusing offenders, and treatment providers should be aware of correctional supervision requirements",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Continuity of care is essential for drug abusers re-entering the community",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        A balance of rewards and sanctions encourages prosocial behavior and treatment participation",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Offenders with co-occurring drug abuse and mental health problems often require an integrated treatment approach",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Medications are an important part of treatment for many drug abusing offenders",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Treatment planning for drug abusing offenders who are living in or re-entering the community should include strategies to prevent and treat serious, chronic medical conditions, such as HIV/AIDS, hepatitis B and C, and tuberculosis",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     NIDA: National Institute on Drug Abuse.",
"    </div>",
"    <div class=\"reference\">",
"     Information from: National Institute on Drug Abuse. InfoFacts: Treatment for Drug Abusers in the Criminal Justice System. National Institutes of Health 2006. Available at:",
"     <a href=\"file://www.drugabuse.gov/publications/infofacts/treatment-drug-abusers-in-criminal-justice-system\" target=\"_blank\">",
"      file://www.drugabuse.gov/publications/infofacts/treatment-drug-abusers-in-criminal-justice-system",
"     </a>",
"     (Accessed on January 18, 2012).",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f11_25_11676=[""].join("\n");
var outline_f11_25_11676=null;
var title_f11_25_11677="DDx Leukocoria";
var content_f11_25_11677=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F73809&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F73809&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Differential diagnosis of leukocoria",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\" class=\"container\">",
"     <tbody>",
"      <tr>",
"       <td class=\"container\">",
"        <table cellspacing=\"0\">",
"         <tbody>",
"          <tr>",
"           <td class=\"subtitle1_single\">",
"            Lens abnormalities",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Cataract (congenital or acquired)",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Posterior lenticonus",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"subtitle1_single\">",
"            Vitreous hemorrhage",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Ocular trauma (especially penetrating)",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"subtitle1_single\">",
"            Retinal detachment",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Ocular trauma",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Nonaccidental trauma (abusive head trauma)",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Norrie disease",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Incontinentia pigmenti",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Cutis marmorata telangiectatica",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Turner syndrome",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Walker-Warburg syndrome",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Stickler syndrome",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Familial exudative vitreoretinopathy",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Retinopathy of prematurity",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"subtitle1_single\">",
"            Other retinal abnormalities",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Coats disease",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Persistent hyperplastic primary vitreous (persistent fetal vasculature)",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Congenital retinoschisis",
"           </td>",
"          </tr>",
"         </tbody>",
"        </table>",
"       </td>",
"       <td class=\"container\">",
"        <table cellspacing=\"0\">",
"         <tbody>",
"          <tr>",
"           <td class=\"subtitle1_single\">",
"            Optic disc abnormalities",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Colobomata of choroid and optic disc",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Morning glory disc anomaly",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Myelinated nerve fibers",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"subtitle1_single\">",
"            Intraocular inflammation/infection",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Juvenile idiopathic arthritis",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Sarcoidosis",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Cytomegalovirus",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Toxoplasmosis",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Ocular toxocariasis",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Endophthalmitis",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"subtitle1_single\">",
"            Tumors",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Retinoblastoma",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Leukemia (with ocular involvement)",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Choroidal melanoma",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Metastatic tumors",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Choroidal osteoma",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Medulloepithelioma (\"diktyoma\")",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Combined hamartoma of the retina and the retinal pigment epithelium",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Choroidal hemangioma",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Benign astrocytic hamartomas in tuberous sclerosis",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Glioma of the optic nerve head",
"           </td>",
"          </tr>",
"         </tbody>",
"        </table>",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f11_25_11677=[""].join("\n");
var outline_f11_25_11677=null;
var title_f11_25_11678="Testosterone LH FSH in MI";
var content_f11_25_11678=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ENDO%2F70755&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ENDO%2F70755&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Serum testosterone and gonadotropin concentrations fall in acute MI",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 383px; height: 266px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Changes in the serum concentrations of testosterone (blue dashed line), luteinizing hormone (LH) (green dashed line), and follicle-stimulating hormone (FSH) (red solid line) throughout hospitalization in a representative 43-year-old man with an acute myocardial infarction. All three hormones decreased acutely and then returned to baseline levels during recovery. The dotted horizontal line indicates the lower limit of the normal range for testosterone. The day of transfer from the intensive care unit to the general medical unit is noted. To convert serum testosterone values to ng/dL, divide by 0.0347.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Redrawn from Spratt, DI, Cox, P, Orav, J, et al, J Clin Endocrinol Metab 1993; 76:1548.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f11_25_11678=[""].join("\n");
var outline_f11_25_11678=null;
var title_f11_25_11679="Cutaneous lichen amyloid general view";
var content_f11_25_11679=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ENDO%2F65753&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ENDO%2F65753&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 488px\">",
"   <div class=\"ttl\">",
"    Cutaneous lichen amyloidosis in a patient with MEN2: General view",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 468px; height: 323px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    The skin lesion is usually described as pruritic, scaly, papular, pigmented, and located in the interscapular region or on the extensor surfaces of the extremities. Amyloid deposition has been documented histologically.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of: Cornelis J Lips, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f11_25_11679=[""].join("\n");
var outline_f11_25_11679=null;
